Harvard Bioscience (HBIO) 10-K 17 Mar 17 2016 FY Annual report Financial data

Document and Entity Information

Document and Entity Information - USD ($)	12 Months Ended
	Dec. 31, 2016	Mar. 07, 2017	Jun. 30, 2016
Document And Entity Information [Abstract]
Document Type	10-K
Document period end date	Dec. 31, 2016
Amendment flag	false
Document Period Focus	FY
Document Fiscal Year Focus	2,016
Current fiscal year end date	--12-31
Entity central index key	1,123,494
Entity current reporting status	Yes
Entity filer category	Accelerated Filer
Entity registrant name	HARVARD BIOSCIENCE INC
Entity voluntary filers	No
Entity well known seasoned issuer	No
Entity common stock shares outstanding		34,582,588
Entity public float			$ 89,715,296
Non Affiliate Share Holding			31,368,985
Trading Symbol	HBIO

Statements of Financial Positio

Statements of Financial Position - USD ($) $ in Thousands	Dec. 31, 2016	Dec. 31, 2015
Current Assets:
Cash and cash equivalents	$ 5,596	$ 6,744
Accounts receivable, net of allowance for doubtful accounts of $611 and $310, respectively	15,746	17,547
Inventories	19,955	22,343
Deferred income tax assets - current	0	42
Other receivables and other assets	4,175	3,873
Total current assets	45,472	50,549
Property, plant and equipment, net	4,296	5,902
Deferred income tax assets - non-current	1,157	995
Amortizable intangible assets, net	17,471	20,872
Goodwill	38,032	40,357
Other indefinite lived intangible assets	1,209	1,223
Other assets	128	152
Total Assets	107,765	120,050
Current liabilities:
Current portion, long-term debt	2,372	2,364
Accounts payable	6,196	8,782
Deferred revenue	500	752
Accrued income taxes payable	223	290
Deferred income tax liabilities - current	0	2,246
Accrued expenses	4,550	4,021
Other liabilities - current	760	868
Total current liabilities	14,601	19,323
Long-term debt	11,374	16,369
Deferred income tax liabilities - non-current	6,417	3,775
Other liabilities- non current	3,177	2,985
Total liabilities	35,569	42,452
Stockholders Equity Abstract
Preferred stock, par value $0.01 per share, 5,000,000 shares authorized	0	0
Common stock, par value $0.01 per share, 80,000,000 shares authorized; 42,186,827 and 41,724,772 shares issued and 34,441,320 and 33,979,265 shares outstanding, respectively	418	416
Additional paid-in-capital	215,134	211,457
Accumulated deficit	(116,030)	(111,723)
Accumulated other comprehensive loss	(16,658)	(11,884)
Treasury stock at cost, 7,745,507 common shares	(10,668)	(10,668)
Total stockholders' equity	72,196	77,598
Total liabilities and stockholders' equity	$ 107,765	$ 120,050

Statements of Financial Positi3

Statements of Financial Position (Parentheticals) - USD ($) $ in Thousands	Dec. 31, 2016	Dec. 31, 2015
CONSOLIDATED BALANCE SHEETS
Allowance for doubtful accounts	$ 611	$ 310
Preferred Stock Par value	$ 0.01	$ 0.01
Preferred Stock - Shares Authorized	5,000,000	5,000,000
Common stock par value	$ 0.01	$ 0.01
Common Stock- Shares Authorized	80,000,000	80,000,000
Common Stock- Shares Issued	42,186,827	41,724,772
Common Stock- Shares Outstanding	34,441,320	33,979,265
Treasury Stock common shares	7,745,507	7,745,507

Statements of Operations

Statements of Operations - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2016	Dec. 31, 2015	Dec. 31, 2014
CONSOLIDATED STATEMENTS OF OPERATIONS
Revenues	$ 104,521	$ 108,664	$ 108,663
Cost of revenues (exclusive of items shown separately below)	56,106	59,941	59,319
Gross profit	48,415	48,723	49,344
Sales and marketing expenses	20,486	20,577	18,225
General and administrative expenses	20,950	19,832	16,826
Research and development expenses	5,392	6,420	4,880
Restructuring charges (credits)	(4)	788	1,027
Amortization of intangible assets	2,722	2,819	2,578
Gain on sale of assets, net	0	0	810
Impairment charges	676	0	0
Loss on sale of AHN	1,190	0	0
Total operating expenses, net	51,412	50,436	42,726
Operating (loss) income	(2,997)	(1,713)	6,618
Other income (expense):
Foreign exchange	737	210	(150)
Interest expense	(642)	(854)	(990)
Interest income	3	8	74
Other income (expense), net	(179)	(1,259)	(1,135)
Other expense, net	(81)	(1,895)	(2,201)
(Loss) income before income taxes	(3,078)	(3,608)	4,417
Total Income Tax Expense	1,229	15,431	2,062
Net income (loss)	$ (4,307)	$ (19,039)	$ 2,355
Earnings (loss) per share:
Basic earnings per common share	$ (0.13)	$ (0.57)	$ 0.07
Diluted Earnings Per Common Share	$ (0.13)	$ (0.57)	$ 0.07
Weighted average common shares:
Basic	34,211,521	33,592,775	32,170,683
Diluted	34,211,521	33,592,775	33,236,569

Statement of Comprehensive Inco

Statement of Comprehensive Income - USD ($)	12 Months Ended
	Dec. 31, 2016	Dec. 31, 2015	Dec. 31, 2014
Consolidated Statements of Comprehensive Income [Abstract]
Net income (loss)	$ (4,307,000)	$ (19,039,000)	$ 2,355,000
Other Comprehensive Income (Loss), Net of Tax [Abstract]
Foreign currency translation adjustments	(4,606,000)	(4,936,000)	(5,941,000)
Other Comprehensive Income Derivatives Qualifying As Hedges Net Of Tax Period Increase Decrease [Abstract]
Loss on derivative instruments designated and qualifying as cash flow hedges	(29,000)	(85,000)	(99,000)
Amounts reclassified from accumulated other comprehensive income to net income	(39,000)	(93,000)	(130,000)
Derivatives qualifying as hedges, net of tax total	10,000	8,000	31,000
Other Comprehensive Income (Loss), Pension and Other Postretirement Benefit Plans, Adjustment, Net of Tax [Abstract]
Amount of net loss included in net periodic pension costs, net of tax expense of $52, $58 and $52 in 2016, 2015 and 2014, respectively	(252,000)	(248,000)	(207,000)
Net gain (loss), net of tax expense (benefits) of ($88), $241 and $29 in 2016, 2015 and 2014, respectively	(430,000)	1,029,000	114,000
Unrealized losses on pension benefit obligation, net of tax	(178,000)	1,277,000	321,000
Other Comprehensive Income (Loss), Net of Tax, total	(4,774,000)	(3,651,000)	(5,589,000)
Total Comprehensive Income (Loss), Net of Tax, total	$ (9,081,000)	$ (22,690,000)	$ (3,234,000)

Statement of Comprehensive Inc6

Statement of Comprehensive Income (Parentheticals) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2016	Dec. 31, 2015	Dec. 31, 2014
Consolidated Statements of Comprehensive Income [Abstract]
Other Comprehensive Income (Loss), Reclassification, Pension and Other Postretirement Benefit Plans, Net Gain (Loss) Recognized in Net Periodic Benefit Cost, Tax	$ 52	$ 58	$ 52
Other Comprehensive Income (Loss), Pension and Other Postretirement Benefit Plans, Net Unamortized Gain (Loss) Arising During Period, Tax	$ (88)	$ 241	$ 29

Statement of Shareholders Equit

Statement of Shareholders Equity - USD ($)	Total	Common Stock [Member]	Additional Paid-in Capital [Member]	Retained Earnings [Member]	Accumulated Other Comprehensive Income (Loss) [Member]	Treasury Stock [Member]
Total stockholders' equity at begining of the year, Value at Dec. 31, 2013	$ 94,485,000	$ 390,000	$ 202,446,000	$ (95,039,000)	$ (2,644,000)	$ (10,668,000)
Stock option exercises during the year, Value	2,160,000	7,000	2,153,000	0	0	0
Stock issued during the year, Value, Employee Stock Purchase Plan	228,000	0	228,000	0	0	0
Shares Withheld For Taxes- Value	(327,000)	0	(327,000)	0	0	0
Stock-based compensation expense	2,156,000	0	2,156,000	0	0	0
Net income (loss)	2,355,000	0	0	2,355,000	0	0
Other Comprehensive Income (Loss), Net of Tax [Abstract]
Other Comprehensive Income (Loss), Net of Tax	(5,589,000)	0	0	0	(5,589,000)	0
Total stockholders' equity at year end, Value at Dec. 31, 2014	$ 95,468,000	397,000	206,656,000	(92,684,000)	(8,233,000)	(10,668,000)
Beginning balance shares at Dec. 31, 2013	39,385,000
Other Comprehensive Income (Loss), Net of Tax [Abstract]
Stock option exercises during the year, Shares	695,000
Stock issued during the year, Shares, Employee Stock Purchase Plans	57,848
Restricted Stock Unit Issuance	233,000
Shares Withheld For Taxes	(62,000)
Ending balance shares at Dec. 31, 2014	40,309,000
Stock option exercises during the year, Value	$ 2,630,000	25,000	2,605,000	0	0	0
Stock issued during the year, Value, Employee Stock Purchase Plan	208,000	0	208,000	0	0	0
Shares Withheld For Taxes- Value	(773,000)	(6,000)	(767,000)	0	0	0
Stock-based compensation expense	2,755,000	0	2,755,000	0	0	0
Net income (loss)	(19,039,000)	0	0	(19,039,000)	0	0
Other Comprehensive Income (Loss), Net of Tax [Abstract]
Other Comprehensive Income (Loss), Net of Tax	(3,651,000)	0	0	0	(3,651,000)	0
Total stockholders' equity at year end, Value at Dec. 31, 2015	$ 77,598,000	416,000	211,457,000	(111,723,000)	(11,884,000)	(10,668,000)
Other Comprehensive Income (Loss), Net of Tax [Abstract]
Stock option exercises during the year, Shares	1,772,000
Stock issued during the year, Shares, Employee Stock Purchase Plans	58,823
Restricted Stock Unit Issuance	237,000
Shares Withheld For Taxes	(652,000)
Ending balance shares at Dec. 31, 2015	41,725,000
Stock option exercises during the year, Value	$ 171,000	4,000	167,000	0	0	0
Stock issued during the year, Value, Employee Stock Purchase Plan	196,000	0	196,000	0	0	0
Shares Withheld For Taxes- Value	(185,000)	(2,000)	(183,000)	0	0	0
Stock-based compensation expense	3,497,000	0	3,497,000	0	0	0
Net income (loss)	(4,307,000)	0	0	(4,307,000)	0	0
Other Comprehensive Income (Loss), Net of Tax [Abstract]
Other Comprehensive Income (Loss), Net of Tax	(4,774,000)	0	0	0	(4,774,000)	0
Total stockholders' equity at year end, Value at Dec. 31, 2016	$ 72,196,000	$ 418,000	$ 215,134,000	$ (116,030,000)	$ (16,658,000)	$ (10,668,000)
Other Comprehensive Income (Loss), Net of Tax [Abstract]
Stock option exercises during the year, Shares	375,000
Stock issued during the year, Shares, Employee Stock Purchase Plans	81,228
Restricted Stock Unit Issuance	302,000
Shares Withheld For Taxes	(296,000)
Ending balance shares at Dec. 31, 2016	42,187,000

Statements of Cash Flows

Statements of Cash Flows - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2016	Dec. 31, 2015	Dec. 31, 2014
Cash flows from operating activities:
Net income (loss)	$ (4,307)	$ (19,039)	$ 2,355
Adjustments to reconcile net income to net cash provided by operating activities:
Stock-based compensation expense	3,497	2,755	2,156
Impairment charges	676	0	0
Depreciation	1,532	1,745	1,253
Loss on sale of AHN	1,190	0	0
(Gain) loss on sales of fixed assets	0	25	(810)
Non cash restructuring charge	(27)	(85)	(120)
Amortization Of Catalog Costs	20	9	47
Provision for allowance for doubtful accounts	309	(7)	(67)
Amortization of intangible assets	2,722	2,819	2,578
Amortization of deferred financing costs	91	86	61
Deferrred Income Taxes	(279)	15,116	1,412
Changes in operating assets and liabilities:
(Increase) decrease in accounts receivable	566	(1,340)	(735)
Increase in inventories	1,248	(1,223)	(3,056)
Increase in other receivables and other assets	(658)	755	(370)
Increase in trade accounts payable	(2,413)	2,577	1,069
(Decrease) increase in accrued income taxes	(195)	(311)	(269)
Increase in accrued expenses	871	(1,511)	(345)
(Decrease) increase in deferred revenue	(187)	120	28
Increase (decrease) in other liabilities	727	(1,786)	(836)
Net cash provided by operating activities	5,383	705	4,351
Cash flows (used in) provided by investing activities:
Additions to property, plant and equipment	(1,445)	(2,960)	(2,005)
Additions to catalog costs	(34)	(18)	0
Dispositions, net of cash	1,417	0	0
Proceeds from sales of property, plant and equipment	0	6	1,141
Acquisitions, net of cash acquired	0	(4,545)	(12,653)
Net cash used in investing activities	(62)	(7,517)	(13,517)
Cash flows provided by (used in) financing activities:
Repayments of debt	(9,050)	(8,350)	(5,500)
Net proceeds from issuance of debt	4,000	5,800	2,200
Payments of debt issuance costs	0	(32)	0
Net proceeds from issuance of common stock	182	2,042	2,066
Net cash (used in) provided by financing activities	(4,868)	(540)	(1,234)
Effect of exchange rate changes on cash	(1,601)	(38)	(1,237)
Increase in cash and cash equivalents	(1,148)	(7,390)	(11,637)
Cash and cash equivalents at the begining of period	6,744	14,134	25,771
Cash and cash equivalents at the end of period	5,596	6,744	14,134
Supplemental disclosures of cash flow information [Abstract]
Cash paid for interest	620	854	997
Cash paid for income taxes, net of refunds	$ 928	$ 963	$ 843

Organiziation

Organiziation	12 Months Ended
	Dec. 31, 2016
Organization Disclosure [Abstract]
Organization Disclosure [Text Block]	1 . Organization Harvard Bioscience, Inc. ( “Harvard Bioscience” or “the Company”) is a global developer, manufacturer and marketer of a broad range of scientific instruments, systems and lab consumables used to advance life science for basic research, drug discovery, clinical and environmental testing. The Company’s products are sold to thousands of researchers in over 100 countries through its global sales organization, catalogs, web sites, and through distributors including Ther mo Fisher Scientific Inc., VWR and other specialized distributors. The Company has sales and manufacturing operations in the United States, the United Kingdom, Germany, Sweden, Spain, France, Can ada and China.

Basis of Presentation and Summa

Basis of Presentation and Summary of Significant Accounting Policies	12 Months Ended
	Dec. 31, 2016
Basis of Presentation and Summary of Significant Accounting Policies Disclosure [Abstract]
Basis of Presentation and Summary of Significant Accounting Policies Disclosure [Text Block]	2. Summary of Significant Accounting Policies (a) Principles of Consolidation The consolidated financial statements include the accounts of Harvard Bioscience, Inc. and its wholly-owned subsidiaries. All intercompany balances and transactions have been eliminated in consolidation. (b) Use of Estimates The preparation of financial statements in conformity with accounting principles generally accepted in the United States requires the use of management estimates. Such estimates include the determination and establishment of certain accruals and provisions, including those for invent ory excess and obsolescence, income tax and reserves for bad debts. In addition, certain estimates are required in order to determine the value of assets and liabilities associated with acquisitions, as well as the Company’s defined benefit pension obligations . Estimates are also required to e valuate the value and recoverability of existing long-lived and intangible assets, including goodwill. On an ongoing basis, the Company reviews its estimates based upon currently available information. Actual results could differ materially from those esti mates. (c) Cash and Cash Equivalents For purposes of the consolidated balance sheets and statements of cash flows, the Company considers all highly liquid instruments with original maturities of three months or less to be cash equivalents. (d) Allowance for Doubtful Accounts Allowance for doubtful accounts is based on the Company’s assessment of collectability of customer accounts. The Company regularly reviews the allowance by considering factors such as historical experience, credit quality, age of the accounts receivable balances and other factors that may affect a customer’s ability to pay. (e) Inventories The Company values its inventories at the lower of the actual cost to purchase (first-in, first-out method) and/or manufacture the in ventories or the current estimated market value of the inventories. The Company regularly reviews inventory quantities on hand and records a provision to write down excess and obsolete inventories to its estimated net realizable value if less than cost, ba sed primarily on historical inventory usage and estimated forecast of product demand. (f) Property, Plant and Equipment Property, plant and equipment are stated at cost and depreciated using the straight-line method over the estimated useful lives of th e assets as follows: Buildings 40 years Machinery and equipment 3 - 10 years Computer equipment and software 3 - 7 years Furniture and fixtures 5 - 10 years Automobiles 3 - 6 years Property and equipment held under capital leases and leasehold improvements are amortized using the straight line method over the shorter of the lease term or estimated useful life of the asset. (g) Catalog Costs Significant costs of product catalog design, development and production are capitalized and amortized over the expected useful life of the catalog (usually one to three years). (h) Income Taxes Income taxes are accounted for under the asset and liability method. Deferred tax assets and l iabilities are recognized for the future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax bases. Deferred tax assets and liabilities are measured using enacted tax rates expected to be applied to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that includes the enactment date. The Company recognizes the effect of income tax positions only if those positions are more likely than not of being sustained. Recognized income tax positions are measured at the largest amount that is more than 5 0% likely of being realized. Changes in recognition are reflected in the period in which the judgement occurs. (i) Foreign Currency Translation The functional currency of the Company’s foreign subsidiaries is generally their local currency. All assets and liabilities of its foreign subsidiaries are translated at exchange rates in effect at period-end. Income and expenses are translated at rates which approximate those in effect on the transaction dates. The resulting translation adjustment is recorded a s a separate component of stockholders’ equity in accumulated other comprehensive (loss) income (AOCI) in the consolidated balance sheets. Gains and losses resulting from foreign currency transactions are included in net (loss) income. (j) Earnings per Sh are Basic earnings per share is computed by dividing net income by the weighted average number of shares of common stock outstanding during the periods presented. The computation of diluted earnings per share is similar to the computation of basic earnin gs per share, except that the denominator is increased for the assumed exercise of dilutive options and other potentially dilutive securities using the treasury stock method unless the effect is antidilutive . (k) Comprehensive (Loss) Income The Company follows the provisions of Financial Accounting Standards Board (FASB) Accounting Standards Codification (ASC) 220, “Comprehensive Income”. FASB ASC 220 requires companies to report all changes in equity during a period, resulting from net (loss) income and transactions from non-owner sources, in a financial statement in the period in which they are recognized. The Company has chosen to disclose comprehensive (loss) income, which encompasses net (loss) income, foreign currency translation adjustments, gains and losses on derivatives, the underfunded status of its pension plans, and pension minimum additional liability adjustments, net of tax, in the consolidated statements of comprehensive (loss) income. (l) Revenue Recognition The Company follows the prov isions of FASB ASC 605, “Revenue Recognition”. The Company recognizes product revenues when persuasive evidence of a sales arrangement exists, the price to the buyer is fixed or determinable, delivery has occurred, and collectability of the sales price is reasonably assured. Sales of some of its products include provisions to provide additional services such as installation and training. Revenues on these products are recognized when the additional services have been performed. Service agreements on its equ ipment are typically sold separately from the sale of the equipment. Cash received prior to rendering of the service on these contracts is recorded as deferred revenue and the revenues are recognized ratably over the life of the agreement, typically one ye ar, in accordance with the provisions of FASB ASC 605-20, “Revenue Recognition—Services”. The Company accounts for shipping and handling fees and costs in accordance with the provisions of FASB ASC 605-45-45, “Revenue Recognition—Principal Agent Considerations”, which requires all amounts charged to customers for shipping and handling to be classified as revenues. The costs incurred related to shipping and handling is classified as cost of product revenues. Warranties and product returns are estimated and accrued for at the time sales are recorded. The Company has no obligations to customers after the date products are shipped or installed, if applicable, other than pursuant to warranty obligations and service or maintenance contracts. The Company provides for the estimated amount of future returns upon shipment of products or installation, if applicable, based on histor ical experience. (m) Valuation of Identifiable Intangible Assets Acquired in Business Combinations The determination of the fair value of intangible assets, which represents a significant portion of the purchase price in the Company’s acquisitions, requ ires the use of significant judgment with regard to (i) the fair value; and (ii) whether such intangibles are amortizable or not amortizable and, if the former, the period and the method by which the intangibles asset will be amortized. The Company estimat es the fair value of acquisition-related intangible assets principally based on projections of cash flows that will arise from identifiable assets of acquired businesses. The projected cash flows are discounted to determine the present value of the assets at the dates of acquisitions. At December 31, 2016 , amortizable intangible assets include existing technology, trade names, distribution agreements, customer relationships and patents. These amortizable intangible assets are amortized on a straight -line basis over 7 to 15 years, 10 to 15 years, 4 to 5 years, 5 to 15 years and 5 to 15 years, respectively. (n) Goodwill and Other Intangible Assets Goodwill and unamortizable intangible assets acquired in a business combination and determined to have an indefinite useful life are not amortized, but instead are tested for impairment annually or more frequently if events or changes in circumstances indicate that the asset might be impaired, in accordance with the provisions of FASB ASC 350, “Intangibles—Goodwill and Other”. For the purpose of its goodwill analysis, the Company has one reporting unit. The Company conducted its annual impairment analysis in the fourth quarter of f iscal year 2016 . The goodwill impairment test is a two-step process. The first step of the impairment analysis compares the Company’s fair value to its carrying value to determine if there is any indication of impairment. Step two of the analysis c ompares the implied fair value of goodwill to its carrying amount in a manner similar to a purchase price allocation for business combination. If the carrying amount of goodwill exceeds its implied fair value, an impairment loss is recognized equal to that excess. For indefinite-lived intangible assets if the carrying amount exceeds the fair value of the asset, the Company would write down the indefinite-lived intangible asset to fair value. At December 31, 2016 , the fair value of the Company sign ificantly exceeded the carrying value. The Company concluded that none of its goodwill was impaired. The Company evaluates indefinite-lived intangible assets for impairment annually and when events occur or circumstances change that may reduce the fair value of the asset below its carrying amount. Events or circumstances that might require an interim evaluation include unexpected adverse business conditions, economic factors, unanticipated technological changes or competitive activities, loss of key per sonnel and acts by governments and courts. At December 31, 2016 , the Company concluded that none of its indefinite-lived intangible assets were impaired. (o) Impairment of Long-Lived Assets The Company assesses recoverability of its long-lived assets that are held for use, such as property, plant and equipment and amortizable intangible assets in accordance with FASB ASC 360, “Property, Plant and Equipment” when events or changes in circumstances indicate that the carrying amount of an asset or asset group may not be recoverable. Recoverability of assets or an asset group to be held and used is measured by a comparison of the carrying amount of an asset or asset group to estimated undiscounted future cash flows expected to be generated by the ass et or the asset group. Cash flow projections are based on trends of historical performance and management’s estimate of future performance. If the carrying amount of the asset or asset group exceeds the estimated future cash flows, an impairment charge is recognized by the amount by which the carrying amount of the asset or asset group exceeds its estimated fair value. At December 31, 2016 , the Company concluded that none of its long-lived assets were impaired. However, as disclosed in footnote 8, as a result of the initiation of plans to sell the operations of AHN, an operating subsidiary, during the third quarter of 2016, the Company conducted an evaluation of AHN’s assets for impairment. Based on this evaluation, the Company recognized an impairm ent charge of $0.7 million on its long-lived assets. (p) Derivatives The Company uses interest-rate-related derivative instruments to manage its exposure related to changes in interest rates on its variable-rate debt instruments. The Company does not enter into derivative instruments for any purpose other than cash flow hedging. The Company does not speculate using derivative instruments. The Company recognizes all derivative instruments as either assets or liabilities in the balance sheet at their res pective fair values. For derivatives designated in hedging relationships, changes in the fair value are either offset through earnings against the change in fair value of the hedged item attributable to the risk being hedged or recognized in AOCI, to the e xtent the derivative is effective at offsetting the changes in cash flows being hedged until the hedged item affects earnings. The Company only enters into derivative contracts that it intends to designate as a hedge of a forecasted transaction or the var iability of cash flows to be received or paid related to a recognized asset or liability (cash flow hedge). For all hedging relationships, the Company formally documents the hedging relationship and its risk-management objective and strategy for undertakin g the hedge, the hedging instrument, the hedged transaction, the nature of the risk being hedged, how the hedging instrument’s effectiveness in offsetting the hedged risk will be assessed prospectively and retrospectively, and a description of the method u sed to measure ineffectiveness. The Company also formally assesses, both at the inception of the hedging relationship and on an ongoing basis, whether the derivatives that are used in hedging relationships are highly effective in offsetting changes in cas h flows of hedged transactions. For derivative instruments that are designated and qualify as part of a cash flow hedging relationship, the effective portion of the gain or loss on the derivative is reported as a component of other comprehensive income and reclassified into earnings in the same period or periods during which the hedged transaction affects earnings. Gains and losses on the derivative representing either hedge ineffectiveness or hedge components excluded from the assessment of effectiveness a re recognized in current earnings. The Company discontinues hedge accounting prospectively when it determines that the derivative is no longer effective in offsetting cash flows attributable to the hedged risk, the derivative expires or is sold, termina ted, or exercised, the cash flow hedge is de-designated because a forecasted transaction is not probable of occurring, or management determines to remove the designation of the cash flow hedge. In all situations in which hedge accounting is discontinued a nd the derivative remains outstanding, the Company continues to carry the derivative at its fair value on the balance sheet and recognizes any subsequent changes in its fair value in earnings. When it is probable that a forecasted transaction will not occu r, the Company discontinues hedge accounting and recognizes immediately in earnings gains and losses that were accumulated in other comprehensive income related to the hedging relationship. (q) Fair Value of Financial Instruments The carrying values of the Company’s cash and cash equivalents, trade accounts receivable and trade accounts payable and short-term debt approximate their fair values because of the short maturities of those instruments. The fair value of the Company’s long-term debt approximate s its carrying value and is based on the amount of future cash flows associated with the debt discounted using current borrowing rates for similar debt instruments of comparable maturity. Financial reporting standards define a fair value hierarchy that co nsists of three levels:  Level 1 includes instruments for which quoted prices in active markets for identical assets or liabilities accessible to the Company at the measurement date.  Level 2 includes instruments for which the valuations are based on quoted prices for similar assets or liabilities, quoted prices in markets that are not active, or other inputs that are observable or can be corroborated by observable data for substantially the full term of the assets or liabilities.  Level 3 includes valuations based on inputs that are unobservable and significant to the overall fair value measurement. (r) Stock-based Compensation The Company accounts for stock-based payment awards in accordance with the provisions of FASB ASC 718, “Compensation—Stock Compensation”, which requires it to recognize compensation expense for all stock-based payment awards made to employees and directors including stock options, restricted stock units, restricted stock units with a market condition and em ployee stock purchases (“employee stock purchases”) related to its Employee Stock Purchase Plan (as amended, the ESPP). The Company issues new shares upon stock option exercises, upon vesting of restricted stock units and restricted stock units with a mark et condition, and under the Company’s ESPP. Stock-based compensation expense recognized is based on the value of the portion of stock-based payment awards that is ultimately expected to vest and has been reduced for estimated forfeitures. The Company valu es stock-based payment awards, except restricted stock units at grant date using the Black-Scholes option-pricing model (Black-Scholes model). The Company values restricted stock units with a market condition using a Monte-Carlo valuation simulation. The d etermination of fair value of stock-based payment awards on the date of grant using an option-pricing model or Monte-Carlo valuation simulation is affected by its stock price as well as assumptions regarding certain variables. These variables include, but are not limited to its expected stock price volatility over the term of the awards and actual and projected stock option exercise behaviors. The fair value of restricted stock units are based on the market price of the Company’s stock on the date of grant and are recorded as compensation expense ratably over the applicable service period, which ranges from one to four years. Unvested restricted stock units are forfeited in the event of termination of employment with the Company. Stock-based compensation e xpense recognized under FASB ASC 718 for the years ended December 31, 2016 , 2015 and 2014 consisted of stock-based compensation expense related to stock options, the employee stock purchase plan, and the restricted stock un its and was recorded as a component of cost of product revenues, sales and marketing expenses, general and administrative expenses, research and development expenses and discontinued operations. Refer to footnote 19 for further details. (s) Recently Issued Accounting Pronouncements In May 2014, the Financial Accounting Standards Board (FASB) issued Accounting Standards Update (ASU) 2014-09, “Revenue from Contracts with Customers,” a new accounting standard that provides for a comprehensive model to use in the accounting for revenue arising from contracts with customers that will replace most existing revenue recognition guidance within accounting principles generally accepted in the United States. Under this standard, revenue will be recognized to de pict the transfer of promised goods or services to customers in an amount that reflects the consideration to which we expect to be entitled in exchange for those goods or services. The Company expects to adopt this standard as of January 1, 2018 using the modified retrospective approach. The Company intends to complete a comprehensive assessment of its contracts in 2017 concerning any unique customer contract terms or transactions that could have implications to the timing of revenue recognition under the n ew guidance . The Company expects this undertaking will be complete in the second half of 2017. In July 2015, the FASB issued ASU 2015-11, Simplifying Measurement of Inventory . The update requires measurement of most inventory “at the lower of cost and net realizable value”, and applies to all entities that recognize inventory within the scope of ASC 330, except for inventory measured under the last-in, first-out (LIFO) method or the retail inventory method (RIM). ASU 2015-11 requires prospective applicatio n and represents a change in accounting principle. The update is effective for fiscal years beginning after December 15, 2016. The Company will adopt this standard effective January 1, 2017. Adoption of this guidance is not expected to have a material impa ct on the Company's consolidated financial statements.

Recently Issued Accounting Pron

Recently Issued Accounting Pronouncements	12 Months Ended
	Dec. 31, 2016
Recently Issued Accounting Pronouncements [Abstract]
Recently Issued Accounting Pronouncements Disclosure [Text Block]	(s) Recently Issued Accounting Pronouncements In May 2014, the Financial Accounting Standards Board (FASB) issued Accounting Standards Update (ASU) 2014-09, “Revenue from Contracts with Customers,” a new accounting standard that provides for a comprehensive model to use in the accounting for revenue arising from contracts with customers that will replace most existing revenue recognition guidance within accounting principles generally accepted in the United States. Under this standard, revenue will be recognized to de pict the transfer of promised goods or services to customers in an amount that reflects the consideration to which we expect to be entitled in exchange for those goods or services. The Company expects to adopt this standard as of January 1, 2018 using the modified retrospective approach. The Company intends to complete a comprehensive assessment of its contracts in 2017 concerning any unique customer contract terms or transactions that could have implications to the timing of revenue recognition under the n ew guidance . The Company expects this undertaking will be complete in the second half of 2017. In July 2015, the FASB issued ASU 2015-11, Simplifying Measurement of Inventory . The update requires measurement of most inventory “at the lower of cost and net realizable value”, and applies to all entities that recognize inventory within the scope of ASC 330, except for inventory measured under the last-in, first-out (LIFO) method or the retail inventory method (RIM). ASU 2015-11 requires prospective applicatio n and represents a change in accounting principle. The update is effective for fiscal years beginning after December 15, 2016. The Company will adopt this standard effective January 1, 2017. Adoption of this guidance is not expected to have a material impa ct on the Company's consolidated financial statements. In February 2016, the FASB issued ASU 2016-02, Leases , which is intended to improve financial reporting about leasing transactions. The update requires a lessee to record on the balance sheet the asse ts and liabilities for the rights and obligations created by lease terms of more than 12 months. The update is effective for fiscal years beginning after December 15, 2018. The Company is evaluating the requirements of this guidance and has not yet determi ned the impact of the adoption on its consolidated financial position, results of operations and cash flows, however, assets and liabilities will increase upon adoption for right-of-use assets and lease liabilities. The Company’s future commitments under l ease obligations are summarized in Note 14. In June 2016, the FASB issued ASU 2016-13, Financial Instruments – Credit Losses (Topic 326), Measurement of credit losses on Financial Instruments. The update amends the FASB’s guidance on the impairment of financial instruments. The ASU adds to U.S. GAAP an impairment model (known as the current expected credit loss (CECL) model) that is based on expected losses rather than incurred losses. Under the new guidance, an entity recognizes as an allowance its est imate of expected credit losses, which the FASB believes will result in more timely recognition of such losses. The ASU is effective for fiscal years beginning after December 15, 2019, including interim periods within those fiscal years. The Company is eva luating the impact of ASU 2016-13 on its consolidated financial statements. In August 2016, the FASB issued ASU 2016-15, Classification of Certain Cash Receipts and Cash Payments (Topic 230) which amends ASC 230, Statement of Cash Flows to add or clarify guidance on the classification of certain cash receipts and payments in the statement of cash flows. The guidance is effective for fiscal years beginning after December 15, 2017, including interim periods within those fiscal year. The Company is evaluating the impact of ASU 2016-13 on its consolidated financial statements. In March 2016, the FASB issued ASU 2016-09, Compensation – Stock Compensation (Topic 718): Improvements to Employee Share-Based Payment Accounting , which simplifies the accounting for sh are-based payment transactions, including the income tax consequences, classification of awards as either equity or liabilities and classification on the statement of cash flows. The Company will adopt this standard effective January 1, 2017. Adoption of t his guidance is not expected to have a material impact on the Company's consolidated financial statements; however, the impact in any given period will be dependent upon changes in the company's stock price, the volume of employee stock option exercises an d the timing of service and performance-based restricted unit vestings. Recently Adopted Accounting Pronouncements In April 2015, the FASB issued ASU 2015-03, Interest - Imputation of Interest - Simplifying the Presentation of Debt Issuance Costs . Under this guidance, debt issuance costs related to a recognized debt liability should be presented in the balance sheet as a direct deduction from the carrying amount of that debt liability. The provisions of this guidance are to be applied retrospectively and are effective for interim and annual periods beginning after December 15, 2015. The Company adopted this guidance as of January 1, 2016. The consolidated balance sheet as of December 31, 2015, included in these consolidated financial statements, reflects a restatement to reclassify unamortized deferred financing costs of approximately $0.2 million from other long-term assets to long-term debt. For deferred financing costs paid to secure long-term debt, the Company made a policy election to present such cost s as a direct deduction from the debt liability on the consolidated balance sheet. In September 2015, the FASB issued ASU 2015-16 , Simplifying the Accounting for Measurement-Period Adjustments . The update eliminates the requirement to retrospectively adju st financial statements for measurement-period adjustments that occur in periods after a business combination. Under the update, measurement-period adjustments are to be calculated as if they were known at the acquisition date, but are recognized in the re porting period in which they are determined. Additional disclosures are required about the impact on current-period earnings. ASU 2015-16 requires prospective application to adjustments of provisional amounts that occur after the effective date. The update was effective for fiscal years beginning after December 15, 2015. The Company adopted ASU 2015-16 on January 1, 2016. The adoption of ASU 2015-16 did not have a material impact on its consolidated financial statements. In November 2015, the FASB issued ASU 2015-17, Balance Sheet Classification of Deferred Taxes . The update requires all deferred income taxes to be presented on the balance sheet as noncurrent. The new guidance is intended to simplify financial reporting by eliminating the requirement to cl assify deferred taxes between current and noncurrent. The update is effective for fiscal years beginning after December 15, 2016. Early adoption is permitted at the beginning of an interim or annual period. As of January 1, 2016, the Company early adopted the new guidance on a prospective basis and has presented all deferred tax assets and deferred tax liabilities as noncurrent in the consolidated balance sheet at December 31, 2016. Prior periods presented in the consolidated financial statements were not retrospectively adjusted.

Concentrations

Concentrations	12 Months Ended
	Dec. 31, 2016
Concentrations Disclosure [Abstract]
Concentrations Disclosure [Text Block]	3 . Concentrations No customer accounted for more than 10% of the revenues for the years ended December 31, 2016 , 2015 and 2014 . At December 31, 2016 and 2015 , no customer accounted for more than 10% of net accounts receivable.

Accumulated Other Comprehensive

Accumulated Other Comprehensive Income	12 Months Ended
	Dec. 31, 2016
Accumulated Other Comprehensive Income [Abstract]
Accumulated Other Comprehensive Income Disclosure [Text Block]	4 . Accumulated Other Comprehensive Loss Changes in each component of accumulated other comprehensive loss, net of tax are as follows: Foreign currency Derivatives translation qualifying as Defined benefit (in thousands) adjustments hedges pension plans Total Balance at December 31, 2014 $ (4,658) $ (18) $ (3,557) $ (8,233) Other comprehensive (loss) income before reclassifications (4,936) (85) 1,029 (3,992) Amounts reclassified from AOCI - 93 248 341 Net other comprehensive (loss) income (4,936) 8 1,277 (3,651) Balance at December 31, 2015 $ (9,594) $ (10) $ (2,280) $ (11,884) Other comprehensive (loss) income before reclassifications (4,606) (29) (430) (5,065) Amounts reclassified from AOCI - 39 252 291 Other comprehensive (loss) income (4,606) 10 (178) (4,774) Balance at December 31, 2016 $ (14,200) $ - $ (2,458) $ (16,658) The amounts reclassified out of accumulated other comprehensive (loss) income are as follows: Affected line item in the Year Ended December 31, (in thousands) Statements of Operations 2016 2015 2014 Amounts Reclassified From AOCI Derivatives qualifying as hedges Realized loss on derivatives qualifying as hedges Interest expense $ 39 $ 93 $ 130 Income tax Income tax (benefit) expense - - - 39 93 130 Defined benefit pension plans Amortization of net losses included in net periodic pension costs General and administrative expenses 304 306 259 Income tax Income tax (benefit) expense (52) (58) (52) 252 248 207 Total reclassifications $ 291 $ 341 $ 337

Inventories

Inventories	12 Months Ended
	Dec. 31, 2016
Inventories Disclosure [Abstract]
Inventories Disclosure [Text Block]	5 . Inventories Inventories consist of the following: December 31, December 31, 2016 2015 (in thousands) Finished goods $ 9,340 $ 10,957 Work in process 823 888 Raw materials 9,792 10,498 Total $ 19,955 $ 22,343

Property, Plant and Equipment

Property, Plant and Equipment	12 Months Ended
	Dec. 31, 2016
Property, Plant and Equipment Disclosure [Abstract]
Property, Plant and Equipment Disclosure [Text Block]	6 . Property , Plant and Equipment Property, plant and equipment consist of the following: December 31, December 31, 2016 2015 (in thousands) Land, buildings and leasehold improvements $ 2,095 $ 2,825 Machinery and equipment 7,224 10,131 Computer equipment and software 8,115 7,503 Furniture and fixtures 1,274 1,358 Automobiles 196 103 18,904 21,920 Less: accumulated depreciation (14,608) (16,018) Property, plant and equipment, net $ 4,296 $ 5,902

Acquisitions

Acquisitions	12 Months Ended
	Dec. 31, 2016
Acquisition Disclosure [Abstract]
Acquisitions Disclosure [Text Block]	7 . Acquisitions The Company completed one acquisition during the year ended December 31, 2015 . HEKA Elektronik On January 8, 2015, the Company, through its wholly-owned Ealing Scientific Limited and Multi Channel Systems MCS GmbH (MCS ) subsidiaries, acquired all of the issued and outstanding shares of HEKA Elektronik (HEKA ) for approximately $5.9 million, or $4.5 million, net of cash acquired. Included in the acquisition of HEKA were: HEKA Electronik Dr. Schul ze GmbH, based in Lambrecht, Germany (HEKA Germany ); HEKA Electronics Incorporated, based in Chester, Nova Scotia, Canada (HEKA Canada ); and HEKA Instruments Incorporated, based in Bellmore, New York. The Company funded the acquisition from its existin g cash balances. HEKA is a developer, manufacturer and marketer of sophisticated electrophysiology instrumentation and software for biomedical and industrial research applications. This acquisition is complementary to the electrophysiology line currently offered by the Company’s wholly-owned Warner Instruments and MCS subsidiaries. The aggregate purchase price for this acquisition was allocated to tangible and intangible assets acquired as follows: (in thousands) Tangible assets $ 4,165 Liabilities assumed (2,426) Net assets 1,739 Goodwill and intangible assets: Goodwill 1,668 Trade name 774 Customer relationships 1,627 Developed technology 1,338 Non-compete agreements 27 Deferred tax liabilities (1,245) Total goodwill and intangible assets, net of tax 4,189 Acquisition purchase price $ 5,928 Goodwill recorded as a result of the acquisition of HEKA is not deductible for tax purposes. In the second quarter of 2016, an immaterial correction was made to the allocation of the aggregate purchase price to the tangible and intangible assets acquired to increase both accrued liabilities and goodwill by $50,000 as of June 30, 2016. This correction has been reflected in the table above. The results of operations for HEKA have been included in the Company’s consolidated financial statements from the date of acquisition. The following consolidated pro forma information is based on the assumption that the acquisition of HEKA occurred on January 1, 2014 . Accordingly, the historical results have been adjusted to reflect amortization expense that would have been recognized on suc h a pro forma basis. The pro forma information is presented for comparative purposes only and is not necessarily indicative of the financial position or results of operations which would have been reported had we completed the acquisition during these peri ods or which might be reported in the future. Year Ended December 31, 2015 2014 (in thousands) Pro Forma Revenues $ 108,761 $ 114,185 Net (loss) income (19,027) 2,646 The Company completed two acquisitions during 2014. Multi Channel Systems MCS GmbH On October 1, 2014, the Company, through its wholly-owned Biochrom Limited subsidiary, acquired all of the issued and outstanding shares of MCS, which has its principal offices in Germany, for approximately $11.2 million, including a working capital adjustment, or $10.7 million, net of cash acquired . The Company funded the acquisition from its existing cash balances. MCS is a developer, manufacturer and marketer of in vitro and in vivo electrophysiology instr umentation for extracellular recording and stimulation. This acquisition is complementary to the in vitro electrophysiology line currently offered by the Company’s wholly-owned Warner Instruments subsidiary. The aggregate purchase price for this acquisiti on was allocated to tangible and intangible assets acquired as follows: (in thousands) Tangible assets $ 5,070 Liabilities assumed (1,207) Net assets 3,863 Goodwill and intangible assets: Goodwill 4,117 Trade name 1,008 Customer relationships 1,204 Developed technology 2,452 Non-compete agreements 148 Deferred tax liabilities (1,603) Total goodwill and intangible assets, net of tax 7,326 Acquisition purchase price $ 11,189 Goodwill recorded as a result of the acquisition of MCS is not deductible for tax purposes. At December 31, 2015 , an immaterial correction was made to the allocation of the aggregate purchase price to the tangible and intangible assets acquired to decrease inventory and increase goodwill by $0.4 million. This correction has been reflected in the table above. The results of operations for MCS have been included in the Company’s consolidated financial statements from the date of acquisition. The following consolidated pro forma information is based on the assumption that the acquisition of MCS occurred on January 1, 2013. Accordingly, the historical results have been adjusted to reflect amortization expense that would have been recognized on such a pro forma basis. The pro forma information is presented for comparative purposes only and is not necessarily indicative of the financial position or results of operations which would have been reported had we completed the acquisition during these perio ds or which might be reported in the future. Year Ended December 31, 2014 (in thousands) Pro Forma Revenues $ 114,066 Net income 2,600 Triangle BioSystems , Inc. On October 1, 2014, the Company acquired all of the issued and outstanding shares of Triangle BioSystems , Inc. (“TBSI”), which has it s principal offices in North Carolina, for approximately $2.2 million, including a working capital adjustment, or $1.7 million, net of cash acquired . The Company funded the acquisition from borrowings under its credit facility. TBSI is a developer, manufacturer and marketer of wireless neural interface equipment to aid in vivo neuroscience research, especially in the fields of electrophysiology, psychology, neurology and pharmacology. This acquisition is complementary to the behavioral neuroscience lines currently offered by the Company’s whol ly-owned Panlab and Coulbourn subsidiaries. The aggregate purchase price for this acquisition was allocated to tangible and intangible assets acquired as follows: (in thousands) Tangible assets $ 1,278 Liabilities assumed (530) Net assets 748 Goodwill and intangible assets: Goodwill 946 Trade name 143 Customer relationships 308 Developed technology 363 Non-compete agreements 30 Deferred tax liabilities (325) Total goodwill and intangible assets, net of tax 1,465 Acquisition purchase price $ 2,213 The results of operations for TBSI have been included in the Company’s consolidated financial statements from the date of acquisition . The Company considers this acquisition immaterial for the purposes of proforma financial statement disclosures. Goodwill recorded as a result of the acquisition of TBSI is not deductible for tax purposes. Direct acquisition costs recorded in other expense, net in the Company’s consolidated statements of operations were $ 0.1 million, $ 1.2 million and $1.1 million for the years ended December 31, 2016 , 2015 and 2014 , respectively .

Disposition

Disposition	12 Months Ended
	Dec. 31, 2016
Discontinued Operations [Abstract]
Discontinued Operations Disclosure [Text Block]	8. Disposition On October 26, 2016, the Company sold the operations of its AHN Biotechnologie GmbH subsidiary (AHN), a manufacturer of liquid handling products, located in Nordhausen, Germany for gross cash proceeds of approximately $1.7 million . Proceeds received at closing, net of cash on hand, were approximately $1.4 million. The results of operations of AHN, through the date of sale, have been reported in the Company’s consolidated statements of operations for the year ended December 31, 2016. As a res ult of the initiation of plans to sell the operations of AHN, during the third quarter of 2016, the Company evaluated the long-lived assets of AHN for impairment, pursuant to ASC 360-10. Based on the impairment analysis, the carrying amount of the long-liv ed assets exceeded the fair value of the long-lived assets as determined using the probability weighted present value of future cash flows. Consequently, the Company recognized an impairment charge of $0.7 million for the year ended December 31, 2016 in op erating expenses within its statements of operations. Of the overall charge, approximately $0.1 million was allocated to AHN’s intangible assets (trade name and customer relationships), while $0.6 million was allocated to its property, plant and equipment (machinery and equipment). Upon the closing of the transaction, the Company recorded a loss on sale of $1.2 million for the year ended December 31, 2016 in operating expenses within the statements of operations. On October 26, 2016, the major classes of assets and liabilities of AHN disposed of, including an allocation of goodwill, were comprised of the following:

Goodwill and Other Intangible A

Goodwill and Other Intangible Assets	12 Months Ended
	Dec. 31, 2016
Goodwill And Other Intangible Assets Disclosure [Abstract]
Goodwill And Other Intangible Assets Disclosure [Text Block]	9 . Goodwill and Other Intangible Assets Intangible assets consist of the following: Weighted Average December 31, 2016 December 31, 2015 Life (a) (in thousands) Amortizable intangible assets: Gross Accumulated Amortization Gross Accumulated Amortization Existing technology $ 15,082 $ (11,710) $ 16,022 $ (11,686) 7.0 Years Trade names 7,379 (3,479) 7,636 (3,076) 8.0 Years Distribution agreements/customer relationships 22,976 (12,862) 23,676 (11,849) 9.0 Years Patents 204 (119) 245 (96) 2.2 Years Total amortizable intangible assets 45,641 $ (28,170) 47,579 $ (26,707) Indefinite-lived intangible assets: Goodwill 38,032 40,357 Other indefinite-lived intangible assets 1,209 1,223 Total goodwill and other indefinite-lived intangible assets 39,241 41,580 Total intangible assets $ 84,882 $ 89,159 (a) Weighted average life as of December 31, 2016. The change in the carrying amount of goodwill for the years ended December 31, 2016 and 2015 is as follows: (in thousands) Balance at December 31, 2014 $ 39,822 Goodwill arising from business combination 1,618 Adjustment to purchase price allocation of prior year acquisition 372 Effect of change in currency translation (1,455) Balance at December 31, 2015 40,357 Adjustment to purchase price allocation of prior year acquisition 50 Adjustment to goodwill for AHN disposition (484) Effect of change in currency translation (1,891) Balance at December 31, 2016 $ 38,032 Intangible asset amortization expense was $ 2.7 million, $ 2.8 million and $ 2.6 million for the years ended December 31, 2016 , 2015 and 2014 , respectively. Amortization expense of existing amortizable intangible assets is currently estimated to be $ 2.4 million for the year ending December 31 , 2017 , $ 2.2 million for the year ending December 31, 2018 , $ 2.1 million for the year ending December 31, 2019 , $ 2.1 million for the year ending December 31, 2020 and $ 2.0 million for the year ending December 31, 2021 .

Restructuring and Other Exit Co

Restructuring and Other Exit Costs	12 Months Ended
	Dec. 31, 2016
Restructuring and Related Activities [Abstract]
Restructuring And Other Exit Costs Disclosure [Text Block]	10 . Restructuring and Other Exit Costs During 2014, and 2015, the Company entered into various restructuring plans, which included eliminating certain positions made redundant as a result of its site consolidations, as well as a realignment of its commercial sales team. The 2014 restructuring plan included plans to relocate the distribution operations of the Company’s Denville Scientific subsidiary from New Jersey to North Carolina, as well as consolidating the manufacturing operations of its Biochr om subsidiary to its headquarters in Holliston, MA. Activity and liability balances related to these charges for the year ended December 31, 2016 , were as follows: Severance Costs Other Total (in thousands) Restructuring balance at December 31, 2015 $ 132 $ - $ 132 Restructuring charges - 23 23 Non-cash reversal of restructuring charges (27) - (27) Cash payments (104) (28) (132) Effect of change in currency translation (1) 5 4 Restructuring balance at December 31, 2016 $ - $ - $ - For the year ended December 31, 2015 , the a ctivity and liability balances related to these charges were as follows: Severance Costs Other Total (in thousands) Restructuring balance at December 31, 2014 $ 626 $ - $ 626 Restructuring charges 434 439 873 Non-cash reversal of restructuring charges (85) - (85) Cash payments (833) (439) (1,272) Effect of change in currency translation (10) - (10) Restructuring balance at December 31, 2015 $ 132 $ - $ 132 For the year ended December 31, 2014 , the a ctivity and liability balances related to restructuring charges were as follows: Severance Costs Other Total (in thousands) Restructuring balance at December 31, 2013 $ 1,437 $ - $ 1,437 Restructuring charges 854 306 1,160 Non-cash reversal of restructuring charges (120) (13) (133) Cash payments (1,545) (293) (1,838) Restructuring balance at December 31, 2014 $ 626 $ - $ 626 Aggregate net restructuring charges for the years ended December 31, 2016 , 2015 and 2014 were as follows: Year Ended December 31, 2016 2015 2014 (in thousands) Restructuring (credits) charges $ (4) $ 788 $ 1,027

Long Term Debt

Long Term Debt	12 Months Ended
	Dec. 31, 2016
Long Term Debt Disclosure [Abstract]
Long Term Debt Disclosure [Text Block]	11. Long Term Debt On August 7, 2009, the Company entered into an Amended and Restated Revolving Credit Loan Agreement related to a $20.0 million revolving credit facility with Bank of America, as agent, and Bank of America and Brown Brothers Harriman & Co as lenders (as amended, the “2009 Credit Agreement”). On March 29, 2013 , the Company entered into a Second Amended and Restated Revolving Credit Agreement (as amended, the Credit Agreement) with Bank of America, as agent, and Bank of America and Brown Brothers Harriman & Co, as lenders that amended and restated the 2009 Credit Agreement. Between September 2011 and March 2016, the Company entered into a series of amendments that among other things did the following: on September 30, 2011, reduced interest rates to the London Interbank Offered Rate plus 3.0%; on March 29, 2013, converted existing loan advances into a term loan in the principal amount of $15.0 million (the “Term Loan”), provided a revolving credit facility in the maximum principal amount of $25.0 million (“Revolving Line”) and a delayed draw term loan (“DDTL”) of up to $15.0 million (all with a maturity date of March 29, 2018); on October 31, 2013, reduced the DDTL from up to $15.0 million to up to $10.0 million; on April 24, 2015, extended the maturity date of the Revolving Line to March 29, 2018 and reduced the interest rates on the Revolving Line, Term Loan and DDTL; on June 30, 2015, amended our quarterly minimum fixed charge coverage financial covenant; and on March 9, 2016, amended the principal payment amortization of the Term Loan and DDTL to five years, as well as amended our quarterly minimum fixed charge coverage financial covenant. The maximum amount available under the Credit Agreement is $50.0 million as borrowings against the DDTL in excess of $10.0 million results in a dollar for dollar reduction in the Revolving Line capacity. The Revolving Line, Term Loan and DDTL each have a maturity date of March 29, 2018. Borrowings under the Term Loan and the DDTL accrue interest at a rate based on eithe r the effective London Interbank Offered Rate (LIBOR) for certain interest periods selected by the Company, or a daily floating rate based on the British Bankers’ Association (BBA) LIBOR as published by Reuters (or other commercially available source provi ding quotations of BBA LIBOR), plus in either case, a margin of 2.75%. Additionally, the Revolving Line accrues interest at a rate based on either the effective LIBOR for certain interest periods selected by the Company, or a daily floating rate based on t he BBA LIBOR, plus in either case, a margin of 2.25%. The Company was required to fix the rate of interest on at least 50% of the Term Loan and the DDTL through the purchase of interest rate swaps. In April 2015, the FASB issued Accounting Standards Upd ate No. 2015-03, Interest - Imputation of Interest - Simplifying the Presentation of Debt Issuance Costs . Under this guidance, debt issuance costs related to a recognized debt liability should be presented in the balance sheet as a direct deduction from th e carrying amount of that debt liability. The provisions of this guidance are to be applied retrospectively and are effective for interim and annual periods beginning after December 15, 2015. The Company adopted this guidance as of January 1, 2016. The con solidated balance sheet as of December 31, 2015, included in these consolidated financial statements, reflects a restatement to reclassify unamortized deferred financing costs of approximately $0.2 million from other long-term assets to long-term debt. For deferred financing costs paid to secure long-term debt, the Company made a policy election to present such costs as a direct deduction from the debt liability on the consolidated balance sheet. The loans evidenced by the Credit Agreement, or the Loans, a re guaranteed by all of the Company’s direct and indirect domestic subsidiaries, and secured by substantially all of the assets of the Company and the guarantors. The Loans are subject to restrictive covenants under the Credit Agreement, and financial cove nants that require the Company and its subsidiaries to maintain certain financial ratios on a consolidated basis, including a maximum leverage, minimum fixed charge coverage and minimum working capital. Prepayment of the Loans is allowed by the Credit Agre ement at any time during the terms of the Loans. The Loans also contain limitations on the Company’s ability to incur additional indebtedness and requires lender approval for acquisitions funded with cash, promissory notes and/or other consideration in exc ess of $6.0 million and for acquisitions funded solely with equity in excess of $10.0 million. As of December 31, 2016 and December 31, 2015 , the C ompany had borrowings of $ 13.7 million and $ 18.7 million, net of deferre d financing costs, respectively, outstanding under its Credit Agreement. The carrying value of the debt approximates fair value because the interest rate under the obligation approximates market rates of interest available to the Company for similar instru ments. As of December 31, 2016 , the Company was in compliance with all financial covenants contained in the Credit A greement, was subject to covenant and w orking capital borrowing restriction s and had available borrowing capacity und er its Credit Agreement of $ 8.7 million . As of December 31, 2016 , the weighted effective interest rates , net of the impact of the Company’s interest rate swaps, on its Term Loan, DDTL and Revolving Line borrowings were 3.96% , 3.73% and 3.02% , respectively. As of December 31, 2016 and December 31, 2015 , the Company’s borrowings were comprised of: December 31, December 31, 2016 2015 (in thousands) Long-term debt: Term loan $ 5,400 $ 6,750 DDTL 4,400 5,500 Revolving line 4,050 6,650 Total unamortized deferred financing costs (104) (167) Total debt 13,746 18,733 Less: current installments (2,450) (2,450) Current unamortized deferred financing costs 78 86 Long-term debt $ 11,374 $ 16,369 The aggregate amounts of debt maturing during the next five years are as follows: (in thousands) 2017 $ 2,450 2018 11,400 2019 - 2020 - 2021 - Total $ 13,850

Derivatives

Derivatives	12 Months Ended
	Dec. 31, 2016
Derivative Instruments and Hedging Activities Disclosure [Abstract]
Derivative Instruments and Hedging Activities Disclosure [Text Block]	12 . Derivatives The Company uses interest -rate -related derivative instruments to manage its exposure related to changes in interest rates on its variable -rate debt instruments. The Company does not enter into derivative instruments for any purpose other than cash flow hedging. The Company does not speculate using derivative instruments. By using derivative financial instruments to hedge exposures to changes in interest rates, the Company exposes itself to credit risk and market risk. Credit risk is the f ailure of the counterparty to perform under the terms of the derivative contract. When the fair value of a derivative contract is positive, the counterparty owes the Company, which creates credit risk for the Company. When the fair value of a derivative co ntract is negative, the Company owes the counterparty and, therefore, the Company is not exposed to the counterparty’s credit risk in those circumstances. The Company minimizes counterparty credit risk in derivative instruments by entering into transaction s with carefully selected major financial institutions based upon their credit profile. Market risk is the adverse effect on the value of a derivative instrument that results from a change in interest rates. The market risk associated with interest -rat e contracts is managed by establishing and monitoring parameters that limit the types and degree of market risk that may be undertaken. The Company assesses interest rate risk by continually identifying and monitoring changes in interest rate exposures th at may adversely impact expected future cash flows and by evaluating hedging opportunities. The Company maintains risk management control systems to monitor interest rate risk attributable to both the Company’s outstanding or forecasted debt obligations as well as the Company’s offsetting hedge positions. The risk management control systems involve the use of analytical techniques, including cash flow sensitivity analysis, to estimate the expected impact of changes in interest rates on the Company’s future cash flows. The Company uses variable -rate London Interbank Offered Rate (LIBOR) debt to finance its operations. The debt obligations expose the Company to variability in interest payments due to changes in interest rates. Management believes that it is p rudent to limit the variability of a portion of its interest payments. To meet this objective, management enters into LIBOR based interest rate swap agreements to manage fluctuations in cash flows resulting from changes in the benchmark interest rate of LI BOR. These swaps change the variable -rate cash flow exposure on the debt obligations to fixed cash flows. Under the terms of the interest rate swaps, the Company receives LIBOR based variable interest rate payments and makes fixed interest rate payments, thereby creating the equivalent of fixed-rate debt for the notional amount of its debt hedged. In accordance with its Credit Agreement, the Company was required to fix the rate of interest on at least 50% of its Term Loan and the DDTL through the purchase of interest rate swaps. On June 5, 2013, the Company entered into an interest rate swap contract with an original notional amount of $15.0 million and a maturity date of March 29, 2018 in order to hedge the risk of changes in the effective benchmark inter est rate (LIBOR) associated with the Company’s Term Loan. On November 29, 2013, the Company entered into a second interest rate swap contract with an original notional amount of $5.0 million and a maturity date of March 29, 2018 in order to hedge the risk of changes in the effective benchmark interest rate (LIBOR) associated with the DDTL. The notional amount of the Company’s derivative instruments as of December 31, 2016 was $5 .5 million . The Term Loan swap contract effectively converted specific variable-rate debt into fixed-rate debt and fixed the LIBOR rate associated with the Term Loan at 0.96% plus a ba nk margin of 2.75% . The DDTL swap contract effectively converted specific variable-rate debt into fixed-rate debt and fixed the LIBOR rate associated with the Term Loan at 0.93% plus a bank margin of 2.75% .The interest rate swap s were designated as cash flow hedge s in accordance with ASC 815, Derivatives and Hedging . The following table pr esents the notional amount and fair value of the Company ’ s derivative instrument s as of December 31, 2016 and December 31, 2015 . December 31, 2016 December 31, 2016 Notional Amount Fair Value (a) Derivatives designated as hedging instruments under ASC 815 Balance sheet classification (in thousands) Interest rate swaps Other liabilities-non current $ 5,500 $ - December 31, 2015 December 31, 2015 Notional Amount Fair Value (a) Derivatives designated as hedging instruments under ASC 815 Balance sheet classification (in thousands) Interest rate swaps Other liabilities-non current $ 9,500 $ (10) (a) See Note 13 for the fair value measurements related to these financial instruments. All of the Company’s derivative instruments are designated as hedging instruments. The Company has structured its interest rate swap agreements to be 100% effective and as a result, there was no impact to earnings resulting from hedge ineffectiveness. Changes in the fair value of interest rate swaps designated as hedging instruments that effectively offset the variability of cash flows associate d with variable -rate, long -term debt obligations are reported in accumulated other comprehensive income (“AOCI”). These amounts subsequently are reclassified into interest expense as a yield adjustment of the hedged interest payments in the same period in which the related interest affects earnings. The Company’s interest rate swap agreement was deemed to be fully effective in accordance with ASC 815, and, as such, unrealized gains and losses related to these derivatives were recorded as AOCI. The followi ng table summarizes the effect of derivatives designated as cash flow hedging instruments and their classification within comprehensive loss for the years ended December 31, 2016 , 2015 and 2014 : Derivatives in Hedging Relationships Amount of gain or (loss) recognized in OCI on derivative (effective portion) Year Ended December 31, 2016 2015 2014 (in thousands) Interest rate swaps $ (29) $ (85) $ (99) The following table summarizes the reclassifications out of accumulated other comprehensive loss for the years ended December 31, 2016 , 2015 and 2014 : Details about AOCI Components Amount reclassified from AOCI into income (effective portion) Location of amount Year Ended December 31, reclassified from AOCI 2016 2015 2014 into income (effective portion) (in thousands) Interest rate swaps $ 39 $ 93 $ 130 Interest expense As of December 31, 2016 , the deferred losses on derivative inst ruments accumulated in AOCI expected to be reclassified to earnings during the next twelve months were immaterial . Transactions and events expected to occur over the next twelve months that will necessitate reclassifying these derivatives’ losses to earnings include the repricing of variable -rate debt. There were no cash flow hedges discontinued during 2016 or 2015 .

Fair Value Measurements

Fair Value Measurements	12 Months Ended
	Dec. 31, 2016
Fair Value Disclosures [Abstract]
Fair Value Disclosures [Text Block]	13 . Fair Value Measurements Fair value measurement is defined as the price that would be received to sell an asset or paid to transfer a liability in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants at the measurement date. A fair value hierarchy is established, which prioritizes the inputs used in measuring fair value into three broad levels as follows: Level 1—Quoted prices in active markets for identical assets or liabilities. Level 2—Inputs, other than the quoted prices in active markets, that are observable either directly or indirectly. Level 3—Unobservable inputs based on the Company’s own assumptions. The following table s present the fair value hierarchy for those liabili ties measured at fair value on a recurring basis: Fair Value as of December 31, 2016 (In thousands) Level 1 Level 2 Level 3 Total Liabilities: Interest rate swap agreements $ - $ - $ - $ - Fair Value as of December 31, 2015 (In thousands) Level 1 Level 2 Level 3 Total Liabilities: Interest rate swap agreements $ - $ 10 $ - $ 10 The Company uses the market approach technique to value its financial liabilities. The Company’s financial liabilities carried at fair value include derivative instruments used to hedge the Company’s interest rate risks. The fair value of the Company’s interest rate swap agreement s was based on LIBOR yield curves at the reporting date.

Leases

Leases	12 Months Ended
	Dec. 31, 2016
Leases Disclosure [Abstract]
Leases Disclosure [Text Block]	14 . Leases The Company has noncancelable operating leases for office and warehouse space expiri ng at various dates through 2021 and thereafter. Rent expense, which is recorded on a straight-line basis, was $ 1.8 million, $ 2.1 million and $ 1.7 million for the years ended December 31, 2016 , 2015 and 2014 , respectively. Future minimum lease payments for operating leases, with initial or remaining terms in excess of one year at December 31, 2016 , are a s follows: Operating Leases (in thousands) 2017 $ 1,600 2018 1,614 2019 1,489 2020 1,284 2021 1,087 Thereafter 2,919 Net minimum lease payments $ 9,993

Accrued Expenses

Accrued Expenses	12 Months Ended
	Dec. 31, 2016
Accrued Liabilities Current [Abstract]
Accrued Expenses Disclosure [Text Block]	15 . Accrued Expenses Accrued expenses consist of: December 31, 2016 2015 (in thousands) Accrued compensation and payroll $ 1,468 $ 1,264 Accrued professional fees 1,105 1,055 Accrued severance - 132 Warranty costs 193 147 Other 1,784 1,423 Total $ 4,550 $ 4,021

Income Taxes

Income Taxes	12 Months Ended
	Dec. 31, 2016
Income Tax [Abstract]
Income Taxes Disclosure [Text Block]	16. Income Tax Year Ended December 31, 2016 2015 2014 (in thousands) Current income tax expense: Federal and state $ 170 $ (4) $ 27 Foreign 790 677 424 960 673 451 Deferred income tax expense: Federal and state 166 15,598 1,793 Foreign 103 (840) (182) 269 14,758 1,611 Total income tax expense $ 1,229 $ 15,431 $ 2,062 Income tax expense for the years ended December 31, 2016 , 2015 and 2014 differed from the amount computed by applying the U.S. federal income tax ra te of 34% to pre-tax operations income as a result of the following: Year Ended December 31, 2016 2015 2014 (in thousands) Computed "expected" income tax (benefit) expense $ (1,046) $ (1,227) $ 1,503 Increase (decrease) in income taxes resulting from: Permanent differences, net (128) 32 (93) Foreign tax rate differential 165 (12) (364) State income taxes, net of federal income tax benefit (93) 82 22 Non-deductible stock compensation expense 110 (161) 67 Impact of foreign rate change 30 89 - Tax credits (89) (169) (385) Change in reserve for uncertain tax position 127 35 - Impact of change to prior year tax accruals 291 370 - U.S. tax on foreign dividends 497 - - Foreign withholding taxes 74 - - Conversion of U.S. foreign tax credits from credit to deduction 1,772 - - Non-deductible loss on subsidiary stock sale 501 - - Change in valuation allowance allocated to income tax expense (benefit) (983) 16,401 1,346 Other 1 (9) (34) Total income tax expense $ 1,229 $ 15,431 $ 2,062 Income tax expense is based on the following pre-tax (loss) income from operations for the years ended December 31, 2016 , 2015 and 2014 : Year Ended December 31, 2016 2015 2014 (in thousands) Domestic $ (3,107) $ (3,331) $ 1,846 Foreign 29 (277) 2,571 Total $ (3,078) $ (3,608) $ 4,417 The tax effects of temporary differences that give rise to significant components of the deferred tax assets and deferred tax liabilities from operations at December 31, 2016 and 2015 are as follows: December 31, 2016 2015 (in thousands) Deferred tax assets: Accounts receivable $ 170 $ 45 Inventory 1,336 1,447 Operating loss and credit carryforwards 12,586 14,456 Property, plant and equipment 5 18 Accrued expenses - 107 Pension liabilities 631 535 Contingent consideration 3,262 2,987 Tax credits on repatriation - 1,728 Stock compensation expense 2,076 1,491 Other assets 23 588 Total gross deferred assets 20,089 23,402 Less: valuation allowance (17,840) (18,823) Deferred tax assets $ 2,249 $ 4,579 Deferred tax liabilities: Indefinite-lived intangible assets $ 4,567 $ 4,593 Definite-lived intangible assets 2,593 2,587 Accrued tax liability on repatriation - 1,728 Other accrued liabilities 349 655 Total deferred tax liabilities 7,509 9,563 Net deferred tax liabilities $ (5,260) $ (4,984) Certain prior year amounts in the above table have been reclassified for consistency with the current year presentation. These reclassifications had no effect on the Company’s consolidated financial statements. The Company’s deferred tax assets in the table above as of December 31, 201 6 and December 31, 201 5 , do not include any excess tax benefits from the exercise of employee stock options that are a component of net operating losses as these benefits can only be recognized when the related tax deduction reduces income taxes payable. As of December 31, 2016 and 2015, the Company’s operating loss carryforwards included $1.6 million in income tax deductions related to stock options, the benefit of which will be re flected as a credit to additional paid-in capital if realized , of which $0.9 million arose in 2015 . The amounts recorded as deferred tax assets as of December 31, 2016 and 2015 represent the amount of tax benefits of existing deductible temporary differences and carryforwards that are more likely than not to be realized through the generation of sufficient future taxable income within the carryforward period. Significant management judgment is required in determining any valuation allowa nce recorded against deferred tax assets and liabilities. During the year ended December 31, 2015 , the Company determined that it was more likely than not that its U.S. deferred tax assets would not be re alized and therefore recorded a net in crease to the valuation allowance of $16. 4 million to offset U.S. deferred tax assets net of deferred tax liabilities except for deferred tax liabilities associated with certain indefinite-lived intangible assets. The Company’s judgment was based on consid eration of all available evidence. At December 31, 2016, a full valuation allowance continues to be maintained on net U.S. deferred tax assets. At December 31, 2016 , the Company had federal net operating loss carryforwards of $21.4 million, which begin to expire in 2022 and state net operating loss carryforwards of $ 8.9 million, which begin to expire in 2017. The Company also had foreign tax credit carryforwards of $1.0 million which expire in 2017, and research and development tax credit carryfor wards of $1.6 million which begin to expire in 2020. The Company had $0.2 million of alternative minimum tax credit carryforwards which are not subject to expiration. In addition, the Company had a total of $0.9 million of state investment tax credit car ryforwards, research and development tax credit carryforwards, and EZ credit carryforwards, which begin to expire in 2017 . Approximately $4.7 million of net operating losses are subject to an annual limitation of $0.7 million imposed by change in ownership provisions of Section 382 of the Internal Revenue Code. As mentioned above, these net operating loss and credit carryforwards have full valuation allowances set up against them. Undistributed earnings of the Company’s fore ign subsidiaries amounted to approximately $48.6 million, $48.7 million, and $51.9 million at December 31, 2016 , 2015 and 2014 , respectively. At December 31, 2016 and 2015 , cash and cash equivalents held by th e Company’s foreign subsidiaries was $4.5 million and $5.7 million, respectively. Funds held by the Company’s foreign subsidiaries are not available for domestic operations unless the funds are repatriated. If the Company planned to or did repatriate thes e funds, then U.S. federal and state income taxes would have to be recorded on such amounts. The Company’s reinvestment determination is based on the future operational and capital requirements of its U.S. and non-U.S. operations. As of December 31, 2015 , the Company determined that the assertion of permanent reinvestment at its foreign subsidiaries in Canada and France was no longer appropriate and it repatriated approximately $3.5 million during th e year ended December 31, 2016, which comprised all of the funds available for repatriation. The total tax liability of approximately $1.2 million associated with the repatriation of undistributed earnings in Canada and France , will be offset by the use of carried forward net operating losses. The Com pany does not intend to repatriate any of the undistributed foreign earnings in any other countries. These balances are considered permanently reinvested and will be used for foreign items including foreign acquisitions, capital investments, pension obliga tions and operations. It is impracticable to estimate the total tax liability, if any, which would be created by the future distribution of these earnings. In 2014, the Company utilized approximately $11.2 million of foreign cash to acquire all issued and outstanding shares of MCS, a German manufacturer. In 2015, the Company utilized approximately $5.9 million of foreign cash to acquire all issued and outstanding shares of HEKA, a manufacturer with operations in Germany and Canada. In 2015 , the Co mpany also used $0.3 million of foreign cash on hand for capital improvements at AHN, a German subsidiary . (in thousands) Balance at December 31, 2014 $ 250 Additions based on tax positions of prior years 35 Balance at December 31, 2015 285 Additions based on current year tax positions 59 Additions based on tax positions of prior years 62 Balance at December 31, 2016 $ 406 At December 31, 2016 and 2015 the amount of unrecognized tax benefits that would affect the Compa ny’s effective tax rate was $0.4 million and $0.3 million , respectively. The Company classifies interest and penalties related to unrecognized tax benefits as a component of income tax expense. For the years ended December 31, 2016 and 2015 , respectively, interest recognized in the consolidated statement of oper ations was immaterial, and there were no penalties recognized. The Company or one of its subsidiaries files income tax returns in the U.S. federal jurisdiction, and various states and foreign jurisdictions. With few exceptions, the Company is no longer s ubject to income tax examinations by tax authorities for years before 20 12 . During 2013, the Company closed its IRS audit for the 2009 and 2010 tax years. There were no material adjustments. During 2014 the Company closed its audit for tax years 2009 and 2 010 by the Massachusetts Department of Revenue with no material adjustments. The Com p any’s Canadian subsidiary audit by the Canadian Revenue Agency for the 2011 tax year was closed in February 2015 with no adjustments. During 2015, one of the Company’s Ger man subsidiar ies began an income tax audit and d uring 2016, various transfer pricing issues were raised, for which the Company has recorded a reserve in the amount of $62 ,000. In June 2015, the Company’s acquired German subsidiary, HEKA, closed an income t ax audit for 2008-2012 with no material adjustments. In 2016, HEKA closed an income tax audit for 2013-2014 with no material adjustments. The Company is not aware of any tax audits in other major jurisdictions .

Employee Benefit Plans

Employee Benefit Plans	12 Months Ended
	Dec. 31, 2016
Employee Benefit Plans Disclosure [Abstract]
Employee Benefit Plans Disclosure [Text Block]	17 . Employee Benefit Plans The Company sponsors profit sharing retirement plans for its U.S. employees, which includes employee savings plans established under Section 401(k) of the U.S. Internal Revenue Code (the 401(k) Plans ). The 401(k) Plans cover substantially all full-time employees who meet certain eligibility requirements. Contributions to the profit sharing retirement plans are at the discretion of management. For the years ended December 31, 2016 , 2015 and 2014 , the Company contributed approximately $ 0.6 million, $ 0.5 million and $0.5 million , respectively, to the 401(k) Plans. Certain of the Company’s subs idiaries in the United Kingdom, Harvard Apparatus Limited and Biochrom, maintain contributory, defin ed benefit or defined contribution pension plans for substantially all of their employees. As of December 31, 2014, the principal employer of the Harvard Apparatus Limited pension plan was changed from Harvard Apparatus Limited to Biochrom. As of December 31, 2014, these defined benefit pension plans were closed to new employees, as well as closed to the future accrual of benefits for existing employees. The provisions of FASB ASC 715-20 require that the funded status of the Company’s pension plans be rec ognized in its balance sheet. FASB ASC 715-20 does not change the measurement or income statement recognition of these plans, although it does require that plan assets and benefit obligations be measured as of the balance sheet date. The Company has histor ically measured the plan assets and benefit obligations as of the balance sheet date. The components of the Company’s defined benefit pension expense were as follows: Year Ended December 31, 2016 2015 2014 (in thousands) Components of net periodic benefit cost: Interest cost 632 711 893 Expected return on plan assets (683) (668) (649) Net amortization loss 304 306 259 Net periodic benefit cost $ 253 $ 349 $ 503 The measurement date is December 31 for these plans. The funded status of the Company’s defined benefit pension plans and the amount recognized in the consolidated balance sheets at December 31, 2016 and 2015 is as follo ws: December 31, 2016 2015 (in thousands) Change in benefit obligation: Balance at beginning of year $ 18,582 $ 21,170 Interest cost 632 711 Actuarial loss (gain) 4,636 (1,360) Benefits paid (982) (1,021) Currency translation adjustment (3,654) (918) Balance at end of year $ 19,214 $ 18,582 December 31, 2016 2015 (in thousands) Change in fair value of plan assets: Balance at beginning of year $ 15,767 $ 16,724 Actual return on plan assets 3,868 70 Employer contributions 694 752 Benefits paid (982) (1,021) Currency translation adjustment (3,095) (758) Balance at end of year $ 16,252 $ 15,767 December 31, 2016 2015 (in thousands) Change in benefit obligation: Funded status $ (2,962) $ (2,815) Unrecognized net loss N/A N/A Net amount recognized $ (2,962) $ (2,815) The accumulated benefit obligation for all defined benefit pension plans was $ 19.2 million and $ 18.6 million at December 31, 2016 and 2015 , respectively. The amounts recognized in the consolidated balance sheets consist of: December 31, 2016 2015 (in thousands) Deferred income tax assets $ 504 $ 535 Other long term liabilities (2,962) (2,815) Net amount recognized $ (2,458) $ (2,280) The amounts recognized in accumulated other comprehensive loss , net of tax consist of: December 31, 2016 2015 (in thousands) Underfunded status of pension plans $ (2,458) $ (2,280) Net amount recognized $ (2,458) $ (2,280) The weighted average assumptions used in determining the net pension cost for these plans follows: Year Ended December 31, 2016 2015 2014 Discount rate 2.62% 3.57% 4.43% Expected return on assets 4.68% 4.43% 4.15% The discount rate assumptions used for pension accounting reflect the prevailing rates available on high-quality, fixed-income debt instruments with terms that match the average expected duration of the Company’s defined benefit pension plan obligations. The Company use s the iBoxx AA 15yr+ index, which matches the average duration of its pension plan liability of approximately 15 years. With the current base of assets in the pension plans, a one percent increase/decrease in the discount rate assumption wo uld decrease/increase annual pension expense by approximately $ 30,000 . The Company’s mix of pension plan investments among asset classes also affects the long-term expected rate of return on plan assets. As of December 31, 2016 , the Company’s actual asset mix approximated its target mix. Differences between actual and expected returns are recognized in the calculation of net periodic pension (income)/cost over the average remaining expected future working lifetime, which is appr oximately 1 5 years, of active plan participants. With the current base of assets, a one percent increase/decrease in the asset return assumption would decrease/increase annual pension expense by approximately $ 163,000 . The fair value and asse t allocations of the Company’s pension benefits as of December 31, 2016 and 2015 measurement dates were as follows: December 31, 2016 2015 (in thousands) Asset category: Equity securities $ 8,577 53% $ 8,506 54% Debt securities 7,447 46% 7,103 45% Cash and cash equivalents 228 1% 158 1% Total $ 16,252 100% $ 15,767 100% Financial reporting standards define a fair value hierarchy that consists of three levels. The fair values of the plan assets by fair value hierarchy level as of December 31, 2016 and 2015 is as follows: December 31, 2016 2015 (in thousands) Quoted Prices in Active Markets for Identical Assets (Level 1) $ 228 $ 158 Significant Other Observable Inputs (Level 2) 16,024 15,609 Significant Other Unobservable Inputs (Level 3) - - Total $ 16,252 $ 15,767 Level 1 assets consist of cash and cash equivalents held in the pension plans at December 31, 2016 . The Level 2 assets primarily consist of investments in private investment funds that are valued using the net asset values provided by the trust or fund, including an insurance contract. Although these funds are not traded in an active market with quoted prices, the investments underlying the net asset value are based on quoted prices. Included in Level 3 assets is an investment in a longevity fund which invests in a portfolio of physical life insurance settlements that are valued using the net asset values provided by the fund. Since June 2011, the fund has been closed to all activity. Due to the illiquidity and inactivity of the fund, during the year en ded December 31, 2014, the Company wrote down its Level 3 investment to $0. The Company expects to contribute approximately $ 0.7 million to its pension plans during 2017 . The benefits expected to be paid from the pension plans are $ 0.5 million in 2017 , $ 0.4 million in 2018 , $ 0.6 million in 2019 , $ 0.5 million in 2020 and $ 0.5 million in 2021 . The expected benefits to be paid in the five years from 2021 —2025 are $ 3.6 million. The expected benefits are based on the same assumptions used to measure the Company’s benefit obligation at December 31, 2016 .

Commitments and Contingent Liab

Commitments and Contingent Liabilities	12 Months Ended
	Dec. 31, 2016
Commitments and Contingencies Disclosure [Abstract]
Commitments and Contingencies Disclosure [Text Block]	18 . Commitments and Contingent Liabilities From time to time, the Company may be involved in various claims and legal proceedings arising in the ordinary course of business. The Company is not currently a party to any such material claims or proceedings.

Capital Stock

Capital Stock	12 Months Ended
	Dec. 31, 2016
Capital Stock Disclosure [Abstract]
Capital Stock Disclosure [Text Block]	19 . Capital Stock Common Stock On February 5, 2008, the Company’s Board of Directors adopted a Shareholder Rights Plan and declared a dividend distribution of one preferred stock purchase right for each outstanding share of the Company’s common stock to shareholders of record as of the close of business on February 6, 2 008. Initially, these rights will not be exercisable and will trade with the shares of the Company’s common stock. Under the Shareholder Rights Plan, the rights generally will become exercisable if a person becomes an “acquiring person” by acquiring 20% or more of the common stock of the Company or if a person commences a tender offer that could result in that person owning 20% or more of the common stock of the Company. If a person becomes an acquiring person, each holder of a right (other than the acquiri ng person) would be entitled to purchase, at the then-current exercise price, such number of shares of preferred stock which are equivalent to shares of the Company’s common stock having a value of twice the exercise price of the right. If the Company is a cquired in a merger or other business combination transaction after any such event, each holder of a right would then be entitled to purchase, at the then-current exercise price, shares of the acquiring company’s common stock having a value of twice the ex ercise price of the right. Preferred Stock The Company’s Board of Directors has the authority to issue up to 5.0 million shares of preferred stock and to determine the price privileges and other terms of the shares. The Board of Directors may exercise th is authority without any further approval of stockholders. As of December 31, 2016 , the Company had no preferred stock issued or outstanding . Employee Stock Purchase Plan (as amended, the “ESPP”) In 2000, the Company approved the ESPP . Under thi s ESPP , participating employees can authorize the Company to withhold a portion of their base pay during consecutive six-month payment periods for the purchase of shares of the Company’s common stock. At the conclusion of the period, participating employee s can purchase shares of the Company’s common stock at 85% of the lower of the fair market value of the Company’s common stock at the beginning or end of the period. Shares are iss ued under the ESPP for the six-month periods ending June 30 and December 31. Under this plan, 750,000 shares of common stock are authorized for issuance of which 725,239 shares were issue d as of December 31, 2016 . During the years ended December 31, 2016 , 2015 and 2014 , the C ompany issued 81,228 shares, 58,823 shares and 57,848 , respectively, of the Company’s common stock under the ESPP. Stock Option Plans Third Amended and Restated 2000 Stock Option and Incentive Plan (as amended, the “Thi rd A&R Plan”) The Second Amendment to the Third A&R Plan (the “Amendment”) was adopted by the Board of Directors on April 3, 2015. Such Amendment was approved by the stockholders at the Company’s 2015 Annual Meeting of Stockholders . Pursuant to the Amendment, the aggregate number of shares authorized for issuance under the Third A&R Plan was increased by 2,500,000 shares to 17,508,929. Through December 31, 2016 , 2015 and 2014 , incentive stock options to purchase 10,218, 057 shares and non-qualified stock options to purchase 13,131 ,374, 13,088,374 and 12,143,374 shares, respectively, had been granted to employees and directors under the Stock Plans. Generally, both the incentive stock options and non -qualified stock option s become fully vested over a range of one to four-year periods. Restricted Stock Units with a Market Condition (the “Market Condition RSU’s”) On August 3, 2015, the Compensation Committee of the Board of Directors of the Company approved and granted defe rred stock awards of Market Condition RSU’s to members of the Company’s management team under the Third A&R Plan. The vesting of these Market Condition RSU’s is cliff-based and linked to the achievement of a relative total shareholder return of the Compan y’s common stock from August 3, 2015 to the earlier of (i) August 3, 2018 or (ii) upon a change of control (measured relative to the Russell 3000 index and based on the 20-day trading average price before each such date). As of December 31, 2016 , t he target number of these restricted stock units that may be earned is 182,150 shares; the maximum amount is 150% of the target number. Stock-Based Payment Awards The Company accounts for stock-based payment awards in accordance with the provisions of F ASB ASC 718, which requires it to recognize compensation expense for all stock-based payment awards made to employees and directors including stock options, restricted stock units, Market Condition RSU’s and employee stock purchases related to the ESPP. F ASB ASC 718 requires companies to estimate the fair value of stock-based payment awards, except restricted stock units, on the date of grant using an option-pricing model. The value of the portion of the award that is ultimately expected to vest is recogni zed as expense over the requisite service periods in its consolidated statements of operations. The Company values stock-based payment awards, except restricted stock units, using the Black-Scholes option-pricing model. The Company values the Market Cond ition RSU’s using a Monte-Carlo valuation simulation. The determination of fair value of stock-based payment awards on the date of grant using an option-pricing model or Monte-Carlo valuation simulation is affected by its stock price as well as assumptions regarding certain variables . These variables include, but are not limited to its expected stock price volatility over the term of the awards and actual and projected stock option exercise behaviors. The Company records stock compensation expense on a stra ight-line basis over the requisite service period for all awards granted since the adoption of FASB ASC 718. Earnings per share Basic earnings per share is based upon net income divided by the number of weighted average common shares outstanding during the period. The calculation of diluted earnings per share assumes conversion of stock options, restricted stock units and Market Condition RSU’s into common stock using the treasury method. The weighted av erage number of shares used to compute basic and diluted earnings per share consists of the following: Year Ended December 31, 2016 2015 2014 Basic 34,211,521 33,592,775 32,170,683 Effect of assumed conversion of employee and director stock options, restricted stock units and Market Condition RSU's - - 1,065,886 Diluted 34,211,521 33,592,775 33,236,569 Excluded from the shares used in calculating the diluted earnings per common share in the above table are options, restricted stock units and Market Condition RSU’s of approximately 5,351,261 , 5,521,283 and 2,526,641 shares of common stock for the years ended December 31, 2016 , 2015 and 2014 , respectively, as the impact of these shares would be anti-dilutive. General Option Information The following is a summary of stock option and t he restricted stock unit activity: Stock Options Restricted Stock Units Market Condition RSU's Weighted Stock Average Restricted Market Options Exercise Stock Units Grant Date Condition RSU's Grant Date Outstanding Price Outstanding Fair Value Outstanding Fair Value Balance at December 31, 2013 6,690,845 $ 3.42 463,973 $ 4.32 - $ - Granted 1,115,300 4.18 116,400 4.12 - - Exercised (695,173) 3.08 - - - - Vested (RSUs) - - (233,098) - - - Cancelled / forfeited (847,860) 4.67 (40,878) 4.36 - - Balance at December 31, 2014 6,263,112 3.42 306,397 4.30 - - Granted 945,000 5.31 254,685 5.56 196,785 4.81 Exercised (1,772,062) 3.04 - - - - Vested (RSUs) - - (237,188) - - - Cancelled / forfeited (413,864) 4.15 (10,335) 5.56 (11,247) 4.81 Balance at December 31, 2015 5,022,186 3.85 313,559 5.29 185,538 4.81 Granted 43,000 3.10 1,095,190 2.92 - - Exercised (374,772) 2.80 - - - - Vested (RSUs) - - (301,520) - - - Cancelled / forfeited (593,596) 3.84 (34,576) 3.89 (3,388) 4.81 Balance at December 31, 2016 4,096,818 $ 3.94 1,072,653 $ 3.15 182,150 $ 4.81 The Company’s policy is to issue stock available from its registered but unissued stock pool through its transfer agent to satisfy stock option exercises and vesting of the restricted stock units. The following table summarizes information concerning currently outstanding and exercisable options as of December 31, 2016 (Aggregate Intrinsic Value, in thousands): Options Outstanding Options Exercisable Weighted Weighted Average Weighted Average Weighted Range of Shares Remaining Average Aggregate Shares Remaining Average Aggregate Exercise Outstanding at Contractual Life Exercise Intrinsic Exercisable at Contractual Life Exercise Intrinsic Price Dec. 31, 2016 in Years Price Value Dec. 31, 2016 in Years Price Value $ 2.02-2.42 462,464 2.13 $ 2.21 $ 388 462,464 2.13 $ 2.21 $ 388 2.43-2.72 436,028 4.60 2.57 209 436,028 4.60 2.57 209 2.73-3.68 511,706 6.10 3.50 - 344,052 5.33 3.59 - 3.69-4.07 411,070 3.75 3.97 - 393,570 3.53 3.98 - 4.08-4.17 653,875 7.41 4.12 - 321,875 7.41 4.12 - 4.18-4.26 71,500 7.65 4.21 - 37,625 7.61 4.21 - 4.27-4.41 750,000 6.88 4.31 - 687,500 6.88 4.31 - 4.42-5.39 161,800 7.92 4.97 - 79,117 7.86 4.92 - 5.40-5.51 353,375 8.18 5.51 - 89,750 8.18 5.51 - 5.52-5.63 285,000 8.41 5.56 - 71,250 8.41 5.56 - $ 2.02-5.63 4,096,818 6.05 $ 3.94 $ 597 2,923,231 5.33 $ 3.65 $ 597 The aggregate intrinsic value in the preceding table represents the total pre-tax intrinsic value, based on the Company’s closing stock price of $ 3.05 as of December 31, 2016 , which would have been received by the option holders had all option holders exercised their options as of that date. T he aggregate in trinsic value of options exercised for the years ended December 31, 2016 , 2015 and 2014 was approximately $ 0.1 million, $ 0.8 million and $ 1.8 million , respectively. The to tal number of in-the-money options that were exercisable as of December 31, 2016 was 914,492 . For the year ended December 31, 2016 , the total compensation costs related to unvested awards not yet recognized is $ 3.8 million and the weighted average period over which it is expected to be recognized is 2.07 years. Valuation and Expense Information under Stock-Based-Payment Accounting Stock-based compensation expense related to stock option s, restricted stock units, Market Condition RSU’s and the employee stock purchase plan for the years ended December 31, 2016 , 2015 and 2014 was allocated as follows: Year Ended December 31, 2016 2015 2014 (in thousands) Cost of revenues $ 60 $ 70 $ 132 Sales and marketing 546 418 343 General and administrative 2,780 2,170 1,620 Research and development 111 97 61 Total stock-based compensation $ 3,497 $ 2,755 $ 2,156 On April 28, 2015, the Company announced the appointment of James Green to its Board of Directors and the retirement of Robert Dishman from its Board of Directors . As part of Dr. Dishman’s retirement, the Company (i ) awarded an unrestricted stock award to Dr. Dishman on April 28, 2015, having an aggregate cash value of $80,000, (ii) accelerated the vesting of all outstanding stock options and restricted stock units that were unvested as of April 28, 2015, and (iii) e xtended the post-retirement option exercise period for each option to the earlier to occur of the respective scheduled expiration date or April 28, 2016. Total compensation expense recognized as part of general and administrative expenses for the year ended December 31, 2015 , as part of these modifications, was approximately $0.1 million. The Company did not capitalize any stock-based compensation. The weighted-average estimated fair value per share of stock options granted during 2016 , 2015 and 2014 was $ 1.21 , $ 2.12 and $ 2.18 , respectively, using the Black Scholes option-pricing model with the following weighted-average assumptions: Year Ended December 31, 2016 2015 2014 Volatility 41.97 % 40.97 % 55.78 % Risk-free interest rate 1.29 % 1.72 % 1.80 % Expected holding period (in years) 5.21 years 5.50 years 5.76 years Dividend yield - % - % - % The weighted average fair value of the Market Condition RSU’s granted under the Third A&R Plan during the year ended December 31, 2015 was $ 4.81 . The following assumptions were used to estimate the fair value , using a Monte-Carlo valuation simulation, of the Market Condition RSU’s granted during the year ended December 31, 2015 : Year Ended December 31, 2015 Volatility 35.88 % Risk-free interest rate 0.99 % Correlation coefficient 0.25 % Dividend yield - % The Company used historical volatility to calculate the expected volatility as of December 31, 2016 . Historical volatility was determined by calculating the mean reversion of the daily adjusted closing stock price. The risk-free interest rate assumption is based upon observed U.S. Treasury bill interest rates (risk-free) appropriate for the term of the Co mpany’s stock options. The expected holding period of stock options represents the period of time options are expected to be outstanding and were based on historical experience. The vesting period ranges from one to four years and the contractual life is t en years. Stock-based compensation expense recognized in the consolidated statement s of operations for the years ended December 31, 2016 , 2015 and 2014 is based on awards ultimately expected to vest and has be en reduced for annual ized estimated forfeitures of 8.41% , 8.06% and 7.05% , respectively. Stock-based-payment accounting requires forfeitures to be estimated at the time of grant and revised, if necessary, in subsequent periods if actual forfeitur es differ from those estimates. Forfeitures were estimated based on historical experience.

Related Party Transactions

Related Party Transactions	12 Months Ended
	Dec. 31, 2015
Related Party Transactions [Abstract]
Related Party Transactions Disclosure [Text Block]	20 . Related Party Transactions As part of the acquisitions of MCS and TBSI, the Company signed lease agreements with the former owners of the acquired companies. The principals of such former owners were employees of the Com pany as of December 31, 2016 . Pursuant to a lease agreement , the Company incurred rent expense of approximately $ 0.2 million to the former owners of MCS for both of the years ended December 31, 2016 and 2015 , respectively, and $ 62,000 for the year ended December 31, 2014 . Pursuant to a lease agreement , the Company incurred rent expense of approximately $ 42,000 to the former owner of TBSI for both of the years ended December 31, 2016 and 2015 , respectively, and $ 11,000 for the year ended December 31, 2014 .

Segment Reporting

Segment Reporting	12 Months Ended
	Dec. 31, 2016
Segment and Related Information Disclosure [Abstract]
Segment Reporting Disclosure [Text Block]	21 . Segment and Related Information Operating segments are determined by products and services provided by each segment, internal organization structure, the manner in which operations are managed, criteria used by the C hief Operating Decision Maker, or CODM, to assess the segment performance, as well as resource allocation and the availability of discrete financial information. The Company has one ope rating segment. As such, segment results and consolidated results are the same. The following tables summarize selected financial information of the Company’s continuing operations by geographic location: Revenues originating from the following geographic areas consist of: Year Ended December 31, 2016 2015 2014 (in thousands) United States $ 65,179 $ 64,766 $ 63,727 Germany 13,477 15,755 8,240 United Kingdom 16,421 18,051 24,754 Rest of the world 9,444 10,092 11,942 Total revenues $ 104,521 $ 108,664 $ 108,663 Long-lived assets by geographic area consist of the following: December 31, 2016 2015 (in thousands) United States $ 12,004 $ 13,610 Germany 5,504 7,817 United Kingdom 918 1,440 Rest of the world 3,341 3,907 Total long-lived assets (1) $ 21,767 $ 26,774 (1) Total long-lived assets includes property, plant and equipment, net and amortizable intangible assets, net. Net assets by geographic area consist of the following: December 31, 2016 2015 (in thousands) United States $ 25,736 $ 22,312 Germany 15,026 18,512 United Kingdom 16,083 17,908 Rest of the world 15,351 18,866 Total net assets $ 72,196 $ 77,598

Allowance for Doubtful Debts

Allowance for Doubtful Debts	12 Months Ended
	Dec. 31, 2016
Allowance For Doubtful Debts Disclosure [Abstract]
Allowance For Doubtful Debts Disclosure [Text Block]	22 . Allowance for Doubtful Accounts Allowance for doubtful accounts is based on the Company’s assessment of the collectability of customer accounts . A rollforward of allowance for doubtful accounts is as follows: Charged (credited) to Beginning Bad Debt Charged to Ending Balance Expense (Recoveries) Allowance (1) Other (2) Balance (in thousands) Year ended December 31, 2014 $ 358 (67) 56 (19) $ 328 Year ended December 31, 2015 $ 328 (4) 4 (18) $ 310 Year ended December 31, 2016 $ 310 309 11 (19) $ 611 (1) Consists of accounts written off, net of recoveries. (2) Consists of the effect of currency translation.

Warranties

Warranties	12 Months Ended
	Dec. 31, 2016
Warranties Disclosure [Abstract]
Warranties Disclosure [Text Block]	23 . Warranties Warranties are estimated and accrued at the time revenues are recorded. A rollforward of the Company’s product warranty accrual is as follows: Beginning Additions/ Ending Balance Payments (Credits) Balance (in thousands) Year ended December 31, 2014 $ 305 (102) 49 $ 252 Year ended December 31, 2015 $ 252 (81) (24) $ 147 Year ended December 31, 2016 $ 147 (97) 143 $ 193

Quarterly Financial Information

Quarterly Financial Information (unaudited)	12 Months Ended
	Dec. 31, 2016
Quarterly Financial Information Disclosure [Abstract]
Quarterly Financial Information (unaudited) Disclosure [Text Block]	24 . Quarterly Financial Information (unaudited) Statement of Operations Data: First Second Third Fourth Fiscal 2016 Quarter Quarter Quarter Quarter Year (in thousands, except per share data) Revenues $ 26,963 $ 26,136 $ 25,007 $ 26,415 $ 104,521 Cost of revenues 14,018 14,461 13,317 14,310 56,106 Gross profit 12,945 11,675 11,690 12,105 48,415 Total operating expenses 13,166 12,515 12,503 13,228 51,412 Operating loss (221) (840) (813) (1,123) (2,997) Other (expense) income, net (222) 73 (67) 135 (81) Loss before income taxes (443) (767) (880) (988) (3,078) Income tax expense (benefit) 193 (54) 758 332 1,229 Net loss $ (636) $ (713) $ (1,638) $ (1,320) $ (4,307) Loss per share: Basic loss per common share $ (0.02) $ (0.02) $ (0.05) $ (0.04) $ (0.13) Diluted loss per common share $ (0.02) $ (0.02) $ (0.05) $ (0.04) $ (0.13) Statement of Operations Data : First Second Third Fourth Fiscal 2015 Quarter Quarter Quarter Quarter Year (in thousands, except per share data) Revenues $ 25,763 $ 28,800 $ 25,731 $ 28,370 $ 108,664 Cost of revenues 14,285 16,205 14,005 15,446 59,941 Gross profit 11,478 12,595 11,726 12,924 48,723 Total operating expenses 12,628 12,496 12,501 12,811 50,436 Operating (loss) income (1,150) 99 (775) 113 (1,713) Other expense, net (614) (526) (321) (434) (1,895) (Loss) income before income taxes (1,764) (427) (1,096) (321) (3,608) Income tax (benefit) expense (363) (776) (249) 16,819 15,431 Net (loss) income $ (1,401) $ 349 $ (847) $ (17,140) $ (19,039) (Loss) earnings per share: Basic (loss) earnings per common share $ (0.04) $ 0.01 $ (0.02) $ (0.51) $ (0.57) Diluted (loss) earnings per common share $ (0.04) $ 0.01 $ (0.02) $ (0.51) $ (0.57)

Summary of Significant Accounti

Summary of Significant Accounting Policies (Policies)	12 Months Ended
	Dec. 31, 2016
Summary of Significant Accounting Policies [Abstract]
Principles of Consolidation [Policy Text Block]	(a) Principles of Consolidation The consolidated financial statements include the accounts of Harvard Bioscience, Inc. and its wholly-owned subsidiaries. All intercompany balances and transactions have been eliminated in consolidation.
Use of Estimates [Policy Text Block]	(b) Use of Estimates The preparation of financial statements in conformity with accounting principles generally accepted in the United States requires the use of management estimates. Such estimates include the determination and establishment of certain accruals and provisions, including those for invent ory excess and obsolescence, income tax and reserves for bad debts. In addition, certain estimates are required in order to determine the value of assets and liabilities associated with acquisitions, as well as the Company’s defined benefit pension obligations . Estimates are also required to e valuate the value and recoverability of existing long-lived and intangible assets, including goodwill. On an ongoing basis, the Company reviews its estimates based upon currently available information. Actual results could differ materially from those esti mates.
Cash and Cash Equivalents [Policy Text Block]	(c) Cash and Cash Equivalents For purposes of the consolidated balance sheets and statements of cash flows, the Company considers all highly liquid instruments with original maturities of three months or less to be cash equivalents.
Allowance for Doubtful Accounts [Policy Text Block]	(d) Allowance for Doubtful Accounts Allowance for doubtful accounts is based on the Company’s assessment of collectability of customer accounts. The Company regularly reviews the allowance by considering factors such as historical experience, credit quality, age of the accounts receivable balances and other factors that may affect a customer’s ability to pay.
Inventories [Policy Text Block]	(e) Inventories The Company values its inventories at the lower of the actual cost to purchase (first-in, first-out method) and/or manufacture the in ventories or the current estimated market value of the inventories. The Company regularly reviews inventory quantities on hand and records a provision to write down excess and obsolete inventories to its estimated net realizable value if less than cost, ba sed primarily on historical inventory usage and estimated forecast of product demand.
Property, Plant and Equipment [Policy Text Block]	(f) Property, Plant and Equipment Property, plant and equipment are stated at cost and depreciated using the straight-line method over the estimated useful lives of th e assets as follows: Buildings 40 years Machinery and equipment 3 - 10 years Computer equipment and software 3 - 7 years Furniture and fixtures 5 - 10 years Automobiles 3 - 6 years Property and equipment held under capital leases and leasehold improvements are amortized using the straight line method over the shorter of the lease term or estimated useful life of the asset.
Catalog Costs [Policy Text Block]	(g) Catalog Costs Significant costs of product catalog design, development and production are capitalized and amortized over the expected useful life of the catalog (usually one to three years).
Income Taxes [Policy Text Block]	(h) Income Taxes Income taxes are accounted for under the asset and liability method. Deferred tax assets and l iabilities are recognized for the future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax bases. Deferred tax assets and liabilities are measured using enacted tax rates expected to be applied to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that includes the enactment date. The Company recognizes the effect of income tax positions only if those positions are more likely than not of being sustained. Recognized income tax positions are measured at the largest amount that is more than 5 0% likely of being realized. Changes in recognition are reflected in the period in which the judgement occurs.
Foreign Currency Transaction [Policy Text Block]	(i) Foreign Currency Translation The functional currency of the Company’s foreign subsidiaries is generally their local currency. All assets and liabilities of its foreign subsidiaries are translated at exchange rates in effect at period-end. Income and expenses are translated at rates which approximate those in effect on the transaction dates. The resulting translation adjustment is recorded a s a separate component of stockholders’ equity in accumulated other comprehensive (loss) income (AOCI) in the consolidated balance sheets. Gains and losses resulting from foreign currency transactions are included in net (loss) income.
Earnings Per Share [Policy Text Block]	(j) Earnings per Sh are Basic earnings per share is computed by dividing net income by the weighted average number of shares of common stock outstanding during the periods presented. The computation of diluted earnings per share is similar to the computation of basic earnin gs per share, except that the denominator is increased for the assumed exercise of dilutive options and other potentially dilutive securities using the treasury stock method unless the effect is antidilutive
Comprehensive Income Loss [Policy Text Block]	(k) Comprehensive (Loss) Income The Company follows the provisions of Financial Accounting Standards Board (FASB) Accounting Standards Codification (ASC) 220, “Comprehensive Income”. FASB ASC 220 requires companies to report all changes in equity during a period, resulting from net (loss) income and transactions from non-owner sources, in a financial statement in the period in which they are recognized. The Company has chosen to disclose comprehensive (loss) income, which encompasses net (loss) income, foreign currency translation adjustments, gains and losses on derivatives, the underfunded status of its pension plans, and pension minimum additional liability adjustments, net of tax, in the consolidated statements of comprehensive (loss) income.
Revenue Recognition [Policy Text Block]	(l) Revenue Recognition The Company follows the prov isions of FASB ASC 605, “Revenue Recognition”. The Company recognizes product revenues when persuasive evidence of a sales arrangement exists, the price to the buyer is fixed or determinable, delivery has occurred, and collectability of the sales price is reasonably assured. Sales of some of its products include provisions to provide additional services such as installation and training. Revenues on these products are recognized when the additional services have been performed. Service agreements on its equ ipment are typically sold separately from the sale of the equipment. Cash received prior to rendering of the service on these contracts is recorded as deferred revenue and the revenues are recognized ratably over the life of the agreement, typically one ye ar, in accordance with the provisions of FASB ASC 605-20, “Revenue Recognition—Services”. The Company accounts for shipping and handling fees and costs in accordance with the provisions of FASB ASC 605-45-45, “Revenue Recognition—Principal Agent Considerations”, which requires all amounts charged to customers for shipping and handling to be classified as revenues. The costs incurred related to shipping and handling is classified as cost of product revenues. Warranties and product returns are estimated and accrued for at the time sales are recorded. The Company has no obligations to customers after the date products are shipped or installed, if applicable, other than pursuant to warranty obligations and service or maintenance contracts. The Company provides for the estimated amount of future returns upon shipment of products or installation, if applicable, based on histor ical experience.
Intangible Assets Finite Lived [Policy Text Block]	(m) Valuation of Identifiable Intangible Assets Acquired in Business Combinations The determination of the fair value of intangible assets, which represents a significant portion of the purchase price in the Company’s acquisitions, requ ires the use of significant judgment with regard to (i) the fair value; and (ii) whether such intangibles are amortizable or not amortizable and, if the former, the period and the method by which the intangibles asset will be amortized. The Company estimat es the fair value of acquisition-related intangible assets principally based on projections of cash flows that will arise from identifiable assets of acquired businesses. The projected cash flows are discounted to determine the present value of the assets at the dates of acquisitions. At December 31, 2016 , amortizable intangible assets include existing technology, trade names, distribution agreements, customer relationships and patents. These amortizable intangible assets are amortized on a straight -line basis over 7 to 15 years, 10 to 15 years, 4 to 5 years, 5 to 15 years and 5 to 15 years, respectively.
Goodwill and Other Intangible Assets [Policy Text Block]	(n) Goodwill and Other Intangible Assets Goodwill and unamortizable intangible assets acquired in a business combination and determined to have an indefinite useful life are not amortized, but instead are tested for impairment annually or more frequently if events or changes in circumstances indicate that the asset might be impaired, in accordance with the provisions of FASB ASC 350, “Intangibles—Goodwill and Other”. For the purpose of its goodwill analysis, the Company has one reporting unit. The Company conducted its annual impairment analysis in the fourth quarter of f iscal year 2016 . The goodwill impairment test is a two-step process. The first step of the impairment analysis compares the Company’s fair value to its carrying value to determine if there is any indication of impairment. Step two of the analysis c ompares the implied fair value of goodwill to its carrying amount in a manner similar to a purchase price allocation for business combination. If the carrying amount of goodwill exceeds its implied fair value, an impairment loss is recognized equal to that excess. For indefinite-lived intangible assets if the carrying amount exceeds the fair value of the asset, the Company would write down the indefinite-lived intangible asset to fair value. At December 31, 2016 , the fair value of the Company sign ificantly exceeded the carrying value. The Company concluded that none of its goodwill was impaired. The Company evaluates indefinite-lived intangible assets for impairment annually and when events occur or circumstances change that may reduce the fair value of the asset below its carrying amount. Events or circumstances that might require an interim evaluation include unexpected adverse business conditions, economic factors, unanticipated technological changes or competitive activities, loss of key per sonnel and acts by governments and courts. At December 31, 2016 , the Company concluded that none of its indefinite-lived intangible assets were impaired.
Impairment Of Long-Lived Assets [Policy Text Block]	(o) Impairment of Long-Lived Assets The Company assesses recoverability of its long-lived assets that are held for use, such as property, plant and equipment and amortizable intangible assets in accordance with FASB ASC 360, “Property, Plant and Equipment” when events or changes in circumstances indicate that the carrying amount of an asset or asset group may not be recoverable. Recoverability of assets or an asset group to be held and used is measured by a comparison of the carrying amount of an asset or asset group to estimated undiscounted future cash flows expected to be generated by the ass et or the asset group. Cash flow projections are based on trends of historical performance and management’s estimate of future performance. If the carrying amount of the asset or asset group exceeds the estimated future cash flows, an impairment charge is recognized by the amount by which the carrying amount of the asset or asset group exceeds its estimated fair value. At December 31, 2016 , the Company concluded that none of its long-lived assets were impaired. However, as disclosed in footnote 8, as a result of the initiation of plans to sell the operations of AHN, an operating subsidiary, during the third quarter of 2016, the Company conducted an evaluation of AHN’s assets for impairment. Based on this evaluation, the Company recognized an impairm ent charge of $0.7 million on its long-lived assets.
Derivatives [Policy Text Block]	(p) Derivatives The Company uses interest-rate-related derivative instruments to manage its exposure related to changes in interest rates on its variable-rate debt instruments. The Company does not enter into derivative instruments for any purpose other than cash flow hedging. The Company does not speculate using derivative instruments. The Company recognizes all derivative instruments as either assets or liabilities in the balance sheet at their res pective fair values. For derivatives designated in hedging relationships, changes in the fair value are either offset through earnings against the change in fair value of the hedged item attributable to the risk being hedged or recognized in AOCI, to the e xtent the derivative is effective at offsetting the changes in cash flows being hedged until the hedged item affects earnings. The Company only enters into derivative contracts that it intends to designate as a hedge of a forecasted transaction or the var iability of cash flows to be received or paid related to a recognized asset or liability (cash flow hedge). For all hedging relationships, the Company formally documents the hedging relationship and its risk-management objective and strategy for undertakin g the hedge, the hedging instrument, the hedged transaction, the nature of the risk being hedged, how the hedging instrument’s effectiveness in offsetting the hedged risk will be assessed prospectively and retrospectively, and a description of the method u sed to measure ineffectiveness. The Company also formally assesses, both at the inception of the hedging relationship and on an ongoing basis, whether the derivatives that are used in hedging relationships are highly effective in offsetting changes in cas h flows of hedged transactions. For derivative instruments that are designated and qualify as part of a cash flow hedging relationship, the effective portion of the gain or loss on the derivative is reported as a component of other comprehensive income and reclassified into earnings in the same period or periods during which the hedged transaction affects earnings. Gains and losses on the derivative representing either hedge ineffectiveness or hedge components excluded from the assessment of effectiveness a re recognized in current earnings. The Company discontinues hedge accounting prospectively when it determines that the derivative is no longer effective in offsetting cash flows attributable to the hedged risk, the derivative expires or is sold, termina ted, or exercised, the cash flow hedge is de-designated because a forecasted transaction is not probable of occurring, or management determines to remove the designation of the cash flow hedge. In all situations in which hedge accounting is discontinued a nd the derivative remains outstanding, the Company continues to carry the derivative at its fair value on the balance sheet and recognizes any subsequent changes in its fair value in earnings. When it is probable that a forecasted transaction will not occu r, the Company discontinues hedge accounting and recognizes immediately in earnings gains and losses that were accumulated in other comprehensive income related to the hedging relationship.
Fair Value of Financial Instruments [Policy Text Block]	(q) Fair Value of Financial Instruments The carrying values of the Company’s cash and cash equivalents, trade accounts receivable and trade accounts payable and short-term debt approximate their fair values because of the short maturities of those instruments. The fair value of the Company’s long-term debt approximate s its carrying value and is based on the amount of future cash flows associated with the debt discounted using current borrowing rates for similar debt instruments of comparable maturity. Financial reporting standards define a fair value hierarchy that co nsists of three levels:  Level 1 includes instruments for which quoted prices in active markets for identical assets or liabilities accessible to the Company at the measurement date.  Level 2 includes instruments for which the valuations are based on quoted prices for similar assets or liabilities, quoted prices in markets that are not active, or other inputs that are observable or can be corroborated by observable data for substantially the full term of the assets or liabilities.  Level 3 includes valuations based on inputs that are unobservable and significant to the overall fair value measurement.
Share-based Compensation [Policy Text Block]	(r) Stock-based Compensation The Company accounts for stock-based payment awards in accordance with the provisions of FASB ASC 718, “Compensation—Stock Compensation”, which requires it to recognize compensation expense for all stock-based payment awards made to employees and directors including stock options, restricted stock units, restricted stock units with a market condition and em ployee stock purchases (“employee stock purchases”) related to its Employee Stock Purchase Plan (as amended, the ESPP). The Company issues new shares upon stock option exercises, upon vesting of restricted stock units and restricted stock units with a mark et condition, and under the Company’s ESPP. Stock-based compensation expense recognized is based on the value of the portion of stock-based payment awards that is ultimately expected to vest and has been reduced for estimated forfeitures. The Company valu es stock-based payment awards, except restricted stock units at grant date using the Black-Scholes option-pricing model (Black-Scholes model). The Company values restricted stock units with a market condition using a Monte-Carlo valuation simulation. The d etermination of fair value of stock-based payment awards on the date of grant using an option-pricing model or Monte-Carlo valuation simulation is affected by its stock price as well as assumptions regarding certain variables. These variables include, but are not limited to its expected stock price volatility over the term of the awards and actual and projected stock option exercise behaviors. The fair value of restricted stock units are based on the market price of the Company’s stock on the date of grant and are recorded as compensation expense ratably over the applicable service period, which ranges from one to four years. Unvested restricted stock units are forfeited in the event of termination of employment with the Company. Stock-based compensation e xpense recognized under FASB ASC 718 for the years ended December 31, 2016 , 2015 and 2014 consisted of stock-based compensation expense related to stock options, the employee stock purchase plan, and the restricted stock un its and was recorded as a component of cost of product revenues, sales and marketing expenses, general and administrative expenses, research and development expenses and discontinued operations. Refer to footnote 19 for further details.
Recently Issued Accounting Pronouncements [Abstract]
Recently Issued Accounting Pronouncements Disclosure [Text Block]	(s) Recently Issued Accounting Pronouncements In May 2014, the Financial Accounting Standards Board (FASB) issued Accounting Standards Update (ASU) 2014-09, “Revenue from Contracts with Customers,” a new accounting standard that provides for a comprehensive model to use in the accounting for revenue arising from contracts with customers that will replace most existing revenue recognition guidance within accounting principles generally accepted in the United States. Under this standard, revenue will be recognized to de pict the transfer of promised goods or services to customers in an amount that reflects the consideration to which we expect to be entitled in exchange for those goods or services. The Company expects to adopt this standard as of January 1, 2018 using the modified retrospective approach. The Company intends to complete a comprehensive assessment of its contracts in 2017 concerning any unique customer contract terms or transactions that could have implications to the timing of revenue recognition under the n ew guidance . The Company expects this undertaking will be complete in the second half of 2017. In July 2015, the FASB issued ASU 2015-11, Simplifying Measurement of Inventory . The update requires measurement of most inventory “at the lower of cost and net realizable value”, and applies to all entities that recognize inventory within the scope of ASC 330, except for inventory measured under the last-in, first-out (LIFO) method or the retail inventory method (RIM). ASU 2015-11 requires prospective applicatio n and represents a change in accounting principle. The update is effective for fiscal years beginning after December 15, 2016. The Company will adopt this standard effective January 1, 2017. Adoption of this guidance is not expected to have a material impa ct on the Company's consolidated financial statements. In February 2016, the FASB issued ASU 2016-02, Leases , which is intended to improve financial reporting about leasing transactions. The update requires a lessee to record on the balance sheet the asse ts and liabilities for the rights and obligations created by lease terms of more than 12 months. The update is effective for fiscal years beginning after December 15, 2018. The Company is evaluating the requirements of this guidance and has not yet determi ned the impact of the adoption on its consolidated financial position, results of operations and cash flows, however, assets and liabilities will increase upon adoption for right-of-use assets and lease liabilities. The Company’s future commitments under l ease obligations are summarized in Note 14. In June 2016, the FASB issued ASU 2016-13, Financial Instruments – Credit Losses (Topic 326), Measurement of credit losses on Financial Instruments. The update amends the FASB’s guidance on the impairment of financial instruments. The ASU adds to U.S. GAAP an impairment model (known as the current expected credit loss (CECL) model) that is based on expected losses rather than incurred losses. Under the new guidance, an entity recognizes as an allowance its est imate of expected credit losses, which the FASB believes will result in more timely recognition of such losses. The ASU is effective for fiscal years beginning after December 15, 2019, including interim periods within those fiscal years. The Company is eva luating the impact of ASU 2016-13 on its consolidated financial statements. In August 2016, the FASB issued ASU 2016-15, Classification of Certain Cash Receipts and Cash Payments (Topic 230) which amends ASC 230, Statement of Cash Flows to add or clarify guidance on the classification of certain cash receipts and payments in the statement of cash flows. The guidance is effective for fiscal years beginning after December 15, 2017, including interim periods within those fiscal year. The Company is evaluating the impact of ASU 2016-13 on its consolidated financial statements. In March 2016, the FASB issued ASU 2016-09, Compensation – Stock Compensation (Topic 718): Improvements to Employee Share-Based Payment Accounting , which simplifies the accounting for sh are-based payment transactions, including the income tax consequences, classification of awards as either equity or liabilities and classification on the statement of cash flows. The Company will adopt this standard effective January 1, 2017. Adoption of t his guidance is not expected to have a material impact on the Company's consolidated financial statements; however, the impact in any given period will be dependent upon changes in the company's stock price, the volume of employee stock option exercises an d the timing of service and performance-based restricted unit vestings. Recently Adopted Accounting Pronouncements In April 2015, the FASB issued ASU 2015-03, Interest - Imputation of Interest - Simplifying the Presentation of Debt Issuance Costs . Under this guidance, debt issuance costs related to a recognized debt liability should be presented in the balance sheet as a direct deduction from the carrying amount of that debt liability. The provisions of this guidance are to be applied retrospectively and are effective for interim and annual periods beginning after December 15, 2015. The Company adopted this guidance as of January 1, 2016. The consolidated balance sheet as of December 31, 2015, included in these consolidated financial statements, reflects a restatement to reclassify unamortized deferred financing costs of approximately $0.2 million from other long-term assets to long-term debt. For deferred financing costs paid to secure long-term debt, the Company made a policy election to present such cost s as a direct deduction from the debt liability on the consolidated balance sheet. In September 2015, the FASB issued ASU 2015-16 , Simplifying the Accounting for Measurement-Period Adjustments . The update eliminates the requirement to retrospectively adju st financial statements for measurement-period adjustments that occur in periods after a business combination. Under the update, measurement-period adjustments are to be calculated as if they were known at the acquisition date, but are recognized in the re porting period in which they are determined. Additional disclosures are required about the impact on current-period earnings. ASU 2015-16 requires prospective application to adjustments of provisional amounts that occur after the effective date. The update was effective for fiscal years beginning after December 15, 2015. The Company adopted ASU 2015-16 on January 1, 2016. The adoption of ASU 2015-16 did not have a material impact on its consolidated financial statements. In November 2015, the FASB issued ASU 2015-17, Balance Sheet Classification of Deferred Taxes . The update requires all deferred income taxes to be presented on the balance sheet as noncurrent. The new guidance is intended to simplify financial reporting by eliminating the requirement to cl assify deferred taxes between current and noncurrent. The update is effective for fiscal years beginning after December 15, 2016. Early adoption is permitted at the beginning of an interim or annual period. As of January 1, 2016, the Company early adopted the new guidance on a prospective basis and has presented all deferred tax assets and deferred tax liabilities as noncurrent in the consolidated balance sheet at December 31, 2016. Prior periods presented in the consolidated financial statements were not retrospectively adjusted.

Summary of Significant Accoun35

Summary of Significant Accounting Policies (Tables)	12 Months Ended
	Dec. 31, 2016
Summary of Significant Accounting Policies [Abstract]
Property Plant And Equipment Useful Life [Table Text Block]	Buildings 40 years Machinery and equipment 3 - 10 years Computer equipment and software 3 - 7 years Furniture and fixtures 5 - 10 years Automobiles 3 - 6 years

Accumulated Other Comprehensi36

Accumulated Other Comprehensive Income (Tables)	12 Months Ended
	Dec. 31, 2016
Accumulated Other Comprehensive Income [Abstract]
Accumulated Other Comprehensive Income [Table Text Block]	Foreign currency Derivatives translation qualifying as Defined benefit (in thousands) adjustments hedges pension plans Total Balance at December 31, 2014 $ (4,658) $ (18) $ (3,557) $ (8,233) Other comprehensive (loss) income before reclassifications (4,936) (85) 1,029 (3,992) Amounts reclassified from AOCI - 93 248 341 Net other comprehensive (loss) income (4,936) 8 1,277 (3,651) Balance at December 31, 2015 $ (9,594) $ (10) $ (2,280) $ (11,884) Other comprehensive (loss) income before reclassifications (4,606) (29) (430) (5,065) Amounts reclassified from AOCI - 39 252 291 Other comprehensive (loss) income (4,606) 10 (178) (4,774) Balance at December 31, 2016 $ (14,200) $ - $ (2,458) $ (16,658)
Reclassification out of Accumulated Other Comprehensive Income [Table Text Block]	Affected line item in the Year Ended December 31, (in thousands) Statements of Operations 2016 2015 2014 Amounts Reclassified From AOCI Derivatives qualifying as hedges Realized loss on derivatives qualifying as hedges Interest expense $ 39 $ 93 $ 130 Income tax Income tax (benefit) expense - - - 39 93 130 Defined benefit pension plans Amortization of net losses included in net periodic pension costs General and administrative expenses 304 306 259 Income tax Income tax (benefit) expense (52) (58) (52) 252 248 207 Total reclassifications $ 291 $ 341 $ 337 Details about AOCI Components Amount reclassified from AOCI into income (effective portion) Location of amount Year Ended December 31, reclassified from AOCI 2016 2015 2014 into income (effective portion) (in thousands) Interest rate swaps $ 39 $ 93 $ 130 Interest expense

Inventories (Tables)

Inventories (Tables)	12 Months Ended
	Dec. 31, 2016
Inventories Disclosure [Abstract]
Schedule of Inventory [Table Text Block]	December 31, December 31, 2016 2015 (in thousands) Finished goods $ 9,340 $ 10,957 Work in process 823 888 Raw materials 9,792 10,498 Total $ 19,955 $ 22,343

Property, Plant and Equipment (

Property, Plant and Equipment (Tables)	12 Months Ended
	Dec. 31, 2016
Property, Plant and Equipment Disclosure [Abstract]
Schedule Of Property Plant And Equipment [Table Text Block]	December 31, December 31, 2016 2015 (in thousands) Land, buildings and leasehold improvements $ 2,095 $ 2,825 Machinery and equipment 7,224 10,131 Computer equipment and software 8,115 7,503 Furniture and fixtures 1,274 1,358 Automobiles 196 103 18,904 21,920 Less: accumulated depreciation (14,608) (16,018) Property, plant and equipment, net $ 4,296 $ 5,902

Acquisitions (Tables)

Acquisitions (Tables)	12 Months Ended
	Dec. 31, 2016
Acquisition Disclosure [Abstract]
Schedule of Business Acquisitions [Table Text Block]	(in thousands) Tangible assets $ 4,165 Liabilities assumed (2,426) Net assets 1,739 Goodwill and intangible assets: Goodwill 1,668 Trade name 774 Customer relationships 1,627 Developed technology 1,338 Non-compete agreements 27 Deferred tax liabilities (1,245) Total goodwill and intangible assets, net of tax 4,189 Acquisition purchase price $ 5,928 Year Ended December 31, 2015 2014 (in thousands) Pro Forma Revenues $ 108,761 $ 114,185 Net (loss) income (19,027) 2,646 (in thousands) Tangible assets $ 5,070 Liabilities assumed (1,207) Net assets 3,863 Goodwill and intangible assets: Goodwill 4,117 Trade name 1,008 Customer relationships 1,204 Developed technology 2,452 Non-compete agreements 148 Deferred tax liabilities (1,603) Total goodwill and intangible assets, net of tax 7,326 Acquisition purchase price $ 11,189 Year Ended December 31, 2014 (in thousands) Pro Forma Revenues $ 114,066 Net income 2,600 (in thousands) Tangible assets $ 1,278 Liabilities assumed (530) Net assets 748 Goodwill and intangible assets: Goodwill 946 Trade name 143 Customer relationships 308 Developed technology 363 Non-compete agreements 30 Deferred tax liabilities (325) Total goodwill and intangible assets, net of tax 1,465 Acquisition purchase price $ 2,213

Disposition (Tables)

Disposition (Tables)	12 Months Ended
	Dec. 31, 2016
Discontinued Operations [Abstract]
Schedule Of Disposal Groups Including Discontinued Operations Income Statement Balance Sheet And Additional Disclosures [Table Text Block]	8. Disposition On October 26, 2016, the Company sold the operations of its AHN Biotechnologie GmbH subsidiary (AHN), a manufacturer of liquid handling products, located in Nordhausen, Germany for gross cash proceeds of approximately $1.7 million . Proceeds received at closing, net of cash on hand, were approximately $1.4 million. The results of operations of AHN, through the date of sale, have been reported in the Company’s consolidated statements of operations for the year ended December 31, 2016. As a res ult of the initiation of plans to sell the operations of AHN, during the third quarter of 2016, the Company evaluated the long-lived assets of AHN for impairment, pursuant to ASC 360-10. Based on the impairment analysis, the carrying amount of the long-liv ed assets exceeded the fair value of the long-lived assets as determined using the probability weighted present value of future cash flows. Consequently, the Company recognized an impairment charge of $0.7 million for the year ended December 31, 2016 in op erating expenses within its statements of operations. Of the overall charge, approximately $0.1 million was allocated to AHN’s intangible assets (trade name and customer relationships), while $0.6 million was allocated to its property, plant and equipment (machinery and equipment). Upon the closing of the transaction, the Company recorded a loss on sale of $1.2 million for the year ended December 31, 2016 in operating expenses within the statements of operations. On October 26, 2016, the major classes of assets and liabilities of AHN disposed of, including an allocation of goodwill, were comprised of the following: (in thousands) Assets Accounts receivable, net $ 279 Inventory 438 Property, plant and equipment, net 919 Amortizable intangibles, net 196 Allocation of goodwill 484 Liabilities Accounts payable and accrued expenses $ 245 (in thousands) Assets Accounts receivable, net $ 279 Inventory 438 Property, plant and equipment, net 919 Amortizable intangibles, net 196 Allocation of goodwill 484 Liabilities Accounts payable and accrued expenses $ 245

Goodwill and Other Intangible41

Goodwill and Other Intangible Assets (Tables)	12 Months Ended
	Dec. 31, 2016
Goodwill And Other Intangible Assets Disclosure [Abstract]
Schedule of Intangible Assets and Goodwill [Table Text Block]	Weighted Average December 31, 2016 December 31, 2015 Life (a) (in thousands) Amortizable intangible assets: Gross Accumulated Amortization Gross Accumulated Amortization Existing technology $ 15,082 $ (11,710) $ 16,022 $ (11,686) 7.0 Years Trade names 7,379 (3,479) 7,636 (3,076) 8.0 Years Distribution agreements/customer relationships 22,976 (12,862) 23,676 (11,849) 9.0 Years Patents 204 (119) 245 (96) 2.2 Years Total amortizable intangible assets 45,641 $ (28,170) 47,579 $ (26,707) Indefinite-lived intangible assets: Goodwill 38,032 40,357 Other indefinite-lived intangible assets 1,209 1,223 Total goodwill and other indefinite-lived intangible assets 39,241 41,580 Total intangible assets $ 84,882 $ 89,159 (a) Weighted average life as of December 31, 2016.
Goodwill Rollforward [Table Text Block]	(in thousands) Balance at December 31, 2014 $ 39,822 Goodwill arising from business combination 1,618 Adjustment to purchase price allocation of prior year acquisition 372 Effect of change in currency translation (1,455) Balance at December 31, 2015 40,357 Adjustment to purchase price allocation of prior year acquisition 50 Adjustment to goodwill for AHN disposition (484) Effect of change in currency translation (1,891) Balance at December 31, 2016 $ 38,032

Restructuring and Other Exit 42

Restructuring and Other Exit Costs (Tables)	12 Months Ended
	Dec. 31, 2016
Restructuring and Related Activities [Abstract]
Restructuring Plan Table [Table Text Block]	Severance Costs Other Total (in thousands) Restructuring balance at December 31, 2015 $ 132 $ - $ 132 Restructuring charges - 23 23 Non-cash reversal of restructuring charges (27) - (27) Cash payments (104) (28) (132) Effect of change in currency translation (1) 5 4 Restructuring balance at December 31, 2016 $ - $ - $ - Severance Costs Other Total (in thousands) Restructuring balance at December 31, 2014 $ 626 $ - $ 626 Restructuring charges 434 439 873 Non-cash reversal of restructuring charges (85) - (85) Cash payments (833) (439) (1,272) Effect of change in currency translation (10) - (10) Restructuring balance at December 31, 2015 $ 132 $ - $ 132 Severance Costs Other Total (in thousands) Restructuring balance at December 31, 2013 $ 1,437 $ - $ 1,437 Restructuring charges 854 306 1,160 Non-cash reversal of restructuring charges (120) (13) (133) Cash payments (1,545) (293) (1,838) Restructuring balance at December 31, 2014 $ 626 $ - $ 626 Year Ended December 31, 2016 2015 2014 (in thousands) Restructuring (credits) charges $ (4) $ 788 $ 1,027

Long Term Debt (Tables)

Long Term Debt (Tables)	12 Months Ended
	Dec. 31, 2016
Long Term Debt Disclosure [Abstract]
Schedule of Maturities of Long-term Debt [Table Text Block]	The aggregate amounts of debt maturing during the next five years are as follows: (in thousands) 2017 $ 2,450 2018 11,400 2019 - 2020 - 2021 - Total $ 13,850
Schedule of Debt [Table Text Block]	December 31, December 31, 2016 2015 (in thousands) Long-term debt: Term loan $ 5,400 $ 6,750 DDTL 4,400 5,500 Revolving line 4,050 6,650 Total unamortized deferred financing costs (104) (167) Total debt 13,746 18,733 Less: current installments (2,450) (2,450) Current unamortized deferred financing costs 78 86 Long-term debt $ 11,374 $ 16,369

Derivative (Tables)

Derivative (Tables)	12 Months Ended
	Dec. 31, 2016
Derivative Instruments and Hedging Activities Disclosure [Abstract]
Schedule of Derivative Instruments in Statement of Financial Position, Fair Value [Table Text Block]	December 31, 2016 December 31, 2016 Notional Amount Fair Value (a) Derivatives designated as hedging instruments under ASC 815 Balance sheet classification (in thousands) Interest rate swaps Other liabilities-non current $ 5,500 $ - December 31, 2015 December 31, 2015 Notional Amount Fair Value (a) Derivatives designated as hedging instruments under ASC 815 Balance sheet classification (in thousands) Interest rate swaps Other liabilities-non current $ 9,500 $ (10) (a) See Note 13 for the fair value measurements related to these financial instruments.
Schedule of Cash Flow Hedges Included in AOCI [Table Text Block]	Derivatives in Hedging Relationships Amount of gain or (loss) recognized in OCI on derivative (effective portion) Year Ended December 31, 2016 2015 2014 (in thousands) Interest rate swaps $ (29) $ (85) $ (99)
Reclassification out of Accumulated Other Comprehensive Income [Table Text Block]	Affected line item in the Year Ended December 31, (in thousands) Statements of Operations 2016 2015 2014 Amounts Reclassified From AOCI Derivatives qualifying as hedges Realized loss on derivatives qualifying as hedges Interest expense $ 39 $ 93 $ 130 Income tax Income tax (benefit) expense - - - 39 93 130 Defined benefit pension plans Amortization of net losses included in net periodic pension costs General and administrative expenses 304 306 259 Income tax Income tax (benefit) expense (52) (58) (52) 252 248 207 Total reclassifications $ 291 $ 341 $ 337 Details about AOCI Components Amount reclassified from AOCI into income (effective portion) Location of amount Year Ended December 31, reclassified from AOCI 2016 2015 2014 into income (effective portion) (in thousands) Interest rate swaps $ 39 $ 93 $ 130 Interest expense

Fair Value Measurements (Tables

Fair Value Measurements (Tables)	12 Months Ended
	Dec. 31, 2016
Fair Value Disclosures [Abstract]
Schedule Of Fair Value Assets And Liabilities Measured On Recurring Basis [Table Text Block]	Fair Value as of December 31, 2016 (In thousands) Level 1 Level 2 Level 3 Total Liabilities: Interest rate swap agreements $ - $ - $ - $ - Fair Value as of December 31, 2015 (In thousands) Level 1 Level 2 Level 3 Total Liabilities: Interest rate swap agreements $ - $ 10 $ - $ 10

Leases (Tables)

Leases (Tables)	12 Months Ended
	Dec. 31, 2016
Leases Disclosure [Abstract]
Schedule of Future Minimum Rental Payments for Operating Leases [Table Text Block]	Operating Leases (in thousands) 2017 $ 1,600 2018 1,614 2019 1,489 2020 1,284 2021 1,087 Thereafter 2,919 Net minimum lease payments $ 9,993

Accrued Expenses (Tables)

Accrued Expenses (Tables)	12 Months Ended
	Dec. 31, 2016
Accrued Liabilities Current [Abstract]
Schedule of Accrued Liabilities [Table Text Block]	December 31, 2016 2015 (in thousands) Accrued compensation and payroll $ 1,468 $ 1,264 Accrued professional fees 1,105 1,055 Accrued severance - 132 Warranty costs 193 147 Other 1,784 1,423 Total $ 4,550 $ 4,021

Income Taxes (Tables)

Income Taxes (Tables)	12 Months Ended
	Dec. 31, 2016
Income Tax [Abstract]
Schedule of Components of Income Tax Expense (Benefit) [Table Text Block]	Year Ended December 31, 2016 2015 2014 (in thousands) Current income tax expense: Federal and state $ 170 $ (4) $ 27 Foreign 790 677 424 960 673 451 Deferred income tax expense: Federal and state 166 15,598 1,793 Foreign 103 (840) (182) 269 14,758 1,611 Total income tax expense $ 1,229 $ 15,431 $ 2,062
Schedule of Effective Income Tax Rate Reconciliation [Table Text Block]	Year Ended December 31, 2016 2015 2014 (in thousands) Computed "expected" income tax (benefit) expense $ (1,046) $ (1,227) $ 1,503 Increase (decrease) in income taxes resulting from: Permanent differences, net (128) 32 (93) Foreign tax rate differential 165 (12) (364) State income taxes, net of federal income tax benefit (93) 82 22 Non-deductible stock compensation expense 110 (161) 67 Impact of foreign rate change 30 89 - Tax credits (89) (169) (385) Change in reserve for uncertain tax position 127 35 - Impact of change to prior year tax accruals 291 370 - U.S. tax on foreign dividends 497 - - Foreign withholding taxes 74 - - Conversion of U.S. foreign tax credits from credit to deduction 1,772 - - Non-deductible loss on subsidiary stock sale 501 - - Change in valuation allowance allocated to income tax expense (benefit) (983) 16,401 1,346 Other 1 (9) (34) Total income tax expense $ 1,229 $ 15,431 $ 2,062
Schedule of Income before Income Tax, Domestic and Foreign [Table Text Block]	Year Ended December 31, 2016 2015 2014 (in thousands) Domestic $ (3,107) $ (3,331) $ 1,846 Foreign 29 (277) 2,571 Total $ (3,078) $ (3,608) $ 4,417
Schedule of Deferred Tax Assets and Liabilities [Table Text Block]	December 31, 2016 2015 (in thousands) Deferred tax assets: Accounts receivable $ 170 $ 45 Inventory 1,336 1,447 Operating loss and credit carryforwards 12,586 14,456 Property, plant and equipment 5 18 Accrued expenses - 107 Pension liabilities 631 535 Contingent consideration 3,262 2,987 Tax credits on repatriation - 1,728 Stock compensation expense 2,076 1,491 Other assets 23 588 Total gross deferred assets 20,089 23,402 Less: valuation allowance (17,840) (18,823) Deferred tax assets $ 2,249 $ 4,579 Deferred tax liabilities: Indefinite-lived intangible assets $ 4,567 $ 4,593 Definite-lived intangible assets 2,593 2,587 Accrued tax liability on repatriation - 1,728 Other accrued liabilities 349 655 Total deferred tax liabilities 7,509 9,563 Net deferred tax liabilities $ (5,260) $ (4,984)
Summary of Income Tax Contingencies [Table Text Block]	(in thousands) Balance at December 31, 2014 $ 250 Additions based on tax positions of prior years 35 Balance at December 31, 2015 285 Additions based on current year tax positions 59 Additions based on tax positions of prior years 62 Balance at December 31, 2016 $ 406

Employee Benefit Plans (Tables)

Employee Benefit Plans (Tables)	12 Months Ended
	Dec. 31, 2016
Employee Benefit Plans Disclosure [Abstract]
Schedule Of Costs Of Retirement Plans [Table Text Block]	Year Ended December 31, 2016 2015 2014 (in thousands) Components of net periodic benefit cost: Interest cost 632 711 893 Expected return on plan assets (683) (668) (649) Net amortization loss 304 306 259 Net periodic benefit cost $ 253 $ 349 $ 503
Schedule of Changes in Projected Benefit Obligations [Table Text Block]	December 31, 2016 2015 (in thousands) Change in benefit obligation: Balance at beginning of year $ 18,582 $ 21,170 Interest cost 632 711 Actuarial loss (gain) 4,636 (1,360) Benefits paid (982) (1,021) Currency translation adjustment (3,654) (918) Balance at end of year $ 19,214 $ 18,582
Schedule of Changes in Fair Value of Plan Assets [Table Text Block]	December 31, 2016 2015 (in thousands) Change in fair value of plan assets: Balance at beginning of year $ 15,767 $ 16,724 Actual return on plan assets 3,868 70 Employer contributions 694 752 Benefits paid (982) (1,021) Currency translation adjustment (3,095) (758) Balance at end of year $ 16,252 $ 15,767
Schedule of Net Funded Status [Table Text Block]	December 31, 2016 2015 (in thousands) Change in benefit obligation: Funded status $ (2,962) $ (2,815) Unrecognized net loss N/A N/A Net amount recognized $ (2,962) $ (2,815)
Schedule of Amounts Recognized in Balance Sheet [Table Text Block]	December 31, 2016 2015 (in thousands) Deferred income tax assets $ 504 $ 535 Other long term liabilities (2,962) (2,815) Net amount recognized $ (2,458) $ (2,280)
Schedule of Amounts Recognized in Other Comprehensive Income (Loss) [Table Text Block]	December 31, 2016 2015 (in thousands) Underfunded status of pension plans $ (2,458) $ (2,280) Net amount recognized $ (2,458) $ (2,280)
Schedule of Assumptions Used [Table Text Block]	Year Ended December 31, 2016 2015 2014 Discount rate 2.62% 3.57% 4.43% Expected return on assets 4.68% 4.43% 4.15%
Schedule of Allocation of Plan Assets [Table Text Block]	December 31, 2016 2015 (in thousands) Asset category: Equity securities $ 8,577 53% $ 8,506 54% Debt securities 7,447 46% 7,103 45% Cash and cash equivalents 228 1% 158 1% Total $ 16,252 100% $ 15,767 100% December 31, 2016 2015 (in thousands) Quoted Prices in Active Markets for Identical Assets (Level 1) $ 228 $ 158 Significant Other Observable Inputs (Level 2) 16,024 15,609 Significant Other Unobservable Inputs (Level 3) - - Total $ 16,252 $ 15,767

Capital Stock (Tables)

Capital Stock (Tables)	12 Months Ended
	Dec. 31, 2016
Capital Stock Disclosure [Abstract]
Schedule Of Stock Options And Restricted Stock Units Activity Rollforward [Table Text Block]	Stock Options Restricted Stock Units Market Condition RSU's Weighted Stock Average Restricted Market Options Exercise Stock Units Grant Date Condition RSU's Grant Date Outstanding Price Outstanding Fair Value Outstanding Fair Value Balance at December 31, 2013 6,690,845 $ 3.42 463,973 $ 4.32 - $ - Granted 1,115,300 4.18 116,400 4.12 - - Exercised (695,173) 3.08 - - - - Vested (RSUs) - - (233,098) - - - Cancelled / forfeited (847,860) 4.67 (40,878) 4.36 - - Balance at December 31, 2014 6,263,112 3.42 306,397 4.30 - - Granted 945,000 5.31 254,685 5.56 196,785 4.81 Exercised (1,772,062) 3.04 - - - - Vested (RSUs) - - (237,188) - - - Cancelled / forfeited (413,864) 4.15 (10,335) 5.56 (11,247) 4.81 Balance at December 31, 2015 5,022,186 3.85 313,559 5.29 185,538 4.81 Granted 43,000 3.10 1,095,190 2.92 - - Exercised (374,772) 2.80 - - - - Vested (RSUs) - - (301,520) - - - Cancelled / forfeited (593,596) 3.84 (34,576) 3.89 (3,388) 4.81 Balance at December 31, 2016 4,096,818 $ 3.94 1,072,653 $ 3.15 182,150 $ 4.81
Table Of Assumptions [Table Text Block]	Year Ended December 31, 2016 2015 2014 Volatility 41.97 % 40.97 % 55.78 % Risk-free interest rate 1.29 % 1.72 % 1.80 % Expected holding period (in years) 5.21 years 5.50 years 5.76 years Dividend yield - % - % - % Year Ended December 31, 2015 Volatility 35.88 % Risk-free interest rate 0.99 % Correlation coefficient 0.25 % Dividend yield - %
Stock Based Compensation Expense Activity By Function [Table Text Block]	Year Ended December 31, 2016 2015 2014 (in thousands) Cost of revenues $ 60 $ 70 $ 132 Sales and marketing 546 418 343 General and administrative 2,780 2,170 1,620 Research and development 111 97 61 Total stock-based compensation $ 3,497 $ 2,755 $ 2,156
Basic and Diluted Shares [Table Text Block]	Year Ended December 31, 2016 2015 2014 Basic 34,211,521 33,592,775 32,170,683 Effect of assumed conversion of employee and director stock options, restricted stock units and Market Condition RSU's - - 1,065,886 Diluted 34,211,521 33,592,775 33,236,569
Schedule of Summary of Outstanding and Exercisable Options [Table Text Block]	Options Outstanding Options Exercisable Weighted Weighted Average Weighted Average Weighted Range of Shares Remaining Average Aggregate Shares Remaining Average Aggregate Exercise Outstanding at Contractual Life Exercise Intrinsic Exercisable at Contractual Life Exercise Intrinsic Price Dec. 31, 2016 in Years Price Value Dec. 31, 2016 in Years Price Value $ 2.02-2.42 462,464 2.13 $ 2.21 $ 388 462,464 2.13 $ 2.21 $ 388 2.43-2.72 436,028 4.60 2.57 209 436,028 4.60 2.57 209 2.73-3.68 511,706 6.10 3.50 - 344,052 5.33 3.59 - 3.69-4.07 411,070 3.75 3.97 - 393,570 3.53 3.98 - 4.08-4.17 653,875 7.41 4.12 - 321,875 7.41 4.12 - 4.18-4.26 71,500 7.65 4.21 - 37,625 7.61 4.21 - 4.27-4.41 750,000 6.88 4.31 - 687,500 6.88 4.31 - 4.42-5.39 161,800 7.92 4.97 - 79,117 7.86 4.92 - 5.40-5.51 353,375 8.18 5.51 - 89,750 8.18 5.51 - 5.52-5.63 285,000 8.41 5.56 - 71,250 8.41 5.56 - $ 2.02-5.63 4,096,818 6.05 $ 3.94 $ 597 2,923,231 5.33 $ 3.65 $ 597

Segment and Related Information

Segment and Related Information (Tables)	12 Months Ended
	Dec. 31, 2016
Segment and Related Information Disclosure [Abstract]
Schedule of Revenue from External Customers Attributed to Foreign Countries by Geographic Area [Table Text Block]	Revenues originating from the following geographic areas consist of: Year Ended December 31, 2016 2015 2014 (in thousands) United States $ 65,179 $ 64,766 $ 63,727 Germany 13,477 15,755 8,240 United Kingdom 16,421 18,051 24,754 Rest of the world 9,444 10,092 11,942 Total revenues $ 104,521 $ 108,664 $ 108,663
Schedule of Disclosure on Geographic Areas, Long-Lived Assets in Individual Foreign Countries by Country [Table Text Block]	Long-lived assets by geographic area consist of the following: December 31, 2016 2015 (in thousands) United States $ 12,004 $ 13,610 Germany 5,504 7,817 United Kingdom 918 1,440 Rest of the world 3,341 3,907 Total long-lived assets (1) $ 21,767 $ 26,774 (1) Total long-lived assets includes property, plant and equipment, net and amortizable intangible assets, net.
Net Assets By Geographic Area [Table Text Block]	Net assets by geographic area consist of the following: December 31, 2016 2015 (in thousands) United States $ 25,736 $ 22,312 Germany 15,026 18,512 United Kingdom 16,083 17,908 Rest of the world 15,351 18,866 Total net assets $ 72,196 $ 77,598

Allowance for Doubtful Debts (T

Allowance for Doubtful Debts (Tables)	12 Months Ended
	Dec. 31, 2016
Allowance For Doubtful Debts Disclosure [Abstract]
Schedule of Credit Losses for Financing Receivables, Current [Table Text Block]	Charged (credited) to Beginning Bad Debt Charged to Ending Balance Expense (Recoveries) Allowance (1) Other (2) Balance (in thousands) Year ended December 31, 2014 $ 358 (67) 56 (19) $ 328 Year ended December 31, 2015 $ 328 (4) 4 (18) $ 310 Year ended December 31, 2016 $ 310 309 11 (19) $ 611 (1) Consists of accounts written off, net of recoveries. (2) Consists of the effect of currency translation.

Warranties (Tables)

Warranties (Tables)	12 Months Ended
	Dec. 31, 2016
Warranties Disclosure [Abstract]
Warranty Rollforward Disclosure [Table Text Block]	Beginning Additions/ Ending Balance Payments (Credits) Balance (in thousands) Year ended December 31, 2014 $ 305 (102) 49 $ 252 Year ended December 31, 2015 $ 252 (81) (24) $ 147 Year ended December 31, 2016 $ 147 (97) 143 $ 193

Quarterly Financial Informati54

Quarterly Financial Information (unaudited) (Tables)	12 Months Ended
	Dec. 31, 2016
Quarterly Financial Data [Abstract]
Schedule of Quarterly Financial Information [Table Text Block]	First Second Third Fourth Fiscal 2016 Quarter Quarter Quarter Quarter Year (in thousands, except per share data) Revenues $ 26,963 $ 26,136 $ 25,007 $ 26,415 $ 104,521 Cost of revenues 14,018 14,461 13,317 14,310 56,106 Gross profit 12,945 11,675 11,690 12,105 48,415 Total operating expenses 13,166 12,515 12,503 13,228 51,412 Operating loss (221) (840) (813) (1,123) (2,997) Other (expense) income, net (222) 73 (67) 135 (81) Loss before income taxes (443) (767) (880) (988) (3,078) Income tax expense (benefit) 193 (54) 758 332 1,229 Net loss $ (636) $ (713) $ (1,638) $ (1,320) $ (4,307) Loss per share: Basic loss per common share $ (0.02) $ (0.02) $ (0.05) $ (0.04) $ (0.13) Diluted loss per common share $ (0.02) $ (0.02) $ (0.05) $ (0.04) $ (0.13) First Second Third Fourth Fiscal 2015 Quarter Quarter Quarter Quarter Year (in thousands, except per share data) Revenues $ 25,763 $ 28,800 $ 25,731 $ 28,370 $ 108,664 Cost of revenues 14,285 16,205 14,005 15,446 59,941 Gross profit 11,478 12,595 11,726 12,924 48,723 Total operating expenses 12,628 12,496 12,501 12,811 50,436 Operating (loss) income (1,150) 99 (775) 113 (1,713) Other expense, net (614) (526) (321) (434) (1,895) (Loss) income before income taxes (1,764) (427) (1,096) (321) (3,608) Income tax (benefit) expense (363) (776) (249) 16,819 15,431 Net (loss) income $ (1,401) $ 349 $ (847) $ (17,140) $ (19,039) (Loss) earnings per share: Basic (loss) earnings per common share $ (0.04) $ 0.01 $ (0.02) $ (0.51) $ (0.57) Diluted (loss) earnings per common share $ (0.04) $ 0.01 $ (0.02) $ (0.51) $ (0.57)

Summary of Significant Accoun55

Summary of Significant Accounting Policy (Details 1)	12 Months Ended
	Dec. 31, 2016
Land, Buildings and Improvements [Member]
Property, Plant and Equipment [Line Items]
Property, Plant and Equipment useful life	40 years
Machinery and Equipment [Member] | Maximum [Member]
Property, Plant and Equipment [Line Items]
Property, Plant and Equipment useful life	10 years
Machinery and Equipment [Member] | Minimum [Member]
Property, Plant and Equipment [Line Items]
Property, Plant and Equipment useful life	3 years
Computer Equipment [Member] | Maximum [Member]
Property, Plant and Equipment [Line Items]
Property, Plant and Equipment useful life	7 years
Computer Equipment [Member] | Minimum [Member]
Property, Plant and Equipment [Line Items]
Property, Plant and Equipment useful life	3 years
Furniture and Fixtures [Member] | Maximum [Member]
Property, Plant and Equipment [Line Items]
Property, Plant and Equipment useful life	10 years
Furniture and Fixtures [Member] | Minimum [Member]
Property, Plant and Equipment [Line Items]
Property, Plant and Equipment useful life	5 years
Automobiles [Member] | Maximum [Member]
Property, Plant and Equipment [Line Items]
Property, Plant and Equipment useful life	6 years
Automobiles [Member] | Minimum [Member]
Property, Plant and Equipment [Line Items]
Property, Plant and Equipment useful life	3 years
Developed Technology Rights [Member]
Finite-Lived Intangible Assets [Line Items]
Finite-Lived Intangible Assets, Weighted Average Useful Life	7 years
Developed Technology Rights [Member] | Maximum [Member]
Finite-Lived Intangible Assets [Line Items]
Finite-Lived Intangible Assets, Weighted Average Useful Life	15 years
Developed Technology Rights [Member] | Minimum [Member]
Finite-Lived Intangible Assets [Line Items]
Finite-Lived Intangible Assets, Weighted Average Useful Life	7 years
Trade Names [Member]
Finite-Lived Intangible Assets [Line Items]
Finite-Lived Intangible Assets, Weighted Average Useful Life	8 years
Trade Names [Member] | Maximum [Member]
Finite-Lived Intangible Assets [Line Items]
Finite-Lived Intangible Assets, Weighted Average Useful Life	15 years
Trade Names [Member] | Minimum [Member]
Finite-Lived Intangible Assets [Line Items]
Finite-Lived Intangible Assets, Weighted Average Useful Life	10 years
Distribution Agreements [Member] | Maximum [Member]
Finite-Lived Intangible Assets [Line Items]
Finite-Lived Intangible Assets, Weighted Average Useful Life	5 years
Distribution Agreements [Member] | Minimum [Member]
Finite-Lived Intangible Assets [Line Items]
Finite-Lived Intangible Assets, Weighted Average Useful Life	4 years
Customer Relationships [Member]
Finite-Lived Intangible Assets [Line Items]
Finite-Lived Intangible Assets, Weighted Average Useful Life	9 years
Customer Relationships [Member] | Maximum [Member]
Finite-Lived Intangible Assets [Line Items]
Finite-Lived Intangible Assets, Weighted Average Useful Life	15 years
Customer Relationships [Member] | Minimum [Member]
Finite-Lived Intangible Assets [Line Items]
Finite-Lived Intangible Assets, Weighted Average Useful Life	5 years
Patents [Member]
Finite-Lived Intangible Assets [Line Items]
Finite-Lived Intangible Assets, Weighted Average Useful Life	2 years 3 months 14 days
Patents [Member] | Maximum [Member]
Finite-Lived Intangible Assets [Line Items]
Finite-Lived Intangible Assets, Weighted Average Useful Life	15 years
Patents [Member] | Minimum [Member]
Finite-Lived Intangible Assets [Line Items]
Finite-Lived Intangible Assets, Weighted Average Useful Life	5 years

Concentrations (Narratives) (De

Concentrations (Narratives) (Details) - Customers	12 Months Ended
	Dec. 31, 2016	Dec. 31, 2015	Dec. 31, 2014
Sales Revenue, Goods, Net [Member]
Concentration Risk [Line Items]
Concentration Risk, Customer	Revenues: No customer accounted for more than 10% of the revenues for the years ended December 31, 2016, 2015 and 2014.
Number Of Customers With Benchmark Contribution Of More Than 10%	0	0	0
Accounts Receivable [Member]
Concentration Risk [Line Items]
Concentration Risk, Customer	Receivables: At December 31, 2016 and 2015, no customer accounted for more than 10% of net accounts receivable.
Number Of Customers With Benchmark Contribution Of More Than 10%	0	0

Accumulated Other Comprehensi57

Accumulated Other Comprehensive Income (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2016	Dec. 31, 2015	Dec. 31, 2014
Accumulated Other Comprehensive Income (Loss) [Line Items]
Opening Balance	$ (11,884)	$ (8,233)
Other Comprehensive Income (Loss) before Reclassifications	(5,065)	(3,992)
Reclassification from Accumulated Other Comprehensive Income	291	341	$ 337
Other Comprehensive Income (Loss), Net of Tax, total	(4,774)	(3,651)	(5,589)
Closing Balance	(16,658)	(11,884)	(8,233)
Foreign currency translation adjustment [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Opening Balance	(9,594)	(4,658)
Other Comprehensive Income (Loss) before Reclassifications	(4,606)	(4,936)
Reclassification from Accumulated Other Comprehensive Income	0	0
Other Comprehensive Income (Loss), Net of Tax, total	(4,606)	(4,936)
Closing Balance	(14,200)	(9,594)	(4,658)
Derivatives qualifying as hedges [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Opening Balance	(10)	(18)
Other Comprehensive Income (Loss) before Reclassifications	(29)	(85)
Reclassification from Accumulated Other Comprehensive Income	39	93
Other Comprehensive Income (Loss), Net of Tax, total	10	8
Closing Balance	0	(10)	(18)
Defined benefit pension plans [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Opening Balance	(2,280)	(3,557)
Other Comprehensive Income (Loss) before Reclassifications	(430)	1,029
Reclassification from Accumulated Other Comprehensive Income	252	248
Other Comprehensive Income (Loss), Net of Tax, total	(178)	1,277
Closing Balance	$ (2,458)	$ (2,280)	$ (3,557)

Accumulated Other Comprehensi58

Accumulated Other Comprehensive Income (Details 1) - USD ($)	12 Months Ended
	Dec. 31, 2016	Dec. 31, 2015	Dec. 31, 2014
Reclassifications Out of Accumulated Other Comprehensive Income [Line Items]
Derivatives Reclassification Adjustment from AOCI, net tax	$ 39,000	$ 93,000	$ 130,000
Pension Plan Reclassification Adjustment from AOCI, net tax	(252,000)	(248,000)	(207,000)
Reclassification from Accumulated Other Comprehensive Income	(291,000)	(341,000)	(337,000)
Interest Expense [Member]
Reclassifications Out of Accumulated Other Comprehensive Income [Line Items]
Derivatives Reclassification Adjustment from AOCI, before tax	39,000	93,000	130,000
Derivatives Reclassification Adjustment from AOCI, tax	0	0	0
General and Administrative Expense [Member]
Reclassifications Out of Accumulated Other Comprehensive Income [Line Items]
Pension Plan Reclassification Adjustment from AOCI, before tax	304,000	306,000	259,000
Income Tax Expense (Benefit) [Member]
Reclassifications Out of Accumulated Other Comprehensive Income [Line Items]
Pension Plan Reclassification Adjustment from AOCI, tax	$ (52,000)	$ (58,000)	$ (52,000)

Inventories (Details 1)

Inventories (Details 1) - USD ($)	Dec. 31, 2016	Dec. 31, 2015
Inventories Disclosure [Abstract]
Finished Goods	$ 9,340,000	$ 10,957,000
Work in Process	823,000	888,000
Raw Materials	9,792,000	10,498,000
Total Inventories, Net	$ 19,955,000	$ 22,343,000

Property, Plant and Equipment60

Property, Plant and Equipment (Details 1) - USD ($) $ in Thousands	Dec. 31, 2016	Dec. 31, 2015
Property, Plant and Equipment [Line Items]
Property, Plant and Equipment, Gross	$ 18,904	$ 21,920
Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment	(14,608)	(16,018)
Property, plant and equipment, net	4,296	5,902
Land, Buildings and Improvements [Member]
Property, Plant and Equipment [Line Items]
Property, Plant and Equipment, Gross	2,095	2,825
Machinery and Equipment [Member]
Property, Plant and Equipment [Line Items]
Property, Plant and Equipment, Gross	7,224	10,131
Computer Equipment [Member]
Property, Plant and Equipment [Line Items]
Property, Plant and Equipment, Gross	8,115	7,503
Furniture and Fixtures [Member]
Property, Plant and Equipment [Line Items]
Property, Plant and Equipment, Gross	1,274	1,358
Automobiles [Member]
Property, Plant and Equipment [Line Items]
Property, Plant and Equipment, Gross	$ 196	$ 103

Acquisitions (Narratives) (Deta

Acquisitions (Narratives) (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2016	Dec. 31, 2015	Dec. 31, 2014
Business Acquisition [Line Items]
Business Acquisition Direct Acquisition Costs In Income Statement	$ 0	$ 1.2	$ 1.1

Acquisitions (Details 1)

Acquisitions (Details 1) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2015	Dec. 31, 2014	Jan. 08, 2015	Oct. 02, 2014
Multi Channel Systems MCS GmbH [Member]
Business Acquisition [Line Items]
Tangible Assets Acquired				$ 5,070
Liabilities Assumed				(1,207)
Net Tangible Assets Acquired				3,863
Business Acquisition Purchase Price Allocation Intangible Assets [Abstract]
Purchase Price Allocation, Goodwill Amount				4,117
Deferred Tax Liabilities				1,603
Business Acquisition Purchase Price Allocation Total Intangible Assets Amount Including Goodwill				7,326
Total Acquisition Purchase Price				11,189
Business Acquisition, Cost of Acquired Entity 1 [Abstract]
Business Acquisition Cost Of Acquired Entity Purchase Price 1				11,189
Business Acquisitions Pro Forma Revenue		$ 114,066
Business Acquisitions Pro Forma Net Income Loss		2,600
Multi Channel Systems MCS GmbH [Member] | Unpatented Technology [Member]
Business Acquisition Purchase Price Allocation Intangible Assets [Abstract]
Purchase Price Allocation, Amortizable Intangible Assets				2,452
Multi Channel Systems MCS GmbH [Member] | Customer Relationships [Member]
Business Acquisition Purchase Price Allocation Intangible Assets [Abstract]
Purchase Price Allocation, Amortizable Intangible Assets				1,204
Multi Channel Systems MCS GmbH [Member] | Trade Names [Member]
Business Acquisition Purchase Price Allocation Intangible Assets [Abstract]
Purchase Price Allocation, Amortizable Intangible Assets				1,008
Multi Channel Systems MCS GmbH [Member] | Non compete Agreements [Member]
Business Acquisition Purchase Price Allocation Intangible Assets [Abstract]
Purchase Price Allocation, Amortizable Intangible Assets				148
Triangle BioSystems, Inc. [Member]
Business Acquisition [Line Items]
Tangible Assets Acquired				1,278
Liabilities Assumed				(530)
Net Tangible Assets Acquired				748
Business Acquisition Purchase Price Allocation Intangible Assets [Abstract]
Purchase Price Allocation, Goodwill Amount				946
Deferred Tax Liabilities				325
Business Acquisition Purchase Price Allocation Total Intangible Assets Amount Including Goodwill				1,465
Total Acquisition Purchase Price				2,213
Business Acquisition, Cost of Acquired Entity 1 [Abstract]
Business Acquisition Cost Of Acquired Entity Purchase Price 1				2,213
Triangle BioSystems, Inc. [Member] | Customer Relationships [Member]
Business Acquisition Purchase Price Allocation Intangible Assets [Abstract]
Purchase Price Allocation, Amortizable Intangible Assets				308
Triangle BioSystems, Inc. [Member] | Trade Names [Member]
Business Acquisition Purchase Price Allocation Intangible Assets [Abstract]
Purchase Price Allocation, Amortizable Intangible Assets				143
Triangle BioSystems, Inc. [Member] | Patented Technology [Member]
Business Acquisition Purchase Price Allocation Intangible Assets [Abstract]
Purchase Price Allocation, Amortizable Intangible Assets				363
Triangle BioSystems, Inc. [Member] | Non compete Agreements [Member]
Business Acquisition Purchase Price Allocation Intangible Assets [Abstract]
Purchase Price Allocation, Amortizable Intangible Assets				$ 30
HEKA Elektronik [Member]
Business Acquisition [Line Items]
Tangible Assets Acquired			$ 4,165
Liabilities Assumed			(2,426)
Net Tangible Assets Acquired			1,739
Business Acquisition Purchase Price Allocation Intangible Assets [Abstract]
Purchase Price Allocation, Goodwill Amount			1,668
Deferred Tax Liabilities			1,245
Business Acquisition Purchase Price Allocation Total Intangible Assets Amount Including Goodwill			4,189
Total Acquisition Purchase Price			5,928
Business Acquisition, Cost of Acquired Entity 1 [Abstract]
Business Acquisition Cost Of Acquired Entity Purchase Price 1			5,928
Business Acquisitions Pro Forma Revenue	$ 108,761	114,185
Business Acquisitions Pro Forma Net Income Loss	$ (19,027)	$ 2,646
HEKA Elektronik [Member] | Unpatented Technology [Member]
Business Acquisition Purchase Price Allocation Intangible Assets [Abstract]
Purchase Price Allocation, Amortizable Intangible Assets			1,338
HEKA Elektronik [Member] | Customer Relationships [Member]
Business Acquisition Purchase Price Allocation Intangible Assets [Abstract]
Purchase Price Allocation, Amortizable Intangible Assets			1,627
HEKA Elektronik [Member] | Trade Names [Member]
Business Acquisition Purchase Price Allocation Intangible Assets [Abstract]
Purchase Price Allocation, Amortizable Intangible Assets			774
HEKA Elektronik [Member] | Non compete Agreements [Member]
Business Acquisition Purchase Price Allocation Intangible Assets [Abstract]
Purchase Price Allocation, Amortizable Intangible Assets			$ 27

Disposition (Narratives) (Detai

Disposition (Narratives) (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2016	Dec. 31, 2015	Dec. 31, 2014
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Asset Impairment Charges	$ 676	$ 0	$ 0
Loss on sale of AHN	1,190	$ 0	$ 0
AHN
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Cash proceeds from sale of business	1,700
Loss on sale of AHN	1,200
AHN | Machinery and Equipment
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Asset Impairment Charges	600
AHN | Trade name and customer relationships
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Asset Impairment Charges	$ 100

Disposition (Major Classes of A

Disposition (Major Classes of Assets Disposed) (Details) - USD ($) $ in Thousands	Dec. 31, 2016	Dec. 31, 2015	Dec. 31, 2014
Assets
Accounts receivable, net	$ 15,746	$ 17,547
Inventories	19,955	22,343
Property, plant and equipment, net	4,296	5,902
Amortizable intangibles, net	17,471	20,872
Goodwill	38,032	40,357	$ 39,822
Liabilities
Accounts payable and accrued expeneses	6,196	$ 8,782
AHN
Assets
Accounts receivable, net	279
Inventories	438
Property, plant and equipment, net	919
Amortizable intangibles, net	196
Goodwill	484
Liabilities
Accounts payable and accrued expeneses	$ 245

Goodwill and Other Intangible65

Goodwill and Other Intangible Assets (Narratives) (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2016	Dec. 31, 2015	Dec. 31, 2014
Goodwill And Other Intangible Assets Disclosure [Abstract]
Amortization of intangible assets	$ 2,722	$ 2,819	$ 2,578
Estimated Amortization Expense Next Twelve Months	2,400
Estimated Amortization Expense Year 2	2,200
Estimated Amortization Expense Year 3	2,100
Estimated Amortization Expense Year 4	2,100
Estimated Amortization Expense Year 5	$ 2,000

Goodwill and Other Intangible66

Goodwill and Other Intangible Assets (Details 1) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2016	Dec. 31, 2015	Dec. 31, 2014
Finite-Lived Intangible Assets [Line Items]
Finite-Lived Intangible Assets, Gross	$ 45,641	$ 47,579
Finite-Lived Intangible Assets, Accumulated Amortization	(28,170)	(26,707)
Goodwill	38,032	40,357	$ 39,822
Other indefinite lived intangible assets	1,209	1,223
Total goodwill and other indefinite lived intangible assets	39,241	41,580
Total intangible assets	84,882	89,159
Developed Technology Rights [Member]
Finite-Lived Intangible Assets [Line Items]
Finite-Lived Intangible Assets, Gross	15,082	16,022
Finite-Lived Intangible Assets, Accumulated Amortization	$ (11,710)	(11,686)
Finite-Lived Intangible Assets, Weighted Average Useful Life	7 years
Trade Names [Member]
Finite-Lived Intangible Assets [Line Items]
Finite-Lived Intangible Assets, Gross	$ 7,379	7,636
Finite-Lived Intangible Assets, Accumulated Amortization	$ (3,479)	(3,076)
Finite-Lived Intangible Assets, Weighted Average Useful Life	8 years
Customer Relationships [Member]
Finite-Lived Intangible Assets [Line Items]
Finite-Lived Intangible Assets, Gross	$ 22,976	23,676
Finite-Lived Intangible Assets, Accumulated Amortization	$ (12,862)	(11,849)
Finite-Lived Intangible Assets, Weighted Average Useful Life	9 years
Patents [Member]
Finite-Lived Intangible Assets [Line Items]
Finite-Lived Intangible Assets, Gross	$ 204	245
Finite-Lived Intangible Assets, Accumulated Amortization	$ (119)	$ (96)
Finite-Lived Intangible Assets, Weighted Average Useful Life	2 years 3 months 14 days

Goodwill and Other Intangible67

Goodwill and Other Intangible Assets (Details 2) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2016	Dec. 31, 2015
Goodwill And Other Intangible Assets Disclosure [Abstract]
Goodwill, Beginning Balance	$ 40,357	$ 39,822
Acquired during the period		1,618
Adjustment to purchase price allocation of prior year acquisition	50	372
Adjustment to goodwill for AHN disposition	(484)
Effect of change in currency transaltion	(1,891)	(1,455)
Goodwill, Ending Balance	$ 38,032	$ 40,357

Restructuring and Other Exit 68

Restructuring and Other Exit Cots (Narratives) (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2016	Dec. 31, 2015	Dec. 31, 2014
Restructuring Cost and Reserve [Line Items]
Restructuring charges (credits)	$ (4)	$ 788	$ 1,027
Restructuring Plans 2016 Activty (Consolidated) [Member]
Restructuring Cost and Reserve [Line Items]
Restructuring charges (credits)	23
Restructuring Plans 2015 Activty (Consolidated) [Member]
Restructuring Cost and Reserve [Line Items]
Restructuring charges (credits)		873
Restructuring Plans 2014 Activty (Consolidated) [Member]
Restructuring Cost and Reserve [Line Items]
Restructuring charges (credits)			1,160
Employee Severance [Member] | Restructuring Plans 2016 Activty (Consolidated) [Member]
Restructuring Cost and Reserve [Line Items]
Restructuring charges (credits)	0
Employee Severance [Member] | Restructuring Plans 2015 Activty (Consolidated) [Member]
Restructuring Cost and Reserve [Line Items]
Restructuring charges (credits)		434
Employee Severance [Member] | Restructuring Plans 2014 Activty (Consolidated) [Member]
Restructuring Cost and Reserve [Line Items]
Restructuring charges (credits)			854
Other Costs [Member] | Restructuring Plans 2016 Activty (Consolidated) [Member]
Restructuring Cost and Reserve [Line Items]
Restructuring charges (credits)	$ 23
Other Costs [Member] | Restructuring Plans 2015 Activty (Consolidated) [Member]
Restructuring Cost and Reserve [Line Items]
Restructuring charges (credits)		$ 439
Other Costs [Member] | Restructuring Plans 2014 Activty (Consolidated) [Member]
Restructuring Cost and Reserve [Line Items]
Restructuring charges (credits)			$ 306

Restructuring and Other Exit 69

Restructuring and Other Exit Costs (Details 1) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2016	Dec. 31, 2015	Dec. 31, 2014
Restructuring Reserve [Roll Forward]
Restructuring charges (credits)	$ (4)	$ 788	$ 1,027
Restructuring Plans 2016 Activty (Consolidated) [Member]
Restructuring Reserve [Roll Forward]
Restructuring Reserve, Beginning Balance	132
Restructuring charges (credits)	23
Restructuring Reserve, Settled with Cash	(132)
Restructuring Reserve, Accrual Adjustment	(27)
Restructuring Reserve, Translation Adjustment	4
Restructuring Reserve, Ending Balance	0	132
Restructuring Plans 2015 Activty (Consolidated) [Member]
Restructuring Reserve [Roll Forward]
Restructuring Reserve, Beginning Balance	132	626
Restructuring charges (credits)		873
Restructuring Reserve, Settled with Cash		(1,272)
Restructuring Reserve, Accrual Adjustment		(85)
Restructuring Reserve, Translation Adjustment		(10)
Restructuring Reserve, Ending Balance		132	626
Restructuring Plans 2014 Activty (Consolidated) [Member]
Restructuring Reserve [Roll Forward]
Restructuring Reserve, Beginning Balance		626	1,437
Restructuring charges (credits)			1,160
Restructuring Reserve, Settled with Cash			(1,838)
Restructuring Reserve, Accrual Adjustment			(133)
Restructuring Reserve, Ending Balance			626
Employee Severance [Member] | Restructuring Plans 2016 Activty (Consolidated) [Member]
Restructuring Reserve [Roll Forward]
Restructuring Reserve, Beginning Balance	132
Restructuring charges (credits)	0
Restructuring Reserve, Settled with Cash	(104)
Restructuring Reserve, Accrual Adjustment	(27)
Restructuring Reserve, Translation Adjustment	(1)
Restructuring Reserve, Ending Balance	132	132
Employee Severance [Member] | Restructuring Plans 2015 Activty (Consolidated) [Member]
Restructuring Reserve [Roll Forward]
Restructuring Reserve, Beginning Balance	132	626
Restructuring charges (credits)		434
Restructuring Reserve, Settled with Cash		(833)
Restructuring Reserve, Accrual Adjustment		(85)
Restructuring Reserve, Translation Adjustment		(10)
Restructuring Reserve, Ending Balance		132	626
Employee Severance [Member] | Restructuring Plans 2014 Activty (Consolidated) [Member]
Restructuring Reserve [Roll Forward]
Restructuring Reserve, Beginning Balance		626	1,437
Restructuring charges (credits)			854
Restructuring Reserve, Settled with Cash			(1,545)
Restructuring Reserve, Accrual Adjustment			(120)
Restructuring Reserve, Ending Balance			626
Other Costs [Member] | Restructuring Plans 2016 Activty (Consolidated) [Member]
Restructuring Reserve [Roll Forward]
Restructuring Reserve, Beginning Balance	0
Restructuring charges (credits)	23
Restructuring Reserve, Settled with Cash	(28)
Restructuring Reserve, Accrual Adjustment	0
Restructuring Reserve, Translation Adjustment	5
Restructuring Reserve, Ending Balance	0	0
Other Costs [Member] | Restructuring Plans 2015 Activty (Consolidated) [Member]
Restructuring Reserve [Roll Forward]
Restructuring Reserve, Beginning Balance	$ 0	0
Restructuring charges (credits)		439
Restructuring Reserve, Settled with Cash		(439)
Restructuring Reserve, Accrual Adjustment		0
Restructuring Reserve, Translation Adjustment		0
Restructuring Reserve, Ending Balance		0	0
Other Costs [Member] | Restructuring Plans 2014 Activty (Consolidated) [Member]
Restructuring Reserve [Roll Forward]
Restructuring Reserve, Beginning Balance		$ 0	0
Restructuring charges (credits)			306
Restructuring Reserve, Settled with Cash			(293)
Restructuring Reserve, Accrual Adjustment			(13)
Restructuring Reserve, Ending Balance			$ 0

Long Term Debt (Narratives) (De

Long Term Debt (Narratives) (Details) - USD ($) $ in Thousands	Apr. 24, 2015	Oct. 31, 2013	Mar. 29, 2013	Aug. 07, 2009	Dec. 31, 2016	Dec. 31, 2015
Credit Agreement [Line Items]
Previous Approved Credit Facility				$ 20,000
Secured Debt					$ 13,746	$ 18,733
Line of Credit Facility, Maximum Borrowing Capacity			$ 50,000
Minimum percentage of Term Loan and the DDTL that company was required to fix the rate of interest on					50.00%
Line of Credit Facility, Remaining Borrowing Capacity					$ 8,700
Interest Rate In Excess Of LIBOR On Credit Facility				3.00%
DDTL Threshold For Dollar For Dollar Reduction In Revolving Line			10,000
Transfer Of Delayed Draw Down Term Loan Capacity To Revolver Capacity		$ 5,000
Lender Approval To Fund Acquisition With Cash Promissory Note In Excess Of Threshold					6,000
Lender Approval To Fund Acquisition With Equity In Excess Of Threshold					10,000
Revolving Credit Facility [Member]
Credit Agreement [Line Items]
Secured Debt			$ 25,000		$ 4,050	6,650
Maturity Dates			Mar. 29, 2016
Basis Spread Over LIBOR	2.25%
Interest Rate As Of Reporting Date					3.02%
Term Loan [Member]
Credit Agreement [Line Items]
Secured Debt			$ 15,000		$ 5,400	6,750
Maturity Dates			Mar. 29, 2018
Basis Spread Over LIBOR	2.50%
Interest Rate As Of Reporting Date					3.96%
Delayed Drawdown Term Loan [Member]
Credit Agreement [Line Items]
Secured Debt			$ 15,000		$ 4,400	$ 5,500
Maturity Dates			Mar. 29, 2018
Basis Spread Over LIBOR	2.50%
Maximum Borrowings Available Under The Current Credit Agreement		$ 10,000
Interest Rate As Of Reporting Date					3.73%

Long Term Debt (Details 1)

Long Term Debt (Details 1) - USD ($) $ in Thousands	Dec. 31, 2016	Dec. 31, 2015	Mar. 29, 2013
Debt Instrument [Line Items]
Secured Debt	$ 13,746	$ 18,733
Current portion, long-term debt	(2,372)	(2,364)
Unamortized Debt Issuance Expense	(104)	(167)
Long-term debt	11,374	16,369
Revolving Credit Facility [Member]
Debt Instrument [Line Items]
Secured Debt	4,050	6,650	$ 25,000
Term Loan [Member]
Debt Instrument [Line Items]
Secured Debt	5,400	6,750	15,000
Delayed Drawdown Term Loan [Member]
Debt Instrument [Line Items]
Secured Debt	$ 4,400	$ 5,500	$ 15,000

Long Term Debt (Details 2)

Long Term Debt (Details 2) $ in Thousands	Dec. 31, 2016USD ($)
Long Term Debt Disclosure [Abstract]
Debt repayments of principal in the next twelve months	$ 2,450
Debt repayments of principal in Year Two	11,400
Debt repayments of principal in Year Three	0
Debt repayments of principal in Year Four	0
Debt repayments of principal in Year Five	0
Long-term Debt	$ 13,850

Derivative (Narratives) (Detail

Derivative (Narratives) (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2016	Nov. 30, 2013	Jun. 05, 2013
Derivative Instruments And Hedging Activities Disclosure [Line Items]
Minimum percentage of Term Loan and the DDTL that company was required to fix the rate of interest on	50.00%
Derivative Interest Rate Swap Effective Percentage	100.00%
Delayed Drawdown Term Loan [Member]
Derivative Instruments And Hedging Activities Disclosure [Line Items]
Notional Amount of Interest Rate Swaps		$ 5
LIBOR Fixed Rate	0.93%
Term Loan [Member]
Derivative Instruments And Hedging Activities Disclosure [Line Items]
Notional Amount of Interest Rate Swaps			$ 15
LIBOR Fixed Rate	0.96%

Derivative (Details 1)

Derivative (Details 1) - Other liabilities-non current [Member] - Derivatives qualifying as hedges [Member] - USD ($) $ in Thousands	Dec. 31, 2016	Dec. 31, 2015
Derivatives, Fair Value [Line Items]
Notional Amount of Interest Rate Derivatives	$ 5,500	$ 9,500
Derivative Liability, Fair Value, Net	$ 0	$ (10)

Derivative (Details 2)

Derivative (Details 2) - Derivatives qualifying as hedges [Member] - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2016	Dec. 31, 2015	Dec. 31, 2014
Derivative Instruments, Gain (Loss) [Line Items]
Derivative Instruments, Loss Recognized in Other Comprehensive Income (Loss), Effective Portion	$ (29)	$ (85)	$ (99)
Interest Expense [Member]
Derivative Instruments, Gain (Loss) [Line Items]
Derivative Instruments, Loss Reclassified from Accumulated OCI into Income, Effective Portion	$ 39	$ 93	$ 130

Fair Value Measurements (Detail

Fair Value Measurements (Details) - Derivatives qualifying as hedges [Member] - USD ($) $ in Thousands	Dec. 31, 2016	Dec. 31, 2015
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]
Derivative Liabilities	$ 0	$ 10
Fair Value, Inputs, Level 1 [Member]
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]
Derivative Liabilities	0	0
Fair Value, Inputs, Level 2 [Member]
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]
Derivative Liabilities	0	10
Fair Value, Inputs, Level 3 [Member]
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]
Derivative Liabilities	$ 0	$ 0

Leases (Details 1)

Leases (Details 1) $ in Thousands	Dec. 31, 2016USD ($)
Leases Disclosure [Abstract]
2,017	$ 1,600
2,018	1,614
2,019	1,489
2,020	1,284
2,021	1,087
Thereafter	2,919
Operating Leases, Total Future Minimum Payments Due	$ 9,993

Leases (Narratives) (Details)

Leases (Narratives) (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2016	Dec. 31, 2015	Dec. 31, 2014
Leases Disclosure [Abstract]
Operating Leases, Rent Expense, Net	$ 1.8	$ 2.1	$ 1.7

Accrued Expenses (Details 1)

Accrued Expenses (Details 1) - USD ($) $ in Thousands	Dec. 31, 2016	Dec. 31, 2015
Accrued Liabilities Current [Abstract]
Employee Related Liabilities Current	$ 1,468	$ 1,264
Accrued Professional Fees Current	1,105	1,055
Accrued Severance Current	0	132
Product Warranty Accrual Current	193	147
Other Accrued Liabilities Current	1,784	1,423
Total Accrued Expenses	$ 4,550	$ 4,021

Income Tax (Narratives) (Detail

Income Tax (Narratives) (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2016	Dec. 31, 2015	Dec. 31, 2014
Income Tax [Abstract]
Increase (Decrease) In Income Taxes Resulting From Release Of Uncertain Tax Position Liability Due To Expiration Of Statute Of Limitations	$ 127	$ 35	$ 0
US Federal Income Tax Rate	34.00%
Change In Valuation Allowances For Deferred Tax Assets		16,400
Tax Credit Carryforwards	$ 200
Net Operating Loss Carryforwards Subject To Annual Limitation	4,700
Net Operating Loss Carryforwards Annual Limitation	700
Undistributed Foreign Earnings	48,600	48,700	51,900
Cash In Foreign Subsidiaries	4,500	5,700
Cash Held In Foreign Subsidiaries Used For Foreign Capital Improvements		300
Unrecognized Tax Benefits Increases Resulting From Prior Period Tax Positions	62	35
Unrecognized Tax Benefits	406	285	250
Income Tax Disclosure
Income tax deduction related to stock options	1,600	1,600
Tax credit carryforwards	200
Income tax reserve	59	35
Foreign Earnings Repatriated	3,500
Tax Liability On Foreign Earnings Repatriated	1,200
Additional Paid In Capital Net Operating Loss Impact On Deferred Tax Assets	0	900
Federal
Income Tax Disclosure
Income tax reserve		59
Foreign tax
Income Tax Disclosure
Income tax reserve	62
Multi Channel Systems MCS GmbH [Member]
Income Tax Disclosure
Cash Held In Foreign Subsidiaries Used For Acquisitions			$ 11,200
HEKA Elektronik [Member]
Income Tax Disclosure
Cash Held In Foreign Subsidiaries Used For Acquisitions		$ 5,900
Expire in 2017
Income Tax [Abstract]
Tax Credit Carryforwards	1,000
Income Tax Disclosure
Tax credit carryforwards	1,000
Expire in 2017 | State
Income Tax [Abstract]
Tax Credit Carryforwards	900
Income Tax Disclosure
Operating loss carryforwards	8,900
Tax credit carryforwards	900
Expire in 2022 | Federal
Income Tax Disclosure
Operating loss carryforwards	$ 21,400

Income Tax (Details 1)

Income Tax (Details 1) - USD ($) $ in Thousands	3 Months Ended								12 Months Ended
	Dec. 31, 2016	Sep. 30, 2016	Jun. 30, 2016	Mar. 31, 2016	Dec. 31, 2015	Sep. 30, 2015	Jun. 30, 2015	Mar. 31, 2015	Dec. 31, 2016	Dec. 31, 2015	Dec. 31, 2014
Income Tax Expense (benefit) Attributable To Income From Continuing Operations [Abstract]
Current Federal And State Income Tax Expense Benefit Continuing Operations									$ 170	$ (4)	$ 27
Current Foreign Income Tax Expense (benefit) From Continuing Operations									790	677	424
Current Income Tax Expense (Benefit), Total									960	673	451
Deferred Federal And State Income Tax Expense Benefit Continuing Operations									166	15,598	1,793
Deferred Foreign Income Tax Expense (Benefit)									103	(840)	(182)
Deferred Income Taxes Amount									269	14,758	1,611
Income Tax Expense, Total	$ 332	$ 758	$ (54)	$ 193	$ 16,819	$ (249)	$ (776)	$ (363)	1,229	15,431	2,062
Effective Tax Rate Reconciliation [Abstract]
Computed "expected" income tax (benefit) expense									(1,046)	(1,227)	1,503
Permanent differences, net									(128)	32	(93)
Foreign tax rate differential									165	(12)	(364)
State income taxes, net of federal income tax benefit									(93)	82	22
Non-deductible stock compensation expense									110	(161)	67
Impact of foreign rate change									30	89	0
Tax credits									(89)	(169)	(385)
Change in reserve for uncertain tax position									127	35	0
Impact of change to prior year tax accruals									291	0	0
U.S. tax on actual and deemed dividends from foreign subsidiaries									497	0	0
Foreign withholding taxes									74	0	0
Conversion of U.S. foreign tax credits from credit to deduction									1,772	0	0
Loss on subsidiary stock sale without benefit									501	0	0
Change in valuation allowance allocated to income tax expense (benefit)									(983)	16,401	1,346
Income Tax Expense, Total	332	758	(54)	193	16,819	(249)	(776)	(363)	1,229	15,431	2,062
Operating Income (Loss) [Abstract]
Income From Continuing Operations, Domestic									(3,107)	(3,331)	1,846
Income from continuing operations, Foreign									29	(277)	2,571
(Loss) income before income taxes	$ (988)	$ (880)	$ (767)	$ (443)	$ (321)	$ (1,096)	$ (427)	$ (1,764)	(3,078)	(3,608)	4,417
Other									$ 1	$ (9)	$ (34)

Income Tax (Details 2)

Income Tax (Details 2) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2016	Dec. 31, 2015
Components Of Deferred Tax Assets And Liabilities [Abstract]
Accounts receivable	$ 170	$ 45
Inventory	1,336	1,447
Operating loss and credit carryforwards	12,586	14,456
Property, plant and equipment	5	18
Accrued expenses	0	107
Pension liabilities	631	535
Contingent consideration	3,262	2,987
Tax credits on repatriation	0	1,728
Stock compensation expense	2,076	1,491
Other assets	23	588
Total gross deferred assets	20,089	23,402
Less: valuation allowance	17,840	18,823
Deferred tax assets	2,249	4,579
Deferred tax liabilities:
Deferred Tax Liabilities Indefinite Lived Intangible Assets	4,567	4,593
Deferred Tax Liabilities Definite Lived Intangible Assets	2,593	2,587
Deferred Tax Liabilities, Property, Plant and Equipment	0	0
Deferred Tax Liabilities On Repatriation	0	1,728
Deferred Tax Liabilities, Other	349	655
Total Deferred Tax Liabilities	7,509	9,563
Net Deferred Tax Assets	(5,260)	(4,984)
Reconciliation Of Uncertain Tax Liabilities [abstract]
Beginning Balance	285	250
Unrecognized Tax Benefits Increases Resulting from Current Period Tax Positions	59
Unrecognized Tax Benefits Increases Resulting From Prior Period Tax Positions	62	35
Ending Balance	$ 406	$ 285

Employee Benefit Plans (Narrati

Employee Benefit Plans (Narratives) (Details) - USD ($)	12 Months Ended
	Dec. 31, 2016	Dec. 31, 2015	Dec. 31, 2014	Dec. 31, 2013
Employee Benefit Plans Disclosure [Abstract]
Defined Contribution Plan Payments In Current Fiscal Year	$ 600,000		$ 500,000	$ 500,000
Defined Benefit Plan, Estimated Future Employer Contributions in Next Fiscal Year	$ 700,000
Fair Value Impairment Of Pension Assets			0
Defined Benefit Plan, Assumptions Used Calculating Benefit Obligation, Discount Rate Support, Methodology and Source Data		The discount rate assumptions used for pension accounting reflect the prevailing rates available on high-quality, fixed-income debt instruments with terms that match the average expected duration of the Company’s defined benefit pension plan obligations. The Company uses the iBoxx AA 15yr+ index, which matches the average duration of its pension plan liability of approximately 15 years. With the current base of assets in the pension plans, a one percent increase/decrease in the discount rate assumption would decrease/increase annual pension expense by approximately $##D .
Defined Benefit Plan Increase (Decrease) In Discount Rate Percentage	0.10%
Defined Benefit Plan Average Pension Plan Liability	15 years
Defined Benefit Plan Increase (Decrease) In Discount Rate Value	$ 30,000
Defined Benefit Plan Increase (Decrease) In Asset Return Percentage	0.10%
Defined Benefit Plan Average Remaining Work Lifetime	15 years
Defined Benefit Plan Increase (Decrease) In Asset Return Value	$ 163,000
Defined Benefit Plan Payments In Current Fiscal Year	694,000	$ 752,000
Unrealized losses on pension benefit obligation, net of tax	178,000	$ (1,277,000)	$ (321,000)
Defined Benefit Plan, Estimated Future Benefit Payments [Abstract]
Defined Benefit Plan, Expected Future Benefit Payments in Year One	500,000
Defined Benefit Plan, Expected Future Benefit Payments in Year Two	400,000
Defined Benefit Plan, Expected Future Benefit Payments in Year Three	600,000
Defined Benefit Plan, Expected Future Benefit Payments in Year Four	500,000
Defined Benefit Plan, Expected Future Benefit Payments in Year Five	500,000
Defined Benefit Plan, Expected Future Benefit Payments in Five Fiscal Years Thereafter	$ 3,600,000
Defined Benefit Plan, Weighted Average Assumptions Used in Calculating Benefit Obligation [Abstract]
Defined Benefit Plan, Assumptions Used Calculating Benefit Obligation, Discount Rate Support, Methodology and Source Data		The discount rate assumptions used for pension accounting reflect the prevailing rates available on high-quality, fixed-income debt instruments with terms that match the average expected duration of the Company’s defined benefit pension plan obligations. The Company uses the iBoxx AA 15yr+ index, which matches the average duration of its pension plan liability of approximately 15 years. With the current base of assets in the pension plans, a one percent increase/decrease in the discount rate assumption would decrease/increase annual pension expense by approximately $##D .

Employee Benefit Plans (Details

Employee Benefit Plans (Details 1) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2016	Dec. 31, 2015	Dec. 31, 2014
Employee Benefit Plans Disclosure [Abstract]
Service Cost	$ 0	$ 0	$ 0
Interest Cost	632	711	893
Expected Return on Plan Assets	(683)	(668)	(649)
Net Amortization Loss	304	306	259
Curtailment Gain	0	0	0
Net Periodic Benefit Cost, Total	253	349	503
Defined Benefit Plan, Change in Benefit Obligation [Roll Forward]
Defined Benefit Plan, Benefit Obligation	18,582	21,170
Service Cost for Defined Benefit Plan	0	0
Interest Cost	632	711	893
Defined Benefit Plan, Contributions by Plan Participants	0	0
Defined Benefit Plan, Actuarial Net (Gains) Losses	4,636	(1,360)
Defined Benefit Plan, Benefits Paid	(982)	(1,021)
Defined Benefit Plan, Foreign Currency Exchange Rate Changes, Benefit Obligation	(3,654)	(918)
Defined Benefit Plan, Benefit Obligation	19,214	18,582	21,170
Defined Benefit Plan, Change in Fair Value of Plan Assets [Roll Forward]
Defined Benefit Plan, Fair Value of Plan Assets	15,767	16,724
Defined Benefit Plan, Actual Return on Plan Assets	3,868	70
Defined Benefit Plan, Contributions by Plan Participants	0	0
Defined Benefit Plan Payments In Current Fiscal Year	694	752
Defined Benefit Plan, Benefits Paid	(982)	(1,021)
Defined Benefit Plan, Foreign Currency Exchange Rate Changes, Plan Assets	(3,095)	(758)
Defined Benefit Plan, Fair Value of Plan Assets	16,252	15,767	$ 16,724
Defined Benefit Plan, Funded Status of Plan [Abstract]
Defined Benefit Plan Funded Status Of Plan	(2,962)	(2,815)
Defined Benefit Plan, Amounts Recognized in Balance Sheet [Abstract]
Deferred Income Taxes On Pension Liabilities	504	535
Pension Defined Benefit Plans, Liabilities	(2,962)	(2,815)
Defined Benefit Plan, Amounts Recognized in Balance Sheet	(2,458)	(2,280)
Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent [Abstract]
Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent	$ (2,458)	$ (2,280)

Employee Benefit Plans (Detai85

Employee Benefit Plans (Details 2)	12 Months Ended
	Dec. 31, 2016	Dec. 31, 2015	Dec. 31, 2014
Defined Benefit Plan, Weighted Average Assumptions Used in Calculating Net Periodic Benefit Cost [Abstract]
Defined Benefit Plan, Assumptions Used Calculating Net Periodic Benefit Cost, Discount Rate	2.62%	3.57%	4.43%
Defined Benefit Plan, Assumptions Used Calculating Net Periodic Benefit Cost, Expected Long-term Return on Assets	4.68%	4.43%	4.15%
Defined Benefit Plan, Assumptions Used Calculating Net Periodic Benefit Cost, Rate of Compensation Increase	0.00%	0.00%	0.00%

Employee Benefit Plans (Detai86

Employee Benefit Plans (Details 3) - USD ($) $ in Thousands	Dec. 31, 2016	Dec. 31, 2015	Dec. 31, 2014
Defined Benefit Plan Disclosure [Line Items]
Defined Benefit Plan, Fair Value of Plan Assets	$ 16,252	$ 15,767	$ 16,724
Defined Benefit Plan, Actual Plan Asset Allocations	100.00%	100.00%
Fair Value, Inputs, Level 1 [Member]
Defined Benefit Plan Disclosure [Line Items]
Defined Benefit Plan, Fair Value of Plan Assets	$ 228	$ 158
Fair Value, Inputs, Level 2 [Member]
Defined Benefit Plan Disclosure [Line Items]
Defined Benefit Plan, Fair Value of Plan Assets	16,024	15,609
Fair Value, Inputs, Level 3 [Member]
Defined Benefit Plan Disclosure [Line Items]
Defined Benefit Plan, Fair Value of Plan Assets	0	0
Equity Securities [Member]
Defined Benefit Plan Disclosure [Line Items]
Defined Benefit Plan, Fair Value of Plan Assets	$ 8,577	$ 8,506
Defined Benefit Plan, Actual Plan Asset Allocations	53.00%	54.00%
Debt Securities [Member]
Defined Benefit Plan Disclosure [Line Items]
Defined Benefit Plan, Fair Value of Plan Assets	$ 7,447	$ 7,103
Defined Benefit Plan, Actual Plan Asset Allocations	46.00%	45.00%
Cash and Cash Equivalents [Member]
Defined Benefit Plan Disclosure [Line Items]
Defined Benefit Plan, Fair Value of Plan Assets	$ 228	$ 158
Defined Benefit Plan, Actual Plan Asset Allocations	1.00%	1.00%
Other Assets [Member]
Defined Benefit Plan Disclosure [Line Items]
Defined Benefit Plan, Fair Value of Plan Assets	$ 0	$ 0
Defined Benefit Plan, Actual Plan Asset Allocations	0.00%	0.00%

Employee Benefit Plans (Detai87

Employee Benefit Plans (Details 4) - USD ($) $ in Thousands	Dec. 31, 2016	Dec. 31, 2015
Defined Benefit Plan Disclosure [Line Items]
Defined Benefit Plan, Fair Value of Plan Assets	$ 15,767	$ 16,724
Defined Benefit Plan, Fair Value of Plan Assets	16,252	15,767
Fair Value, Inputs, Level 3 [Member]
Defined Benefit Plan Disclosure [Line Items]
Defined Benefit Plan, Fair Value of Plan Assets	0
Defined Benefit Plan, Fair Value of Plan Assets	$ 0	$ 0

Capital Stock (Narratives) (Det

Capital Stock (Narratives) (Details) - USD ($)	Apr. 28, 2015	Dec. 31, 2016	Dec. 31, 2015	Dec. 31, 2014	Dec. 31, 2016	Apr. 03, 2015
Share-Based Compensation Arrangement By Share-Based Payment Award [Line Items]
Share-based Compensation Arrangement by Share-based Payment Award, Discount from Market Price, Offering Date		85.00%
Employee Stock Purchase Plan Shares Authorized		750,000			750,000
Stock issued during the year, Shares, Employee Stock Purchase Plans		81,228	58,823	57,848	725,239
Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Authorized						17,508,929
Increase In Number Of Shares Authorized For Issuance Under Stock Option And Incentive Plan						2,500,000
Equity Instruments Other than Options, Grants in Period		1,095,190	254,685	116,400
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount		5,351,621	5,521,283	2,526,641
Percentage Of Outstanding Common Stock		20.00%			20.00%
Incentive Stock Options Granted To Date		10,218,057	10,218,057		10,218,057
Non Qualified Stock Options Granted To Date		13,131,374	13,088,374	12,143,374	13,131,374
Common Stock Market Value Per Share On Reporting Date		$ 3.05			$ 3.05
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Total Intrinsic Value		$ 100,000	$ 800,000	$ 1,800,000
In The Money Stock Options Exercisable At The Reporting Date		914,492			914,492
Employee Service Share-based Compensation, Nonvested Awards, Total Compensation Cost Not yet Recognized		$ 3,800,000			$ 3,800,000
Employee Service Share-based Compensation, Nonvested Awards, Total Compensation Cost Not yet Recognized, Period for Recognition		2 years 1 month 25 days
Annualized Estimated Forfeiture Rate		8.41%	8.06%	7.05%
Weighted Average Estimated Black Scholes Value Of Option Grants		$ 1.21	$ 2.12	$ 2.18
Preferred Stock - Shares Authorized		5,000,000	5,000,000		5,000,000
Stock Issued During Period, Value, Restricted Stock Award, Gross	$ 80,000
Accelerated Share Based Compensation Expense	$ 100,000
Market Condition Restricted Stock Unit [Member]
Share-Based Compensation Arrangement By Share-Based Payment Award [Line Items]
Equity Instruments Other than Options, Grants in Period		0	196,785	0

Capital Stock (Details 1)

Capital Stock (Details 1) - $ / shares	12 Months Ended
	Dec. 31, 2016	Dec. 31, 2015	Dec. 31, 2014	Apr. 03, 2015
Share-Based Compensation Arrangement By Share-Based Payment Award [Line Items]
Opening Balance Stock Options Outstanding	5,022,186	6,263,112	6,690,845
Begining Balance Weighted Average Exercise Price	$ 3.85	$ 3.42	$ 3.42
Increase In Number Of Shares Authorized For Issuance Under Stock Option And Incentive Plan				2,500,000
Options, Grants in Period, Gross	43,000	945,000	1,115,300
Options, Grants in Period, Weighted Average Grant Date Fair Value	$ 3.1	$ 5.31	$ 4.18
Stock option exercises during the year, Shares	(375,000)	(1,772,000)	(695,000)
Options, Forfeitures and Expirations in Period	(593,596)	(413,864)	(847,860)
Options, Forfeitures and Expirations in Period, Weighted Average Exercise Price	$ 3.84	$ 4.15	$ 4.67
Closing Balance Stock Options Outstanding	4,096,818	5,022,186	6,263,112
Closing Balance Weighted Average Exercise Price	$ 3.94	$ 3.85	$ 3.42
Begining Balance Restricted Stock Units Outstanding	313,559	306,397	463,973
Equity Instruments Other than Options, Grants in Period	1,095,190	254,685	116,400
Equity Instruments Other than Options, Vested in Period	(301,520)	(237,188)	(233,098)
Closing Balance Restricted Stock Units Outstanding	1,072,653	313,559	306,397
Begining Balance Grant Date Fair Value Of Restricted Stock Units	$ 5.29	$ 4.3	$ 4.32
Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value	2.92	5.56	4.12
Closing Balance Grant Date Fair Value Of Restricted Stock Units	$ 3.15	$ 5.29	$ 4.3
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions and Methodology [Abstract]
Fair Value Assumptions, Expected Volatility Rate	41.97%	40.97%	55.78%
Fair Value Assumptions, Risk Free Interest Rate	1.29%	1.72%	1.80%
Fair Value Assumptions, Expected Term	5 years 3 months 16 days	5 years 6 months	5 years 9 months 3 days
Fair Value Assumptions, Expected Dividend Rate	0.00%	0.00%	0.00%
Options, Exercises in Period, Weighted Average Exercise Price	$ 2.8	$ 3.04	$ 3.08
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeited in Period, Weighted Average Grant Date Fair Value	$ 3.89	$ 5.56	$ 4.36
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeited in Period	(34,576)	(10,335)	(40,878)
Preferred Stock - Shares Authorized	5,000,000	5,000,000
Market Condition Restricted Stock Unit [Member]
Share-Based Compensation Arrangement By Share-Based Payment Award [Line Items]
Begining Balance Restricted Stock Units Outstanding	185,538	0	0
Equity Instruments Other than Options, Grants in Period	0	196,785	0
Equity Instruments Other than Options, Vested in Period	0	0	0
Closing Balance Restricted Stock Units Outstanding	182,150	185,538	0
Begining Balance Grant Date Fair Value Of Restricted Stock Units	$ 4.81	$ 0	$ 0
Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value	0	4.81	0
Closing Balance Grant Date Fair Value Of Restricted Stock Units	4.81	$ 4.81	0
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions and Methodology [Abstract]
Fair Value Assumptions, Expected Volatility Rate		35.88%
Fair Value Assumptions, Risk Free Interest Rate		0.99%
Fair Value Assumptions, Expected Dividend Rate		0.00%
Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Correlation Coefficient		0.25%
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeited in Period, Weighted Average Grant Date Fair Value	$ 4.81	$ 4.81	$ 0
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeited in Period	(3,388)	(11,247)	0

Capital Stock (Details 2)

Capital Stock (Details 2) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2016	Dec. 31, 2015	Dec. 31, 2014
Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items]
Share-based Compensation	$ 3,497	$ 2,755	$ 2,156
Weighted Average Number Diluted Shares Outstanding Adjustment [Abstract]
Basic	34,211,521	33,592,775	32,170,683
Weighted Average Number Diluted Shares Outstanding Adjustment	0	0	1,065,886
Diluted	34,211,521	33,592,775	33,236,569
Cost of Sales [Member]
Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items]
Share-based Compensation	$ 60	$ 70	$ 132
Research and Development Expense [Member]
Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items]
Share-based Compensation	111	97	61
Selling and Marketing Expense [Member]
Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items]
Share-based Compensation	546	418	343
General and Administrative Expense [Member]
Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items]
Share-based Compensation	$ 2,780	$ 2,170	$ 1,620

Capital Stock (Details 3)

Capital Stock (Details 3) - USD ($)	12 Months Ended
	Dec. 31, 2016	Dec. 31, 2015	Dec. 31, 2014	Dec. 31, 2013
Share-Based Compensation Arrangement By Share-Based Payment Award [Line Items]
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number	4,096,818	5,022,186	6,263,112	6,690,845
Two Dollars Two Cents To Two Dollars Forty Two Cents [Member]
Share-Based Compensation Arrangement By Share-Based Payment Award [Line Items]
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number	462,464
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term	2 years 2 months 16 days
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price	$ 2.21
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value	$ 388,000
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number	462,464
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Remaining Contractual Term	2 years 2 months 16 days
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price	$ 2.21
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value	$ 388,000
Two Dollars Forty Three Cents to Two Dollars Seventy Two Cents [Member]
Share-Based Compensation Arrangement By Share-Based Payment Award [Line Items]
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number	436,028
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term	4 years 8 months 6 days
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price	$ 2.57
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value	$ 209,000
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number	436,028
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Remaining Contractual Term	4 years 8 months 6 days
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price	$ 2.57
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value	$ 209,000
Two Dollars Seventy Three Cents to Three Dollars Sixty Eight Cents [Member]
Share-Based Compensation Arrangement By Share-Based Payment Award [Line Items]
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number	511,706
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term	6 years 2 months 4 days
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price	$ 3.5
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value	$ 0
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number	344,052
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Remaining Contractual Term	5 years 4 months 29 days
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price	$ 3.59
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value	$ 0
Three Dollars Sixty Nine Cents To Four Dollars Seven Cents [Member]
Share-Based Compensation Arrangement By Share-Based Payment Award [Line Items]
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number	411,070
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term	3 years 9 months 29 days
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price	$ 3.97
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value	$ 0
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number	393,570
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Remaining Contractual Term	3 years 7 months 11 days
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price	$ 3.98
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value	$ 0
Four Dollars Eight Cents to Four Dollars Seventeen Cents [Member]
Share-Based Compensation Arrangement By Share-Based Payment Award [Line Items]
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number	653,875
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term	7 years 5 months 27 days
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price	$ 4.12
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value	$ 0
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number	321,875
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Remaining Contractual Term	7 years 5 months 27 days
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price	$ 4.12
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value	$ 0
Four Dollars Eighteen Cents To Four Dollars Twenty Six Cents[Member]
Share-Based Compensation Arrangement By Share-Based Payment Award [Line Items]
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number	71,500
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term	7 years 8 months 23 days
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price	$ 4.21
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value	$ 0
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number	37,625
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Remaining Contractual Term	7 years 8 months 8 days
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price	$ 4.21
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value	$ 0
Four Dollars Twenty Seven Cents To Four Dollars Forty One Cents [Member]
Share-Based Compensation Arrangement By Share-Based Payment Award [Line Items]
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number	750,000
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term	6 years 11 months 16 days
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price	$ 4.31
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value	$ 0
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number	687,500
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Remaining Contractual Term	6 years 11 months 16 days
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price	$ 4.31
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value	$ 0
Four Dollars Forty Two Cents To Five Dollars Thirty Nine Cents [Member]
Share-Based Compensation Arrangement By Share-Based Payment Award [Line Items]
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number	161,800
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term	7 years 11 months 29 days
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price	$ 4.97
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value	$ 0
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number	79,117
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Remaining Contractual Term	7 years 11 months 7 days
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price	$ 4.92
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value	$ 0
Five Dollars Forty Cents To Five Dollars Fifty One Cents[Member]
Share-Based Compensation Arrangement By Share-Based Payment Award [Line Items]
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number	353,375
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term	8 years 3 months 4 days
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price	$ 5.51
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value	$ 0
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number	89,750
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Remaining Contractual Term	8 years 3 months 4 days
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price	$ 5.51
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value	$ 0
Five Dollars Fifty Two Cents To Five Dollars Sixty Three Cents [Member]
Share-Based Compensation Arrangement By Share-Based Payment Award [Line Items]
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number	285,000
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term	8 years 5 months 27 days
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price	$ 5.56
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value	$ 0
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number	71,250
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Remaining Contractual Term	8 years 5 months 27 days
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price	$ 5.56
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value	$ 0
Two Dollars Two Cents To Five Dollars Sixty Three Cents [Member]
Share-Based Compensation Arrangement By Share-Based Payment Award [Line Items]
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number	4,096,818
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term	6 years 1 month 17 days
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price	$ 3.94
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value	$ 597,000
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number	2,923,231
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Remaining Contractual Term	5 years 4 months 29 days
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price	$ 3.65
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value	$ 597,000

Related Party Transactions (Nar

Related Party Transactions (Narratives) (Details) - USD ($)	12 Months Ended
	Dec. 31, 2016	Dec. 31, 2015	Dec. 31, 2014
Business Acquisition [Line Items]
Operating Leases, Rent Expense, Net	$ 1,800,000	$ 2,100,000	$ 1,700,000
Multi Channel Systems MCS GmbH [Member]
Business Acquisition [Line Items]
Operating Leases, Rent Expense, Net	200,000	200,000	62,000
Triangle BioSystems, Inc. [Member]
Business Acquisition [Line Items]
Operating Leases, Rent Expense, Net	$ 42,000	$ 42,000	$ 11,000

Segment and Related Informati93

Segment and Related Information (Narratives) (Details) - USD ($) $ in Thousands	3 Months Ended								12 Months Ended
	Dec. 31, 2016	Sep. 30, 2016	Jun. 30, 2016	Mar. 31, 2016	Dec. 31, 2015	Sep. 30, 2015	Jun. 30, 2015	Mar. 31, 2015	Dec. 31, 2016	Dec. 31, 2015	Dec. 31, 2014
Segment and Related Information Disclosure [Abstract]
Revenues	$ 26,415	$ 25,007	$ 26,136	$ 26,963	$ 28,370	$ 25,731	$ 28,800	$ 25,763	$ 104,521	$ 108,664	$ 108,663

Segment and Related Informati94

Segment and Related Information (Details 1) - USD ($) $ in Thousands	3 Months Ended								12 Months Ended
	Dec. 31, 2016	Sep. 30, 2016	Jun. 30, 2016	Mar. 31, 2016	Dec. 31, 2015	Sep. 30, 2015	Jun. 30, 2015	Mar. 31, 2015	Dec. 31, 2016	Dec. 31, 2015	Dec. 31, 2014
Segment Reporting Information [Line Items]
Revenues	$ 26,415	$ 25,007	$ 26,136	$ 26,963	$ 28,370	$ 25,731	$ 28,800	$ 25,763	$ 104,521	$ 108,664	$ 108,663
Net Assets	72,196				77,598				72,196	77,598
Long-lived assets, net	21,767				26,774				21,767	26,774
Segment, Geographical, United States [Member]
Segment Reporting Information [Line Items]
Revenues									65,179	64,766	63,727
Net Assets	25,736				22,312				25,736	22,312
Long-lived assets, net	12,004				13,610				12,004	13,610
Segment, Geographical, Germany [Member]
Segment Reporting Information [Line Items]
Revenues									13,477	15,755	8,240
Net Assets	15,026				18,512				15,026	18,512
Long-lived assets, net	5,504				7,817				5,504	7,817
Segment, Geographical, United Kingdom [Member]
Segment Reporting Information [Line Items]
Revenues									16,421	18,051	24,754
Net Assets	16,083				17,908				16,083	17,908
Long-lived assets, net	918				1,440				918	1,440
Rest Of The World [Member]
Segment Reporting Information [Line Items]
Revenues									9,444	10,092	11,942
Net Assets	15,351				18,866				15,351	18,866
Long-lived assets, net	3,341				3,907				3,341	3,907
Total [Member]
Segment Reporting Information [Line Items]
Revenues									104,521	108,664	$ 108,663
Net Assets	72,196				77,598				72,196	77,598
Long-lived assets, net	$ 21,767				$ 26,774				$ 21,767	$ 26,774

Allowance for doubtful debts (D

Allowance for doubtful debts (Details 1) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2016	Dec. 31, 2015	Dec. 31, 2014
Movement in Valuation Allowances and Reserves Roll Forward [Abstract]
Beginning Balance	$ 310	$ 328	$ 358
Charged To Bad Debt Expense	309	(4)	(67)
Charged To Allowance	11	4	56
Valuation Allowances And Reserves Currency Translation	(19)	(18)	(19)
Ending Balance	$ 611	$ 310	$ 328

Warranties (Details 1)

Warranties (Details 1) - USD ($)	12 Months Ended
	Dec. 31, 2016	Dec. 31, 2015	Dec. 31, 2014
Product Warranty Disclosure [Abstract]
Warranty, Beginning Balance	$ 147,000	$ 252,000	$ 305,000
Warranty payments	(97,000)	(81,000)	(102,000)
Warranty additions	143,000	(24,000)	49,000
Warranty, Ending Balance	$ 193,000	$ 147,000	$ 252,000

Quarterly Financial Informati97

Quarterly Financial Information (unaudited) (Details 1) - USD ($) $ / shares in Units, $ in Thousands	3 Months Ended								12 Months Ended
	Dec. 31, 2016	Sep. 30, 2016	Jun. 30, 2016	Mar. 31, 2016	Dec. 31, 2015	Sep. 30, 2015	Jun. 30, 2015	Mar. 31, 2015	Dec. 31, 2016	Dec. 31, 2015	Dec. 31, 2014
Quarterly Financial Information Disclosure [Abstract]
Revenues	$ 26,415	$ 25,007	$ 26,136	$ 26,963	$ 28,370	$ 25,731	$ 28,800	$ 25,763	$ 104,521	$ 108,664	$ 108,663
Cost of revenues (exclusive of items shown separately below)	14,310	13,317	14,461	14,018	15,446	14,005	16,205	14,285	56,106	59,941	59,319
Gross profit	12,105	11,690	11,675	12,945	12,924	11,726	12,595	11,478	48,415	48,723	49,344
Total operating expenses	13,228	12,503	12,515	13,166	12,811	12,501	12,496	12,628	51,412	50,436	42,726
Operating income	(1,123)	(813)	(840)	(221)	113	(775)	99	(1,150)	(2,997)	(1,713)	6,618
Other expense, net	135	(67)	73	(222)	(434)	(321)	(526)	(614)	(81)	(1,895)	(2,201)
(Loss) income before income taxes	(988)	(880)	(767)	(443)	(321)	(1,096)	(427)	(1,764)	(3,078)	(3,608)	4,417
Total Income Tax Expense	332	758	(54)	193	16,819	(249)	(776)	(363)	1,229	15,431	2,062
Net income (loss)	$ (1,320)	$ (1,638)	$ (713)	$ (636)	$ (17,140)	$ (847)	$ 349	$ (1,401)	$ (4,307)	$ (19,039)	$ 2,355
Earnings (loss) per share:
Basic earnings per common share	$ (0.04)	$ (0.05)	$ (0.02)	$ (0.02)	$ (0.51)	$ (0.02)	$ 0.01	$ (0.04)	$ (0.13)	$ (0.57)	$ 0.07
Diluted Earnings Per Common Share	$ (0.04)	$ (0.05)	$ (0.02)	$ (0.02)	$ (0.51)	$ (0.02)	$ 0.01	$ (0.04)	$ (0.13)	$ (0.57)	$ 0.07